{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "41d72f2a",
   "metadata": {},
   "source": [
    "Preprocessing:\n",
    "Matching different names\n",
    "\n",
    "1st process\n",
    "Removing a small number of tests\n",
    "\n",
    "Creating combinations of different tests up to 10 degrees\n",
    "\n",
    "2nd process:\n",
    "Removing blank dates\n",
    "\n",
    "Find those who have multiple tests at different times"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6da69a73",
   "metadata": {},
   "source": [
    "### IMPORTING THE NECESSERY LIBRRRARIES AND LOADING THE DATASET"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "40d64bb5",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\akar\\AppData\\Local\\Temp\\ipykernel_25908\\2148817335.py:6: DtypeWarning: Columns (16) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  df = pd.read_csv('combined_lab_testsV5.csv')\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Date of Birth</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>Date of Sample\\r\\n</th>\n",
       "      <th>Lab</th>\n",
       "      <th>Discritization</th>\n",
       "      <th>Test</th>\n",
       "      <th>Age</th>\n",
       "      <th>Age Disag</th>\n",
       "      <th>Unnamed: 14</th>\n",
       "      <th>Unnamed: 15</th>\n",
       "      <th>Unnamed: 16</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>26699</td>\n",
       "      <td>Fatma Ali Muhamad</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/09/1923</td>\n",
       "      <td>S.Iron</td>\n",
       "      <td>Âµg/dl</td>\n",
       "      <td>Iron Profile</td>\n",
       "      <td>26.4</td>\n",
       "      <td>04/09/2024</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>Low</td>\n",
       "      <td>S.Iron-Low</td>\n",
       "      <td>100</td>\n",
       "      <td>Senior</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>26699</td>\n",
       "      <td>Fatma Ali Muhamad</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/09/1923</td>\n",
       "      <td>CRP Titer</td>\n",
       "      <td>mg/l</td>\n",
       "      <td>Biochemical Test</td>\n",
       "      <td>67.61</td>\n",
       "      <td>04/09/2024</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>Severe Elevation</td>\n",
       "      <td>CRP Titer-Severe Elevation</td>\n",
       "      <td>100</td>\n",
       "      <td>Senior</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7945</td>\n",
       "      <td>Kafya Zorab Mahmod</td>\n",
       "      <td>Female</td>\n",
       "      <td>02/09/1925</td>\n",
       "      <td>Troponin T hs Stat</td>\n",
       "      <td>pg/ml</td>\n",
       "      <td>Cardiac Markers</td>\n",
       "      <td>37.56</td>\n",
       "      <td>02/09/2023</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>High</td>\n",
       "      <td>Troponin T hs Stat-High</td>\n",
       "      <td>98</td>\n",
       "      <td>Senior</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>37445</td>\n",
       "      <td>Manij sharif karim</td>\n",
       "      <td>Female</td>\n",
       "      <td>11/03/1925</td>\n",
       "      <td>Troponin T hs Stat</td>\n",
       "      <td>pg/ml</td>\n",
       "      <td>Cardiac Markers</td>\n",
       "      <td>32.8</td>\n",
       "      <td>11/03/2025</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>High</td>\n",
       "      <td>Troponin T hs Stat-High</td>\n",
       "      <td>98</td>\n",
       "      <td>Senior</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>24500</td>\n",
       "      <td>qadry abdulqadr hamaamin</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/12/1927</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>108</td>\n",
       "      <td>04/12/2024</td>\n",
       "      <td>Hawkari Halabja</td>\n",
       "      <td>Prediabetes</td>\n",
       "      <td>Blood Sugar-Prediabetes</td>\n",
       "      <td>96</td>\n",
       "      <td>Senior</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patient Name</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender Date of Birth  \\\n",
       "0      26699         Fatma Ali Muhamad  Female    04/09/1923   \n",
       "1      26699         Fatma Ali Muhamad  Female    04/09/1923   \n",
       "2       7945        Kafya Zorab Mahmod  Female    02/09/1925   \n",
       "3      37445        Manij sharif karim  Female    11/03/1925   \n",
       "4      24500  qadry abdulqadr hamaamin  Female    04/12/1927   \n",
       "\n",
       "            Test Name    Unit          Category Result Date of Sample\\r\\n  \\\n",
       "0              S.Iron  Âµg/dl      Iron Profile   26.4         04/09/2024   \n",
       "1           CRP Titer    mg/l  Biochemical Test  67.61         04/09/2024   \n",
       "2  Troponin T hs Stat   pg/ml   Cardiac Markers  37.56         02/09/2023   \n",
       "3  Troponin T hs Stat   pg/ml   Cardiac Markers   32.8         11/03/2025   \n",
       "4         Blood Sugar   mg/dl     Diabetes Test    108         04/12/2024   \n",
       "\n",
       "               Lab    Discritization                        Test  Age  \\\n",
       "0   Biolab Halabja               Low                  S.Iron-Low  100   \n",
       "1   Biolab Halabja  Severe Elevation  CRP Titer-Severe Elevation  100   \n",
       "2   Biolab Halabja              High     Troponin T hs Stat-High   98   \n",
       "3   Biolab Halabja              High     Troponin T hs Stat-High   98   \n",
       "4  Hawkari Halabja       Prediabetes     Blood Sugar-Prediabetes   96   \n",
       "\n",
       "  Age Disag  Unnamed: 14  Unnamed: 15   Unnamed: 16  \n",
       "0    Senior          NaN          NaN           NaN  \n",
       "1    Senior          NaN          NaN           NaN  \n",
       "2    Senior          NaN          NaN           NaN  \n",
       "3    Senior          NaN          NaN           NaN  \n",
       "4    Senior          NaN          NaN  Patient Name  "
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "df = pd.read_csv('combined_lab_testsV5.csv')\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "9d1792e5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Date of Birth</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>Date of Sample\\r\\n</th>\n",
       "      <th>Lab</th>\n",
       "      <th>Discritization</th>\n",
       "      <th>Test</th>\n",
       "      <th>Age</th>\n",
       "      <th>Age Disag</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>26699</td>\n",
       "      <td>Fatma Ali Muhamad</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/09/1923</td>\n",
       "      <td>S.Iron</td>\n",
       "      <td>Âµg/dl</td>\n",
       "      <td>Iron Profile</td>\n",
       "      <td>26.4</td>\n",
       "      <td>04/09/2024</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>Low</td>\n",
       "      <td>S.Iron-Low</td>\n",
       "      <td>100</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>26699</td>\n",
       "      <td>Fatma Ali Muhamad</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/09/1923</td>\n",
       "      <td>CRP Titer</td>\n",
       "      <td>mg/l</td>\n",
       "      <td>Biochemical Test</td>\n",
       "      <td>67.61</td>\n",
       "      <td>04/09/2024</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>Severe Elevation</td>\n",
       "      <td>CRP Titer-Severe Elevation</td>\n",
       "      <td>100</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7945</td>\n",
       "      <td>Kafya Zorab Mahmod</td>\n",
       "      <td>Female</td>\n",
       "      <td>02/09/1925</td>\n",
       "      <td>Troponin T hs Stat</td>\n",
       "      <td>pg/ml</td>\n",
       "      <td>Cardiac Markers</td>\n",
       "      <td>37.56</td>\n",
       "      <td>02/09/2023</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>High</td>\n",
       "      <td>Troponin T hs Stat-High</td>\n",
       "      <td>98</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>37445</td>\n",
       "      <td>Manij sharif karim</td>\n",
       "      <td>Female</td>\n",
       "      <td>11/03/1925</td>\n",
       "      <td>Troponin T hs Stat</td>\n",
       "      <td>pg/ml</td>\n",
       "      <td>Cardiac Markers</td>\n",
       "      <td>32.8</td>\n",
       "      <td>11/03/2025</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>High</td>\n",
       "      <td>Troponin T hs Stat-High</td>\n",
       "      <td>98</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>24500</td>\n",
       "      <td>qadry abdulqadr hamaamin</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/12/1927</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>108</td>\n",
       "      <td>04/12/2024</td>\n",
       "      <td>Hawkari Halabja</td>\n",
       "      <td>Prediabetes</td>\n",
       "      <td>Blood Sugar-Prediabetes</td>\n",
       "      <td>96</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender Date of Birth  \\\n",
       "0      26699         Fatma Ali Muhamad  Female    04/09/1923   \n",
       "1      26699         Fatma Ali Muhamad  Female    04/09/1923   \n",
       "2       7945        Kafya Zorab Mahmod  Female    02/09/1925   \n",
       "3      37445        Manij sharif karim  Female    11/03/1925   \n",
       "4      24500  qadry abdulqadr hamaamin  Female    04/12/1927   \n",
       "\n",
       "            Test Name    Unit          Category Result Date of Sample\\r\\n  \\\n",
       "0              S.Iron  Âµg/dl      Iron Profile   26.4         04/09/2024   \n",
       "1           CRP Titer    mg/l  Biochemical Test  67.61         04/09/2024   \n",
       "2  Troponin T hs Stat   pg/ml   Cardiac Markers  37.56         02/09/2023   \n",
       "3  Troponin T hs Stat   pg/ml   Cardiac Markers   32.8         11/03/2025   \n",
       "4         Blood Sugar   mg/dl     Diabetes Test    108         04/12/2024   \n",
       "\n",
       "               Lab    Discritization                        Test  Age  \\\n",
       "0   Biolab Halabja               Low                  S.Iron-Low  100   \n",
       "1   Biolab Halabja  Severe Elevation  CRP Titer-Severe Elevation  100   \n",
       "2   Biolab Halabja              High     Troponin T hs Stat-High   98   \n",
       "3   Biolab Halabja              High     Troponin T hs Stat-High   98   \n",
       "4  Hawkari Halabja       Prediabetes     Blood Sugar-Prediabetes   96   \n",
       "\n",
       "  Age Disag  \n",
       "0    Senior  \n",
       "1    Senior  \n",
       "2    Senior  \n",
       "3    Senior  \n",
       "4    Senior  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.drop(columns=['Unnamed: 14', 'Unnamed: 15', 'Unnamed: 16'], inplace=True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "376983da",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Rename columns for consistency\n",
    "df = df.rename(columns={\n",
    "    'Date of Birth': 'DOB',\n",
    "    'Date of Sample\\r\\n': 'DOS'\n",
    "})\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b7082628",
   "metadata": {},
   "source": [
    "#### CHECKING IF THE DOB AND DOS ARE RELIABLE"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "4b6f45ad",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Count of the first number (aka. the day) in the all dates of `Date of Birth` to be bigger than 12: 0\n",
      "Count of the second number (aka. the month) in the all dates of `Date of Birth` to be bigger than 12: 0\n",
      "Count of the first number (aka. the day) in the all dates of `Date of Sample` to be bigger than 12: 53531\n",
      "Count of the second number (aka. the month) in the all dates of `Date of Sample` to be bigger than 12: 0\n"
     ]
    }
   ],
   "source": [
    "# CHECKING IF THE DOB IS RELIABLE\n",
    "print(f\"Count of the first number (aka. the day) in the all dates of `Date of Birth` to be bigger than 12: {sum(1 for dob in df['DOB'] if int(dob.split('/')[0]) > 12)}\")\n",
    "print(f\"Count of the second number (aka. the month) in the all dates of `Date of Birth` to be bigger than 12: {sum(1 for dob in df['DOB'] if int(dob.split('/')[1]) > 12)}\")\n",
    "print(f\"Count of the first number (aka. the day) in the all dates of `Date of Sample` to be bigger than 12: {sum(1 for dob in df['DOS'] if type(dob) == str and int(dob.split('/')[0]) > 12)}\")\n",
    "print(f\"Count of the second number (aka. the month) in the all dates of `Date of Sample` to be bigger than 12: {sum(1 for dob in df['DOS'] if type(dob) == str and int(dob.split('/')[1]) > 12)}\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7207d0c4",
   "metadata": {},
   "source": [
    "##### DOB IN THE DATA SET IS NOT ACCURATE\n",
    "We get into the conclusion that the DOB is not accurate since we don't have any date with having a day bigger than 12.\n",
    "##### DOS has no similer issue\n",
    "On The other hand we don't have the same issue with DOS and the first number is corresponding to day of the date."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "id": "ca18bc54",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Distribution of first and second number in Date Of Birth (DOB)\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "First position (day) counts: [89095, 5189, 4442, 4804, 4199, 4046, 3981, 4635, 4426, 3982, 4512, 3708]\n",
      "Second position (month) counts: [16174, 10018, 6454, 9137, 12543, 11559, 13631, 10668, 13018, 12925, 9791, 11101]\n"
     ]
    }
   ],
   "source": [
    "first_count = [0] * 12\n",
    "second_count = [0] * 12\n",
    "\n",
    "# Use list comprehension or built-in sum function directly\n",
    "for i in range(12):\n",
    "    first_count[i] = len([1 for dob in df['DOB'] if int(dob.split('/')[0]) == (i+1)])\n",
    "    second_count[i] = len([1 for dob in df['DOB'] if int(dob.split('/')[1]) == (i+1)])\n",
    "\n",
    "print(\"Distribution of first and second number in Date Of Birth (DOB)\")\n",
    "# Visualize the distribution of dates by position (day/month)\n",
    "fig, (ax1, ax2) = plt.subplots(1, 2, figsize=(15, 6))\n",
    "\n",
    "# Plot first position (day) distribution\n",
    "months = list(range(1, 13))\n",
    "ax1.bar(months, first_count, color='skyblue', alpha=0.7)\n",
    "ax1.set_xlabel('Day of Month')\n",
    "ax1.set_ylabel('Count')\n",
    "ax1.set_title('Distribution of First Number in DOB (Day)')\n",
    "ax1.set_xticks(months)\n",
    "ax1.grid(True, alpha=0.3)\n",
    "\n",
    "# Plot second position (month) distribution\n",
    "ax2.bar(months, second_count, color='lightcoral', alpha=0.7)\n",
    "ax2.set_xlabel('Month')\n",
    "ax2.set_ylabel('Count')\n",
    "ax2.set_title('Distribution of Second Number in DOB (Month)')\n",
    "ax2.set_xticks(months)\n",
    "ax2.grid(True, alpha=0.3)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Print the counts for verification\n",
    "print(\"First position (day) counts:\", first_count)\n",
    "print(\"Second position (month) counts:\", second_count)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "id": "b6c35f82",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Distribution of first and second number in Date Of Sample (DOS)\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "First position (day) counts: [2501, 2900, 2665, 2771, 2845, 2709, 2543, 2976, 2675, 2570, 2639, 2538, 2665, 2837, 2856, 2684, 2605, 2931, 2656, 2671, 2832, 2708, 2712, 2738, 2671, 2419, 2614, 2664, 2205, 2434, 1344]\n",
      "Second position (month) counts: [8848, 7233, 5481, 4791, 6236, 6334, 8222, 7119, 7018, 6766, 6297, 7233]\n"
     ]
    }
   ],
   "source": [
    "first_count = [0] * 31\n",
    "second_count = [0] * 12\n",
    "\n",
    "# Use list comprehension or built-in sum function directly\n",
    "for i in range(31):\n",
    "    first_count[i] = len([1 for dos in df['DOS'] if type(dos) == str and int(dos.split('/')[0]) == (i+1)])\n",
    "\n",
    "for i in range(12):\n",
    "    second_count[i] = len([1 for dos in df['DOS'] if type(dos) == str and int(dos.split('/')[1]) == (i+1)])\n",
    "\n",
    "print(\"Distribution of first and second number in Date Of Sample (DOS)\")\n",
    "# Visualize the distribution of dates by position (day/month)\n",
    "fig, (ax1, ax2) = plt.subplots(1, 2, figsize=(15, 6))\n",
    "\n",
    "# Plot first position (day) distribution\n",
    "days = list(range(1, 32))\n",
    "ax1.bar(days, first_count, color='skyblue', alpha=0.7)\n",
    "ax1.set_xlabel('Day of Month')\n",
    "ax1.set_ylabel('Count')\n",
    "ax1.set_title('Distribution of First Number in DOS (Day)')\n",
    "ax1.set_xticks(days)\n",
    "ax1.grid(True, alpha=0.3)\n",
    "\n",
    "# Plot second position (month) distribution\n",
    "ax2.bar(months, second_count, color='lightcoral', alpha=0.7)\n",
    "ax2.set_xlabel('Month')\n",
    "ax2.set_ylabel('Count')\n",
    "ax2.set_title('Distribution of Second Number in DOS (Month)')\n",
    "ax2.set_xticks(months)\n",
    "ax2.grid(True, alpha=0.3)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Print the counts for verification\n",
    "print(\"First position (day) counts:\", first_count)\n",
    "print(\"Second position (month) counts:\", second_count)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c33e4ccc",
   "metadata": {},
   "source": [
    "### Analysis of Date Distribution\n",
    "\n",
    "The visualization reveals significant issues with the Date of Birth (DOB) format in our dataset:\n",
    "\n",
    "#### DOB Distribution Issues:\n",
    "- **First number (day) distribution**: Shows an abnormal concentration of value \"1\" compared to other days, indicating incorrect date formatting\n",
    "- **The other days beyond 12 are converted to 1 in DOB**\n",
    "- **Second number (month) distribution**: Displays a more normal distribution pattern across months 1-12\n",
    "\n",
    "#### DOS Distribution Validation:\n",
    "- **Day distribution**: Shows relatively normal distribution across days 1-31, confirming proper date formatting\n",
    "- **Month distribution**: Exhibits expected seasonal variation patterns\n",
    "\n",
    "This analysis confirms that DOB uses an inconsistent date format (likely month/day/year instead of day/month/year), while DOS maintains the correct day/month/year format throughout the dataset."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c5081887",
   "metadata": {},
   "source": [
    "## PREPROCESSING: NAME MATCHING\n",
    "\n",
    "### Algorithm for finding similer names:\n",
    "- 1. Finding patient names that have more than 65% similarities.\n",
    "- 2. Checking if they have the same `LAB` and `DOB`.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "147d24dc",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "2e638afb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting fuzzywuzzy\n",
      "  Downloading fuzzywuzzy-0.18.0-py2.py3-none-any.whl.metadata (4.9 kB)\n",
      "Downloading fuzzywuzzy-0.18.0-py2.py3-none-any.whl (18 kB)\n",
      "Installing collected packages: fuzzywuzzy\n",
      "Successfully installed fuzzywuzzy-0.18.0\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n",
      "[notice] A new release of pip is available: 24.2 -> 25.2\n",
      "[notice] To update, run: python.exe -m pip install --upgrade pip\n"
     ]
    }
   ],
   "source": [
    "%pip install fuzzywuzzy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "94dbc1bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "d:\\Research\\mhmd_mawlawi\\health_data\\.venv\\Lib\\site-packages\\fuzzywuzzy\\fuzz.py:11: UserWarning: Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning\n",
      "  warnings.warn('Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning')\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 1947 groups of similar names\n",
      "\n",
      "First 10 groups:\n",
      "\n",
      "Group 1:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1940\n",
      "  Similar names (2): ['Waly Abdurahim Awrahim', 'Abdurahman Rashid']\n",
      "\n",
      "Group 2:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1945\n",
      "  Similar names (2): ['Fatma Mahmod Abas', 'Fatma Mahmood Abas']\n",
      "\n",
      "Group 3:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1950\n",
      "  Similar names (2): ['Shamsa Fatah', 'Hafsa Faraj']\n",
      "\n",
      "Group 4:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1950\n",
      "  Similar names (2): ['Suad Muhamad Ali', 'Rwba Mhamad Aziz']\n",
      "\n",
      "Group 5:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1953\n",
      "  Similar names (2): ['Fazil HamaAmin Rahman', 'Fazil Hama Amin']\n",
      "\n",
      "Group 6:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1958\n",
      "  Similar names (2): ['Kamal Othman Ahmed', 'Halima San Ahmad']\n",
      "\n",
      "Group 7:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1962\n",
      "  Similar names (2): ['Aftaw Mhamad', 'Aftaw Muhamad']\n",
      "\n",
      "Group 8:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1963\n",
      "  Similar names (2): ['Atya Muhamad', 'Aftaw Mhamad']\n",
      "\n",
      "Group 9:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1964\n",
      "  Similar names (2): ['Tuba Muhamad Salim', 'Madina Muhamad Abdulhakim']\n",
      "\n",
      "Group 10:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (3): ['Ali Mhamad Saed', 'Ali Muhammed saheed', 'Ali Muhamad Saed']\n"
     ]
    }
   ],
   "source": [
    "from fuzzywuzzy import fuzz\n",
    "from collections import defaultdict\n",
    "\n",
    "def find_similar_names(df, similarity_threshold=65):\n",
    "    \"\"\"\n",
    "    Find similar patient names using fuzzy matching\n",
    "    Returns groups of similar names that share the same LAB and DOB\n",
    "    \"\"\"\n",
    "    # Group by LAB and DOB first to reduce comparison space\n",
    "    grouped = df.groupby(['Lab', 'DOB'])\n",
    "    similar_groups = []\n",
    "    \n",
    "    for (lab, dob), group in grouped:\n",
    "        unique_names = group['Patient Name'].unique()\n",
    "        \n",
    "        if len(unique_names) > 1:\n",
    "            # Compare each pair of names within the same LAB and DOB\n",
    "            name_groups = defaultdict(list)\n",
    "            processed_names = set()\n",
    "            \n",
    "            for i, name1 in enumerate(unique_names):\n",
    "                if name1 in processed_names:\n",
    "                    continue\n",
    "                    \n",
    "                current_group = [name1]\n",
    "                processed_names.add(name1)\n",
    "                \n",
    "                for name2 in unique_names[i+1:]:\n",
    "                    if name2 not in processed_names:\n",
    "                        similarity = fuzz.ratio(name1.lower(), name2.lower())\n",
    "                        if similarity >= similarity_threshold:\n",
    "                            current_group.append(name2)\n",
    "                            processed_names.add(name2)\n",
    "                \n",
    "                if len(current_group) > 1:\n",
    "                    similar_groups.append({\n",
    "                        'lab': lab,\n",
    "                        'dob': dob,\n",
    "                        'similar_names': current_group,\n",
    "                        'count': len(current_group)\n",
    "                    })\n",
    "    \n",
    "    return similar_groups\n",
    "\n",
    "# Find similar names\n",
    "similar_name_groups = find_similar_names(df)\n",
    "\n",
    "print(f\"Found {len(similar_name_groups)} groups of similar names\")\n",
    "print(\"\\nFirst 10 groups:\")\n",
    "for i, group in enumerate(similar_name_groups[:10]):\n",
    "    print(f\"\\nGroup {i+1}:\")\n",
    "    print(f\"  Lab: {group['lab']}\")\n",
    "    print(f\"  DOB: {group['dob']}\")\n",
    "    print(f\"  Similar names ({group['count']}): {group['similar_names']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "c9532743",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 307 groups of similar names\n",
      "\n",
      "First 10 groups:\n",
      "\n",
      "Group 1:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1945\n",
      "  Similar names (2): ['Fatma Mahmod Abas', 'Fatma Mahmood Abas']\n",
      "\n",
      "Group 2:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1962\n",
      "  Similar names (2): ['Aftaw Mhamad', 'Aftaw Muhamad']\n",
      "\n",
      "Group 3:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1963\n",
      "  Similar names (2): ['Atya Muhamad', 'Aftaw Mhamad']\n",
      "\n",
      "Group 4:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (3): ['Ali Mhamad Saed', 'Ali Muhammed saheed', 'Ali Muhamad Saed']\n",
      "\n",
      "Group 5:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (2): ['Nawzad Muhamad', 'Nawzad Mahamad']\n",
      "\n",
      "Group 6:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shno Najim Rashid', 'Shno Najim Rashed']\n",
      "\n",
      "Group 7:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shara Sdeq Hamid', 'Shara Sdiq Hamid']\n",
      "\n",
      "Group 8:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1995\n",
      "  Similar names (2): ['Ruaida Omar Mhamad', 'Trefa Omar Mhamad']\n",
      "\n",
      "Group 9:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1996\n",
      "  Similar names (2): ['Azhin Muhamad', 'Azhin Mhamad Ali']\n",
      "\n",
      "Group 10:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/2001\n",
      "  Similar names (2): ['Lawen Aswad Hasan', 'Lawen Aswad Hsan']\n"
     ]
    }
   ],
   "source": [
    "# Find similar names\n",
    "similar_name_groups = find_similar_names(df, 80)\n",
    "\n",
    "print(f\"Found {len(similar_name_groups)} groups of similar names\")\n",
    "print(\"\\nFirst 10 groups:\")\n",
    "for i, group in enumerate(similar_name_groups[:10]):\n",
    "    print(f\"\\nGroup {i+1}:\")\n",
    "    print(f\"  Lab: {group['lab']}\")\n",
    "    print(f\"  DOB: {group['dob']}\")\n",
    "    print(f\"  Similar names ({group['count']}): {group['similar_names']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "941eaa6f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 83 groups of similar names with threshold 95\n",
      "Found 155 groups of similar names with threshold 90\n",
      "Found 208 groups of similar names with threshold 85\n",
      "Found 307 groups of similar names with threshold 80\n",
      "Found 472 groups of similar names with threshold 75\n",
      "Found 960 groups of similar names with threshold 70\n",
      "Found 1947 groups of similar names with threshold 65\n",
      "Found 2973 groups of similar names with threshold 60\n"
     ]
    }
   ],
   "source": [
    "fine_tuning = [95,90,85, 80, 75, 70, 65, 60]\n",
    "\n",
    "for i in fine_tuning:\n",
    "    similar_name_groups = find_similar_names(df, i)\n",
    "    print(f\"Found {len(similar_name_groups)} groups of similar names with threshold {i}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9747fcd5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 208 groups of similar names\n",
      "\n",
      "First 20 groups:\n",
      "\n",
      "Group 1:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1945\n",
      "  Similar names (2): ['Fatma Mahmod Abas', 'Fatma Mahmood Abas']\n",
      "\n",
      "Group 2:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1962\n",
      "  Similar names (2): ['Aftaw Mhamad', 'Aftaw Muhamad']\n",
      "\n",
      "Group 3:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (2): ['Ali Mhamad Saed', 'Ali Muhamad Saed']\n",
      "\n",
      "Group 4:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (2): ['Nawzad Muhamad', 'Nawzad Mahamad']\n",
      "\n",
      "Group 5:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shno Najim Rashid', 'Shno Najim Rashed']\n",
      "\n",
      "Group 6:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shara Sdeq Hamid', 'Shara Sdiq Hamid']\n",
      "\n",
      "Group 7:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/2001\n",
      "  Similar names (2): ['Lawen Aswad Hasan', 'Lawen Aswad Hsan']\n",
      "\n",
      "Group 8:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/2023\n",
      "  Similar names (2): ['Ela Maewan Mahmood', 'Ela Mariwan Mahmod']\n",
      "\n",
      "Group 9:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/1968\n",
      "  Similar names (2): ['Akram Ahmad Qadr', 'Akram ahmed Qader']\n",
      "\n",
      "Group 10:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/1976\n",
      "  Similar names (2): ['Kazm Karim Qadr', 'Kazm Karem Qadr']\n",
      "\n",
      "Group 11:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/2023\n",
      "  Similar names (2): ['Marwa Kaewan Latef', 'Maawa Kaiwan Latef']\n",
      "\n",
      "Group 12:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/03/2002\n",
      "  Similar names (2): ['Lanya Osman Salh', 'Lanya Osman Ali']\n",
      "\n",
      "Group 13:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/03/2023\n",
      "  Similar names (2): ['Kawa kamaran', 'Kawa Kamaran']\n",
      "\n",
      "Group 14:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1930\n",
      "  Similar names (3): ['Mahmood Hsen Mhamad', 'Mahmud Hseen Mhammad', 'Mahmud Hsen Mhamad']\n",
      "\n",
      "Group 15:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1951\n",
      "  Similar names (2): ['Rwnak Hasan Hama Aziz', 'Rwnak Hasan Hamaziz']\n",
      "\n",
      "Group 16:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1951\n",
      "  Similar names (2): ['Tayar Abdulxalq Qadr', 'Taher Aabdulxalq Qadr']\n",
      "\n",
      "Group 17:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1952\n",
      "  Similar names (2): ['Xadija Abdurahman Rashid', 'Xadeja Abdurahman Rashed']\n",
      "\n",
      "Group 18:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1957\n",
      "  Similar names (2): ['Taiba Mahmud Maulud', 'Taiba Mahmud maulud']\n",
      "\n",
      "Group 19:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1960\n",
      "  Similar names (2): ['Amina Rashed Mhamad', 'Amina Rashid Muhamad']\n",
      "\n",
      "Group 20:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1967\n",
      "  Similar names (2): ['Rzgar Abdula Karem', 'Rzgar Abdulla Karim']\n"
     ]
    }
   ],
   "source": [
    "# Find similar names\n",
    "similar_name_groups = find_similar_names(df, 85)\n",
    "\n",
    "print(f\"Found {len(similar_name_groups)} groups of similar names\")\n",
    "print(\"\\nFirst 20 groups:\")\n",
    "for i, group in enumerate(similar_name_groups[:20]):\n",
    "    print(f\"\\nGroup {i+1}:\")\n",
    "    print(f\"  Lab: {group['lab']}\")\n",
    "    print(f\"  DOB: {group['dob']}\")\n",
    "    print(f\"  Similar names ({group['count']}): {group['similar_names']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "0b918856",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 164 groups of similar names with first name constraint\n",
      "\n",
      "First 20 groups:\n",
      "\n",
      "Group 1:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1945\n",
      "  Similar names (2): ['Fatma Mahmod Abas', 'Fatma Mahmood Abas']\n",
      "\n",
      "Group 2:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1962\n",
      "  Similar names (2): ['Aftaw Mhamad', 'Aftaw Muhamad']\n",
      "\n",
      "Group 3:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (2): ['Ali Mhamad Saed', 'Ali Muhamad Saed']\n",
      "\n",
      "Group 4:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (2): ['Nawzad Muhamad', 'Nawzad Mahamad']\n",
      "\n",
      "Group 5:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shno Najim Rashid', 'Shno Najim Rashed']\n",
      "\n",
      "Group 6:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shara Sdeq Hamid', 'Shara Sdiq Hamid']\n",
      "\n",
      "Group 7:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/2001\n",
      "  Similar names (2): ['Lawen Aswad Hasan', 'Lawen Aswad Hsan']\n",
      "\n",
      "Group 8:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/2023\n",
      "  Similar names (2): ['Ela Maewan Mahmood', 'Ela Mariwan Mahmod']\n",
      "\n",
      "Group 9:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/1968\n",
      "  Similar names (2): ['Akram Ahmad Qadr', 'Akram ahmed Qader']\n",
      "\n",
      "Group 10:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/1976\n",
      "  Similar names (2): ['Kazm Karim Qadr', 'Kazm Karem Qadr']\n",
      "\n",
      "Group 11:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/2023\n",
      "  Similar names (2): ['Marwa Kaewan Latef', 'Maawa Kaiwan Latef']\n",
      "\n",
      "Group 12:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/03/2002\n",
      "  Similar names (2): ['Lanya Osman Salh', 'Lanya Osman Ali']\n",
      "\n",
      "Group 13:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/03/2023\n",
      "  Similar names (2): ['Kawa kamaran', 'Kawa Kamaran']\n",
      "\n",
      "Group 14:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1930\n",
      "  Similar names (2): ['Mahmud Hseen Mhammad', 'Mahmud Hsen Mhamad']\n",
      "\n",
      "Group 15:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1951\n",
      "  Similar names (2): ['Rwnak Hasan Hama Aziz', 'Rwnak Hasan Hamaziz']\n",
      "\n",
      "Group 16:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1952\n",
      "  Similar names (2): ['Xadija Abdurahman Rashid', 'Xadeja Abdurahman Rashed']\n",
      "\n",
      "Group 17:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1957\n",
      "  Similar names (2): ['Taiba Mahmud Maulud', 'Taiba Mahmud maulud']\n",
      "\n",
      "Group 18:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1960\n",
      "  Similar names (2): ['Amina Rashed Mhamad', 'Amina Rashid Muhamad']\n",
      "\n",
      "Group 19:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1967\n",
      "  Similar names (2): ['Rzgar Abdula Karem', 'Rzgar Abdulla Karim']\n",
      "\n",
      "Group 20:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1970\n",
      "  Similar names (2): ['Ibrahim Hamaxan Mhamad', 'Ebrahim Hamaxan Mahmod']\n"
     ]
    }
   ],
   "source": [
    "# Lets optimize more, adding one more constraint\n",
    "# their first name should match exactly or mismatch only on one character.\n",
    "\n",
    "def find_similar_names_v2(df, similarity_threshold=65):\n",
    "    \"\"\"\n",
    "    Find similar patient names using fuzzy matching with first name constraint\n",
    "    Returns groups of similar names that share the same LAB, DOB, and have similar first names\n",
    "    \"\"\"\n",
    "    \n",
    "    def first_names_similar(name1, name2):\n",
    "        \"\"\"Check if first names match exactly or have only one character difference\"\"\"\n",
    "        first1 = name1.split()[0].lower()\n",
    "        first2 = name2.split()[0].lower()\n",
    "        \n",
    "        # Exact match\n",
    "        if first1 == first2:\n",
    "            return True\n",
    "        \n",
    "        # Check if only one character difference\n",
    "        if abs(len(first1) - len(first2)) > 1:\n",
    "            return False\n",
    "        \n",
    "        # Count character differences\n",
    "        differences = 0\n",
    "        min_len = min(len(first1), len(first2))\n",
    "        max_len = max(len(first1), len(first2))\n",
    "        \n",
    "\n",
    "        for i in range(min_len):\n",
    "            if first1[i] != first2[i]:\n",
    "                differences += 1\n",
    "        \n",
    "        # Add difference for length mismatch\n",
    "        differences += max_len - min_len\n",
    "        \n",
    "        return differences <= 1\n",
    "    \n",
    "    # Group by LAB and DOB first to reduce comparison space\n",
    "    grouped = df.groupby(['Lab', 'DOB'])\n",
    "    similar_groups = []\n",
    "    \n",
    "    for (lab, dob), group in grouped:\n",
    "        unique_names = group['Patient Name'].unique()\n",
    "        \n",
    "        if len(unique_names) > 1:\n",
    "            processed_names = set()\n",
    "            \n",
    "            for i, name1 in enumerate(unique_names):\n",
    "                if name1 in processed_names:\n",
    "                    continue\n",
    "                    \n",
    "                current_group = [name1]\n",
    "                processed_names.add(name1)\n",
    "                \n",
    "                for name2 in unique_names[i+1:]:\n",
    "                    if name2 not in processed_names:\n",
    "                        # Check both fuzzy similarity and first name constraint\n",
    "                        similarity = fuzz.ratio(name1.lower(), name2.lower())\n",
    "                        if (similarity >= similarity_threshold and \n",
    "                            first_names_similar(name1, name2)):\n",
    "                            current_group.append(name2)\n",
    "                            processed_names.add(name2)\n",
    "                \n",
    "                if len(current_group) > 1:\n",
    "                    similar_groups.append({\n",
    "                        'lab': lab,\n",
    "                        'dob': dob,\n",
    "                        'similar_names': current_group,\n",
    "                        'count': len(current_group)\n",
    "                    })\n",
    "    \n",
    "    return similar_groups\n",
    "\n",
    "# Test the improved function\n",
    "similar_name_groups_v2 = find_similar_names_v2(df, 85)\n",
    "\n",
    "print(f\"Found {len(similar_name_groups_v2)} groups of similar names with first name constraint\")\n",
    "print(\"\\nFirst 20 groups:\")\n",
    "for i, group in enumerate(similar_name_groups_v2[:20]):\n",
    "    print(f\"\\nGroup {i+1}:\")\n",
    "    print(f\"  Lab: {group['lab']}\")\n",
    "    print(f\"  DOB: {group['dob']}\")\n",
    "    print(f\"  Similar names ({group['count']}): {group['similar_names']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "eb4b3962",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 76 groups of similar names with threshold 95\n",
      "Found 138 groups of similar names with threshold 90\n",
      "Found 164 groups of similar names with threshold 85\n",
      "Found 200 groups of similar names with threshold 80\n",
      "Found 235 groups of similar names with threshold 75\n",
      "Found 312 groups of similar names with threshold 70\n",
      "Found 417 groups of similar names with threshold 65\n",
      "Found 537 groups of similar names with threshold 60\n"
     ]
    }
   ],
   "source": [
    "fine_tuning = [95,90,85, 80, 75, 70, 65, 60]\n",
    "\n",
    "for i in fine_tuning:\n",
    "    similar_name_groups = find_similar_names_v2(df, i)\n",
    "    print(f\"Found {len(similar_name_groups)} groups of similar names with threshold {i}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5a3207e3",
   "metadata": {},
   "source": [
    "#### By adding high constraint on firstname and loosen the general threshold we get more accurate result"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3d683077",
   "metadata": {},
   "source": [
    "Manuel checking of some thresholds:\n",
    "\n",
    "- **60**: 12/20 accurates  \n",
    "- **70**: 16/20 accurates\n",
    "- **75**: 18/20 accurates\n",
    "- **80**: 19/20 accurates\n",
    "- **85**: 20/20 accurates\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4e18f204",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 164 groups of similar names with first name constraint\n",
      "\n",
      "First 20 groups:\n",
      "\n",
      "Group 1:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1945\n",
      "  Similar names (2): ['Fatma Mahmod Abas', 'Fatma Mahmood Abas']\n",
      "\n",
      "Group 2:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1962\n",
      "  Similar names (2): ['Aftaw Mhamad', 'Aftaw Muhamad']\n",
      "\n",
      "Group 3:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (2): ['Ali Mhamad Saed', 'Ali Muhamad Saed']\n",
      "\n",
      "Group 4:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1967\n",
      "  Similar names (2): ['Nawzad Muhamad', 'Nawzad Mahamad']\n",
      "\n",
      "Group 5:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shno Najim Rashid', 'Shno Najim Rashed']\n",
      "\n",
      "Group 6:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/1984\n",
      "  Similar names (2): ['Shara Sdeq Hamid', 'Shara Sdiq Hamid']\n",
      "\n",
      "Group 7:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/2001\n",
      "  Similar names (2): ['Lawen Aswad Hasan', 'Lawen Aswad Hsan']\n",
      "\n",
      "Group 8:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/01/2023\n",
      "  Similar names (2): ['Ela Maewan Mahmood', 'Ela Mariwan Mahmod']\n",
      "\n",
      "Group 9:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/1968\n",
      "  Similar names (2): ['Akram Ahmad Qadr', 'Akram ahmed Qader']\n",
      "\n",
      "Group 10:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/1976\n",
      "  Similar names (2): ['Kazm Karim Qadr', 'Kazm Karem Qadr']\n",
      "\n",
      "Group 11:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/02/2023\n",
      "  Similar names (2): ['Marwa Kaewan Latef', 'Maawa Kaiwan Latef']\n",
      "\n",
      "Group 12:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/03/2002\n",
      "  Similar names (2): ['Lanya Osman Salh', 'Lanya Osman Ali']\n",
      "\n",
      "Group 13:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/03/2023\n",
      "  Similar names (2): ['Kawa kamaran', 'Kawa Kamaran']\n",
      "\n",
      "Group 14:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1930\n",
      "  Similar names (2): ['Mahmud Hseen Mhammad', 'Mahmud Hsen Mhamad']\n",
      "\n",
      "Group 15:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1951\n",
      "  Similar names (2): ['Rwnak Hasan Hama Aziz', 'Rwnak Hasan Hamaziz']\n",
      "\n",
      "Group 16:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1952\n",
      "  Similar names (2): ['Xadija Abdurahman Rashid', 'Xadeja Abdurahman Rashed']\n",
      "\n",
      "Group 17:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1957\n",
      "  Similar names (2): ['Taiba Mahmud Maulud', 'Taiba Mahmud maulud']\n",
      "\n",
      "Group 18:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1960\n",
      "  Similar names (2): ['Amina Rashed Mhamad', 'Amina Rashid Muhamad']\n",
      "\n",
      "Group 19:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1967\n",
      "  Similar names (2): ['Rzgar Abdula Karem', 'Rzgar Abdulla Karim']\n",
      "\n",
      "Group 20:\n",
      "  Lab: Biolab Halabja\n",
      "  DOB: 01/04/1970\n",
      "  Similar names (2): ['Ibrahim Hamaxan Mhamad', 'Ebrahim Hamaxan Mahmod']\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# let see how many errors we have for threshold of 75\n",
    "\n",
    "similar_name_groups_v2 = find_similar_names_v2(df, 85)\n",
    "\n",
    "print(f\"Found {len(similar_name_groups_v2)} groups of similar names with first name constraint\")\n",
    "print(\"\\nFirst 20 groups:\")\n",
    "for i, group in enumerate(similar_name_groups_v2[:20]):\n",
    "    print(f\"\\nGroup {i+1}:\")\n",
    "    print(f\"  Lab: {group['lab']}\")\n",
    "    print(f\"  DOB: {group['dob']}\")\n",
    "    print(f\"  Similar names ({group['count']}): {group['similar_names']}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "8ddefe1b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>DOB</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>DOS</th>\n",
       "      <th>Lab</th>\n",
       "      <th>Discritization</th>\n",
       "      <th>Test</th>\n",
       "      <th>Age</th>\n",
       "      <th>Age Disag</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>26699</td>\n",
       "      <td>Fatma Ali Muhamad</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/09/1923</td>\n",
       "      <td>S.Iron</td>\n",
       "      <td>Âµg/dl</td>\n",
       "      <td>Iron Profile</td>\n",
       "      <td>26.4</td>\n",
       "      <td>04/09/2024</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>Low</td>\n",
       "      <td>S.Iron-Low</td>\n",
       "      <td>100</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>26699</td>\n",
       "      <td>Fatma Ali Muhamad</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/09/1923</td>\n",
       "      <td>CRP Titer</td>\n",
       "      <td>mg/l</td>\n",
       "      <td>Biochemical Test</td>\n",
       "      <td>67.61</td>\n",
       "      <td>04/09/2024</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>Severe Elevation</td>\n",
       "      <td>CRP Titer-Severe Elevation</td>\n",
       "      <td>100</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7945</td>\n",
       "      <td>Kafya Zorab Mahmod</td>\n",
       "      <td>Female</td>\n",
       "      <td>02/09/1925</td>\n",
       "      <td>Troponin T hs Stat</td>\n",
       "      <td>pg/ml</td>\n",
       "      <td>Cardiac Markers</td>\n",
       "      <td>37.56</td>\n",
       "      <td>02/09/2023</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>High</td>\n",
       "      <td>Troponin T hs Stat-High</td>\n",
       "      <td>98</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>37445</td>\n",
       "      <td>Manij sharif karim</td>\n",
       "      <td>Female</td>\n",
       "      <td>11/03/1925</td>\n",
       "      <td>Troponin T hs Stat</td>\n",
       "      <td>pg/ml</td>\n",
       "      <td>Cardiac Markers</td>\n",
       "      <td>32.8</td>\n",
       "      <td>11/03/2025</td>\n",
       "      <td>Biolab Halabja</td>\n",
       "      <td>High</td>\n",
       "      <td>Troponin T hs Stat-High</td>\n",
       "      <td>98</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>24500</td>\n",
       "      <td>qadry abdulqadr hamaamin</td>\n",
       "      <td>Female</td>\n",
       "      <td>04/12/1927</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>108</td>\n",
       "      <td>04/12/2024</td>\n",
       "      <td>Hawkari Halabja</td>\n",
       "      <td>Prediabetes</td>\n",
       "      <td>Blood Sugar-Prediabetes</td>\n",
       "      <td>96</td>\n",
       "      <td>Senior</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender         DOB  \\\n",
       "0      26699         Fatma Ali Muhamad  Female  04/09/1923   \n",
       "1      26699         Fatma Ali Muhamad  Female  04/09/1923   \n",
       "2       7945        Kafya Zorab Mahmod  Female  02/09/1925   \n",
       "3      37445        Manij sharif karim  Female  11/03/1925   \n",
       "4      24500  qadry abdulqadr hamaamin  Female  04/12/1927   \n",
       "\n",
       "            Test Name    Unit          Category Result         DOS  \\\n",
       "0              S.Iron  Âµg/dl      Iron Profile   26.4  04/09/2024   \n",
       "1           CRP Titer    mg/l  Biochemical Test  67.61  04/09/2024   \n",
       "2  Troponin T hs Stat   pg/ml   Cardiac Markers  37.56  02/09/2023   \n",
       "3  Troponin T hs Stat   pg/ml   Cardiac Markers   32.8  11/03/2025   \n",
       "4         Blood Sugar   mg/dl     Diabetes Test    108  04/12/2024   \n",
       "\n",
       "               Lab    Discritization                        Test  Age  \\\n",
       "0   Biolab Halabja               Low                  S.Iron-Low  100   \n",
       "1   Biolab Halabja  Severe Elevation  CRP Titer-Severe Elevation  100   \n",
       "2   Biolab Halabja              High     Troponin T hs Stat-High   98   \n",
       "3   Biolab Halabja              High     Troponin T hs Stat-High   98   \n",
       "4  Hawkari Halabja       Prediabetes     Blood Sugar-Prediabetes   96   \n",
       "\n",
       "  Age Disag  \n",
       "0    Senior  \n",
       "1    Senior  \n",
       "2    Senior  \n",
       "3    Senior  \n",
       "4    Senior  "
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "6966b4a0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of Unique names in the df BEFORE the renaming: 33306\n"
     ]
    }
   ],
   "source": [
    "print(f\"Number of Unique names in the df BEFORE the renaming: {df['Patient Name'].nunique()}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "f9b9ffda",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of Unique names in the df AFTER the renaming: 33142\n"
     ]
    }
   ],
   "source": [
    "# lets go with 85 percent\n",
    "# rename the second matching name with the first one for threshold of 85 in the df\n",
    "\n",
    "similar_name_groups = find_similar_names_v2(df, 85)\n",
    "\n",
    "for group in similar_name_groups:\n",
    "    if len(group['similar_names']) > 1:\n",
    "        df.loc[df['Patient Name'] == group['similar_names'][1], 'Patient Name'] = group['similar_names'][0]\n",
    "        \n",
    "\n",
    "print(f\"Number of Unique names in the df AFTER the renaming: {df['Patient Name'].nunique()}\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0bfb93d6",
   "metadata": {},
   "source": [
    "## Task 1: Removing a Small Number of Tests and Creating Test Combinations\n",
    "\n",
    "### Step 1: Identify Tests with Small Frequencies\n",
    "\n",
    "First, let's analyze the distribution of tests and identify those with small frequencies that should be removed.\n",
    "\n",
    "### Step 2: Remove Tests with Low Frequency\n",
    "\n",
    "We'll remove tests that appear infrequently in the dataset to focus on more common laboratory tests.\n",
    "\n",
    "### Step 3: Create Test Combinations\n",
    "\n",
    "After cleaning, we'll create combinations of different tests up to 10 degrees for patients who have multiple test results."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e0c270ce",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 226 unique test names in the df\n",
      "There are 151111 total items in the df\n",
      "We remove any tests that are below 300 counts\n",
      "AFTER THE REMOVAL OF THE TESTS that are below 300:\n",
      "There are 61 unique test names in the df\n",
      "There are 143308 total items in the df\n"
     ]
    }
   ],
   "source": [
    "# df['Test Name'].value_counts()\n",
    "print(f\"There are {df['Test Name'].nunique()} unique test names in the df\")\n",
    "print(f\"There are {df.shape[0]} total items in the df\")\n",
    "print(\"We remove any tests that are below 300 counts\")\n",
    "for test_name, count in df['Test Name'].value_counts().items():\n",
    "    if count < 300:\n",
    "        df.drop(df[df['Test Name'] == test_name].index, inplace=True, axis=0)\n",
    "\n",
    "print(\"AFTER THE REMOVAL OF THE TESTS that are below 300:\")\n",
    "print(f\"There are {df['Test Name'].nunique()} unique test names in the df\")\n",
    "print(f\"There are {df.shape[0]} total items in the df\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "c9ba67a0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "We remove any tests that are below 500 counts\n",
      "AFTER THE REMOVAL OF THE TESTS that are below 500:\n",
      "There are 46 unique test names in the df\n",
      "There are 137019 total items in the df\n"
     ]
    }
   ],
   "source": [
    "print(\"We remove any tests that are below 500 counts\")\n",
    "for test_name, count in df['Test Name'].value_counts().items():\n",
    "    if count < 500:\n",
    "        df.drop(df[df['Test Name'] == test_name].index, inplace=True, axis=0)\n",
    "\n",
    "print(\"AFTER THE REMOVAL OF THE TESTS that are below 500:\")\n",
    "print(f\"There are {df['Test Name'].nunique()} unique test names in the df\")\n",
    "print(f\"There are {df.shape[0]} total items in the df\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b1161956",
   "metadata": {},
   "outputs": [],
   "source": [
    "# lets create a dummy data for the tests\n",
    "unique_tests = df['Test Name'].unique()\n",
    "\n",
    "# Create binary columns for each test\n",
    "for test in unique_tests:\n",
    "    df[test] = (df['Test Name'] == test).astype(int)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 132,
   "id": "62bac02e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The total number of tests done across all patients is: 137019\n",
      "The total number of rows is: 137019\n"
     ]
    }
   ],
   "source": [
    "sum1=0\n",
    "for i in unique_tests:\n",
    "    sum1+=df[i].value_counts()[1]\n",
    "\n",
    "print(f\"The total number of tests done across all patients is: {sum1}\")\n",
    "print(f\"The total number of rows is: {df.shape[0]}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "b0b4d5d4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Subset ('S.Iron', 'Blood Sugar') has more than 300 patients. with 505 patients.\n",
      "Subset ('S.Iron', 'TSH') has more than 300 patients. with 904 patients.\n",
      "Subset ('S.Iron', 'S.Cholestrol') has more than 300 patients. with 448 patients.\n",
      "Subset ('S.Iron', 'S.Triglyceride') has more than 300 patients. with 451 patients.\n",
      "Subset ('S.Iron', 'S.LDL') has more than 300 patients. with 334 patients.\n",
      "Subset ('S.Iron', 'S.Ferritin') has more than 300 patients. with 396 patients.\n",
      "Subset ('S.Iron', 'S.GOT ( AST )') has more than 300 patients. with 303 patients.\n",
      "Subset ('S.Iron', 'B.Urea') has more than 300 patients. with 378 patients.\n",
      "Subset ('S.Iron', 'S.Creatinine') has more than 300 patients. with 403 patients.\n",
      "Subset ('S.Iron', 'S.GPT ( ALT )') has more than 300 patients. with 305 patients.\n",
      "Subset ('S.Iron', 'Vitamine B12') has more than 300 patients. with 334 patients.\n",
      "Subset ('S.Iron', 'Vitamin D3') has more than 300 patients. with 1635 patients.\n",
      "Subset ('S.Iron', 'ESR') has more than 300 patients. with 348 patients.\n",
      "Subset ('S.Iron', 'PCV') has more than 300 patients. with 710 patients.\n",
      "Subset ('CRP Titer', 'Troponin T hs Stat') has more than 300 patients. with 364 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar') has more than 300 patients. with 2286 patients.\n",
      "Subset ('CRP Titer', 'HBA1C') has more than 300 patients. with 752 patients.\n",
      "Subset ('CRP Titer', 'S.ALP') has more than 300 patients. with 540 patients.\n",
      "Subset ('CRP Titer', 'TSH') has more than 300 patients. with 1519 patients.\n",
      "Subset ('CRP Titer', 'S.Ferritin') has more than 300 patients. with 548 patients.\n",
      "Subset ('CRP Titer', 'S.GOT ( AST )') has more than 300 patients. with 546 patients.\n",
      "Subset ('CRP Titer', 'B.Urea') has more than 300 patients. with 667 patients.\n",
      "Subset ('CRP Titer', 'S.Creatinine') has more than 300 patients. with 2226 patients.\n",
      "Subset ('CRP Titer', 'S.GPT ( ALT )') has more than 300 patients. with 572 patients.\n",
      "Subset ('CRP Titer', 'Vitamin D3') has more than 300 patients. with 783 patients.\n",
      "Subset ('CRP Titer', 'ESR') has more than 300 patients. with 376 patients.\n",
      "Subset ('CRP Titer', 'LDL ( Low density lipoprotein )') has more than 300 patients. with 367 patients.\n",
      "Subset ('CRP Titer', 'HBs Ag') has more than 300 patients. with 354 patients.\n",
      "Subset ('CRP Titer', 'HCV Ab') has more than 300 patients. with 352 patients.\n",
      "Subset ('CRP Titer', 'HIV Ab') has more than 300 patients. with 351 patients.\n",
      "Subset ('CRP Titer', 'Total Cholestrol') has more than 300 patients. with 321 patients.\n",
      "Subset ('CRP Titer', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 889 patients.\n",
      "Subset ('CRP Titer', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 1247 patients.\n",
      "Subset ('Troponin T hs Stat', 'Blood Sugar') has more than 300 patients. with 404 patients.\n",
      "Subset ('Troponin T hs Stat', 'TSH') has more than 300 patients. with 332 patients.\n",
      "Subset ('Troponin T hs Stat', 'S.Creatinine') has more than 300 patients. with 435 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C') has more than 300 patients. with 2328 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP') has more than 300 patients. with 802 patients.\n",
      "Subset ('Blood Sugar', 'TSH') has more than 300 patients. with 4436 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol') has more than 300 patients. with 1131 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride') has more than 300 patients. with 1144 patients.\n",
      "Subset ('Blood Sugar', 'S.HDL') has more than 300 patients. with 742 patients.\n",
      "Subset ('Blood Sugar', 'S.LDL') has more than 300 patients. with 885 patients.\n",
      "Subset ('Blood Sugar', 'S.Ferritin') has more than 300 patients. with 1449 patients.\n",
      "Subset ('Blood Sugar', 'S.GOT ( AST )') has more than 300 patients. with 1200 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea') has more than 300 patients. with 1404 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine') has more than 300 patients. with 5410 patients.\n",
      "Subset ('Blood Sugar', 'S.GPT ( ALT )') has more than 300 patients. with 1228 patients.\n",
      "Subset ('Blood Sugar', 'Vitamine B12') has more than 300 patients. with 498 patients.\n",
      "Subset ('Blood Sugar', 'Vitamin D3') has more than 300 patients. with 1460 patients.\n",
      "Subset ('Blood Sugar', 'Sodium  Na+') has more than 300 patients. with 460 patients.\n",
      "Subset ('Blood Sugar', 'Potassium K+') has more than 300 patients. with 460 patients.\n",
      "Subset ('Blood Sugar', 'Chloride CL-') has more than 300 patients. with 459 patients.\n",
      "Subset ('Blood Sugar', 'ESR') has more than 300 patients. with 473 patients.\n",
      "Subset ('Blood Sugar', 'S.Calcium') has more than 300 patients. with 311 patients.\n",
      "Subset ('Blood Sugar', 'Glucose') has more than 300 patients. with 598 patients.\n",
      "Subset ('Blood Sugar', 'LDL ( Low density lipoprotein )') has more than 300 patients. with 1233 patients.\n",
      "Subset ('Blood Sugar', 'HBs Ag') has more than 300 patients. with 1413 patients.\n",
      "Subset ('Blood Sugar', 'HCV Ab') has more than 300 patients. with 1410 patients.\n",
      "Subset ('Blood Sugar', 'HIV Ab') has more than 300 patients. with 1409 patients.\n",
      "Subset ('Blood Sugar', 'PCV') has more than 300 patients. with 581 patients.\n",
      "Subset ('Blood Sugar', 'Free T4 ( FT4 )') has more than 300 patients. with 320 patients.\n",
      "Subset ('Blood Sugar', 'Total Cholestrol') has more than 300 patients. with 1078 patients.\n",
      "Subset ('Blood Sugar', 'Triglyceride') has more than 300 patients. with 850 patients.\n",
      "Subset ('Blood Sugar', 'HDL ( High density lipoprotein )') has more than 300 patients. with 359 patients.\n",
      "Subset ('Blood Sugar', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 778 patients.\n",
      "Subset ('Blood Sugar', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 3140 patients.\n",
      "Subset ('Blood Sugar', 'Blood Group & Rh') has more than 300 patients. with 347 patients.\n",
      "Subset ('Blood Sugar', 'Pregnancy Test (BHCG)') has more than 300 patients. with 348 patients.\n",
      "Subset ('Blood Sugar', 'Stool For H.pylori ( H.pylori Ag ) titer') has more than 300 patients. with 629 patients.\n",
      "Subset ('HBA1C', 'TSH') has more than 300 patients. with 1540 patients.\n",
      "Subset ('HBA1C', 'S.Cholestrol') has more than 300 patients. with 735 patients.\n",
      "Subset ('HBA1C', 'S.Triglyceride') has more than 300 patients. with 745 patients.\n",
      "Subset ('HBA1C', 'S.HDL') has more than 300 patients. with 495 patients.\n",
      "Subset ('HBA1C', 'S.LDL') has more than 300 patients. with 604 patients.\n",
      "Subset ('HBA1C', 'S.Ferritin') has more than 300 patients. with 440 patients.\n",
      "Subset ('HBA1C', 'S.GOT ( AST )') has more than 300 patients. with 375 patients.\n",
      "Subset ('HBA1C', 'B.Urea') has more than 300 patients. with 693 patients.\n",
      "Subset ('HBA1C', 'S.Creatinine') has more than 300 patients. with 1630 patients.\n",
      "Subset ('HBA1C', 'S.GPT ( ALT )') has more than 300 patients. with 428 patients.\n",
      "Subset ('HBA1C', 'Vitamin D3') has more than 300 patients. with 650 patients.\n",
      "Subset ('HBA1C', 'Glucose') has more than 300 patients. with 548 patients.\n",
      "Subset ('HBA1C', 'LDL ( Low density lipoprotein )') has more than 300 patients. with 679 patients.\n",
      "Subset ('HBA1C', 'Total Cholestrol') has more than 300 patients. with 576 patients.\n",
      "Subset ('HBA1C', 'Triglyceride') has more than 300 patients. with 505 patients.\n",
      "Subset ('HBA1C', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 321 patients.\n",
      "Subset ('HBA1C', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 804 patients.\n",
      "Subset ('S.ALP', 'TSH') has more than 300 patients. with 676 patients.\n",
      "Subset ('S.ALP', 'S.Ferritin') has more than 300 patients. with 366 patients.\n",
      "Subset ('S.ALP', 'S.GOT ( AST )') has more than 300 patients. with 1116 patients.\n",
      "Subset ('S.ALP', 'B.Urea') has more than 300 patients. with 314 patients.\n",
      "Subset ('S.ALP', 'S.Creatinine') has more than 300 patients. with 910 patients.\n",
      "Subset ('S.ALP', 'S.GPT ( ALT )') has more than 300 patients. with 1125 patients.\n",
      "Subset ('S.ALP', 'Vitamin D3') has more than 300 patients. with 305 patients.\n",
      "Subset ('S.ALP', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 327 patients.\n",
      "Subset ('S.ALP', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 1043 patients.\n",
      "Subset ('TSH', 'S.Cholestrol') has more than 300 patients. with 872 patients.\n",
      "Subset ('TSH', 'S.Triglyceride') has more than 300 patients. with 878 patients.\n",
      "Subset ('TSH', 'S.HDL') has more than 300 patients. with 592 patients.\n",
      "Subset ('TSH', 'S.LDL') has more than 300 patients. with 710 patients.\n",
      "Subset ('TSH', 'S.Ferritin') has more than 300 patients. with 1844 patients.\n",
      "Subset ('TSH', 'S.GOT ( AST )') has more than 300 patients. with 936 patients.\n",
      "Subset ('TSH', 'B.Urea') has more than 300 patients. with 1029 patients.\n",
      "Subset ('TSH', 'S.Creatinine') has more than 300 patients. with 3779 patients.\n",
      "Subset ('TSH', 'S.GPT ( ALT )') has more than 300 patients. with 1069 patients.\n",
      "Subset ('TSH', 'Vitamine B12') has more than 300 patients. with 654 patients.\n",
      "Subset ('TSH', 'Vitamin D3') has more than 300 patients. with 2613 patients.\n",
      "Subset ('TSH', 'Sodium  Na+') has more than 300 patients. with 444 patients.\n",
      "Subset ('TSH', 'Potassium K+') has more than 300 patients. with 444 patients.\n",
      "Subset ('TSH', 'Chloride CL-') has more than 300 patients. with 444 patients.\n",
      "Subset ('TSH', 'ESR') has more than 300 patients. with 515 patients.\n",
      "Subset ('TSH', 'S.Calcium') has more than 300 patients. with 508 patients.\n",
      "Subset ('TSH', 'Glucose') has more than 300 patients. with 773 patients.\n",
      "Subset ('TSH', 'LDL ( Low density lipoprotein )') has more than 300 patients. with 1240 patients.\n",
      "Subset ('TSH', 'HBs Ag') has more than 300 patients. with 799 patients.\n",
      "Subset ('TSH', 'HCV Ab') has more than 300 patients. with 794 patients.\n",
      "Subset ('TSH', 'HIV Ab') has more than 300 patients. with 794 patients.\n",
      "Subset ('TSH', 'PCV') has more than 300 patients. with 618 patients.\n",
      "Subset ('TSH', 'Free T4 ( FT4 )') has more than 300 patients. with 631 patients.\n",
      "Subset ('TSH', 'Total Cholestrol') has more than 300 patients. with 1114 patients.\n",
      "Subset ('TSH', 'Triglyceride') has more than 300 patients. with 880 patients.\n",
      "Subset ('TSH', 'HDL ( High density lipoprotein )') has more than 300 patients. with 422 patients.\n",
      "Subset ('TSH', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 878 patients.\n",
      "Subset ('TSH', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 2429 patients.\n",
      "Subset ('TSH', 'LH') has more than 300 patients. with 617 patients.\n",
      "Subset ('TSH', 'FSH') has more than 300 patients. with 723 patients.\n",
      "Subset ('TSH', 'BHCG Titer') has more than 300 patients. with 469 patients.\n",
      "Subset ('TSH', 'Prolactin') has more than 300 patients. with 1288 patients.\n",
      "Subset ('TSH', 'Pregnancy Test (BHCG)') has more than 300 patients. with 420 patients.\n",
      "Subset ('TSH', 'Stool For H.pylori ( H.pylori Ag ) titer') has more than 300 patients. with 492 patients.\n",
      "Subset ('TSH', 'Testosterone') has more than 300 patients. with 533 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride') has more than 300 patients. with 2512 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL') has more than 300 patients. with 1586 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL') has more than 300 patients. with 1929 patients.\n",
      "Subset ('S.Cholestrol', 'S.GOT ( AST )') has more than 300 patients. with 503 patients.\n",
      "Subset ('S.Cholestrol', 'B.Urea') has more than 300 patients. with 735 patients.\n",
      "Subset ('S.Cholestrol', 'S.Creatinine') has more than 300 patients. with 808 patients.\n",
      "Subset ('S.Cholestrol', 'S.GPT ( ALT )') has more than 300 patients. with 511 patients.\n",
      "Subset ('S.Cholestrol', 'Vitamin D3') has more than 300 patients. with 793 patients.\n",
      "Subset ('S.Cholestrol', 'ESR') has more than 300 patients. with 477 patients.\n",
      "Subset ('S.Cholestrol', 'PCV') has more than 300 patients. with 627 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL') has more than 300 patients. with 1580 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL') has more than 300 patients. with 1902 patients.\n",
      "Subset ('S.Triglyceride', 'S.GOT ( AST )') has more than 300 patients. with 518 patients.\n",
      "Subset ('S.Triglyceride', 'B.Urea') has more than 300 patients. with 742 patients.\n",
      "Subset ('S.Triglyceride', 'S.Creatinine') has more than 300 patients. with 817 patients.\n",
      "Subset ('S.Triglyceride', 'S.GPT ( ALT )') has more than 300 patients. with 526 patients.\n",
      "Subset ('S.Triglyceride', 'Vitamin D3') has more than 300 patients. with 809 patients.\n",
      "Subset ('S.Triglyceride', 'ESR') has more than 300 patients. with 482 patients.\n",
      "Subset ('S.Triglyceride', 'PCV') has more than 300 patients. with 633 patients.\n",
      "Subset ('S.HDL', 'S.LDL') has more than 300 patients. with 1602 patients.\n",
      "Subset ('S.HDL', 'S.GOT ( AST )') has more than 300 patients. with 359 patients.\n",
      "Subset ('S.HDL', 'B.Urea') has more than 300 patients. with 514 patients.\n",
      "Subset ('S.HDL', 'S.Creatinine') has more than 300 patients. with 562 patients.\n",
      "Subset ('S.HDL', 'S.GPT ( ALT )') has more than 300 patients. with 368 patients.\n",
      "Subset ('S.HDL', 'Vitamin D3') has more than 300 patients. with 538 patients.\n",
      "Subset ('S.HDL', 'ESR') has more than 300 patients. with 312 patients.\n",
      "Subset ('S.HDL', 'PCV') has more than 300 patients. with 367 patients.\n",
      "Subset ('S.LDL', 'S.GOT ( AST )') has more than 300 patients. with 395 patients.\n",
      "Subset ('S.LDL', 'B.Urea') has more than 300 patients. with 590 patients.\n",
      "Subset ('S.LDL', 'S.Creatinine') has more than 300 patients. with 651 patients.\n",
      "Subset ('S.LDL', 'S.GPT ( ALT )') has more than 300 patients. with 406 patients.\n",
      "Subset ('S.LDL', 'Vitamin D3') has more than 300 patients. with 634 patients.\n",
      "Subset ('S.LDL', 'ESR') has more than 300 patients. with 366 patients.\n",
      "Subset ('S.LDL', 'PCV') has more than 300 patients. with 453 patients.\n",
      "Subset ('S.Ferritin', 'S.GOT ( AST )') has more than 300 patients. with 392 patients.\n",
      "Subset ('S.Ferritin', 'S.Creatinine') has more than 300 patients. with 1354 patients.\n",
      "Subset ('S.Ferritin', 'S.GPT ( ALT )') has more than 300 patients. with 414 patients.\n",
      "Subset ('S.Ferritin', 'Vitamine B12') has more than 300 patients. with 478 patients.\n",
      "Subset ('S.Ferritin', 'Vitamin D3') has more than 300 patients. with 1275 patients.\n",
      "Subset ('S.Ferritin', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 391 patients.\n",
      "Subset ('S.Ferritin', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 1089 patients.\n",
      "Subset ('S.Ferritin', 'Stool For H.pylori ( H.pylori Ag ) titer') has more than 300 patients. with 302 patients.\n",
      "Subset ('S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 782 patients.\n",
      "Subset ('S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 1360 patients.\n",
      "Subset ('S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 1820 patients.\n",
      "Subset ('S.GOT ( AST )', 'Vitamin D3') has more than 300 patients. with 500 patients.\n",
      "Subset ('S.GOT ( AST )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 1064 patients.\n",
      "Subset ('B.Urea', 'S.Creatinine') has more than 300 patients. with 2865 patients.\n",
      "Subset ('B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 809 patients.\n",
      "Subset ('B.Urea', 'Vitamin D3') has more than 300 patients. with 660 patients.\n",
      "Subset ('B.Urea', 'Sodium  Na+') has more than 300 patients. with 422 patients.\n",
      "Subset ('B.Urea', 'Potassium K+') has more than 300 patients. with 422 patients.\n",
      "Subset ('B.Urea', 'Chloride CL-') has more than 300 patients. with 422 patients.\n",
      "Subset ('B.Urea', 'ESR') has more than 300 patients. with 385 patients.\n",
      "Subset ('B.Urea', 'HBs Ag') has more than 300 patients. with 537 patients.\n",
      "Subset ('B.Urea', 'HCV Ab') has more than 300 patients. with 535 patients.\n",
      "Subset ('B.Urea', 'HIV Ab') has more than 300 patients. with 535 patients.\n",
      "Subset ('B.Urea', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 439 patients.\n",
      "Subset ('S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 1405 patients.\n",
      "Subset ('S.Creatinine', 'Vitamine B12') has more than 300 patients. with 464 patients.\n",
      "Subset ('S.Creatinine', 'Vitamin D3') has more than 300 patients. with 974 patients.\n",
      "Subset ('S.Creatinine', 'Sodium  Na+') has more than 300 patients. with 630 patients.\n",
      "Subset ('S.Creatinine', 'Potassium K+') has more than 300 patients. with 630 patients.\n",
      "Subset ('S.Creatinine', 'Chloride CL-') has more than 300 patients. with 629 patients.\n",
      "Subset ('S.Creatinine', 'ESR') has more than 300 patients. with 408 patients.\n",
      "Subset ('S.Creatinine', 'S.Calcium') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Creatinine', 'Glucose') has more than 300 patients. with 464 patients.\n",
      "Subset ('S.Creatinine', 'LDL ( Low density lipoprotein )') has more than 300 patients. with 1232 patients.\n",
      "Subset ('S.Creatinine', 'HBs Ag') has more than 300 patients. with 816 patients.\n",
      "Subset ('S.Creatinine', 'HCV Ab') has more than 300 patients. with 814 patients.\n",
      "Subset ('S.Creatinine', 'HIV Ab') has more than 300 patients. with 813 patients.\n",
      "Subset ('S.Creatinine', 'PCV') has more than 300 patients. with 303 patients.\n",
      "Subset ('S.Creatinine', 'Free T4 ( FT4 )') has more than 300 patients. with 353 patients.\n",
      "Subset ('S.Creatinine', 'Total Cholestrol') has more than 300 patients. with 1049 patients.\n",
      "Subset ('S.Creatinine', 'Triglyceride') has more than 300 patients. with 808 patients.\n",
      "Subset ('S.Creatinine', 'HDL ( High density lipoprotein )') has more than 300 patients. with 357 patients.\n",
      "Subset ('S.Creatinine', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 781 patients.\n",
      "Subset ('S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 3279 patients.\n",
      "Subset ('S.Creatinine', 'Stool For H.pylori ( H.pylori Ag ) titer') has more than 300 patients. with 628 patients.\n",
      "Subset ('S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 528 patients.\n",
      "Subset ('S.GPT ( ALT )', 'ESR') has more than 300 patients. with 303 patients.\n",
      "Subset ('S.GPT ( ALT )', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 402 patients.\n",
      "Subset ('S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 1077 patients.\n",
      "Subset ('Vitamine B12', 'Vitamin D3') has more than 300 patients. with 863 patients.\n",
      "Subset ('Vitamin D3', 'ESR') has more than 300 patients. with 647 patients.\n",
      "Subset ('Vitamin D3', 'S.Calcium') has more than 300 patients. with 622 patients.\n",
      "Subset ('Vitamin D3', 'HBs Ag') has more than 300 patients. with 386 patients.\n",
      "Subset ('Vitamin D3', 'HCV Ab') has more than 300 patients. with 382 patients.\n",
      "Subset ('Vitamin D3', 'HIV Ab') has more than 300 patients. with 381 patients.\n",
      "Subset ('Vitamin D3', 'PCV') has more than 300 patients. with 818 patients.\n",
      "Subset ('Vitamin D3', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 381 patients.\n",
      "Subset ('Vitamin D3', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 368 patients.\n",
      "Subset ('Vitamin D3', 'Prolactin') has more than 300 patients. with 448 patients.\n",
      "Subset ('Vitamin D3', 'H.Pylori Antigen Titer') has more than 300 patients. with 315 patients.\n",
      "Subset ('Sodium  Na+', 'Potassium K+') has more than 300 patients. with 955 patients.\n",
      "Subset ('Sodium  Na+', 'Chloride CL-') has more than 300 patients. with 954 patients.\n",
      "Subset ('Potassium K+', 'Chloride CL-') has more than 300 patients. with 954 patients.\n",
      "Subset ('Glucose', 'HBs Ag') has more than 300 patients. with 452 patients.\n",
      "Subset ('Glucose', 'HCV Ab') has more than 300 patients. with 452 patients.\n",
      "Subset ('Glucose', 'HIV Ab') has more than 300 patients. with 452 patients.\n",
      "Subset ('LDL ( Low density lipoprotein )', 'Total Cholestrol') has more than 300 patients. with 1467 patients.\n",
      "Subset ('LDL ( Low density lipoprotein )', 'Triglyceride') has more than 300 patients. with 1189 patients.\n",
      "Subset ('LDL ( Low density lipoprotein )', 'HDL ( High density lipoprotein )') has more than 300 patients. with 675 patients.\n",
      "Subset ('LDL ( Low density lipoprotein )', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 304 patients.\n",
      "Subset ('LDL ( Low density lipoprotein )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 760 patients.\n",
      "Subset ('HBs Ag', 'HCV Ab') has more than 300 patients. with 4851 patients.\n",
      "Subset ('HBs Ag', 'HIV Ab') has more than 300 patients. with 4844 patients.\n",
      "Subset ('HBs Ag', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 325 patients.\n",
      "Subset ('HBs Ag', 'Blood Group & Rh') has more than 300 patients. with 572 patients.\n",
      "Subset ('HCV Ab', 'HIV Ab') has more than 300 patients. with 4845 patients.\n",
      "Subset ('HCV Ab', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 325 patients.\n",
      "Subset ('HCV Ab', 'Blood Group & Rh') has more than 300 patients. with 572 patients.\n",
      "Subset ('HIV Ab', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 322 patients.\n",
      "Subset ('HIV Ab', 'Blood Group & Rh') has more than 300 patients. with 572 patients.\n",
      "Subset ('PCV', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 444 patients.\n",
      "Subset ('Total Cholestrol', 'Triglyceride') has more than 300 patients. with 1215 patients.\n",
      "Subset ('Total Cholestrol', 'HDL ( High density lipoprotein )') has more than 300 patients. with 663 patients.\n",
      "Subset ('Total Cholestrol', 'Erythrocyte Sedimentation Rate ( ESR )') has more than 300 patients. with 317 patients.\n",
      "Subset ('Total Cholestrol', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 654 patients.\n",
      "Subset ('Triglyceride', 'HDL ( High density lipoprotein )') has more than 300 patients. with 627 patients.\n",
      "Subset ('Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 487 patients.\n",
      "Subset ('Erythrocyte Sedimentation Rate ( ESR )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 638 patients.\n",
      "Subset ('T.S.B ( Total Serum Bilirubin )', 'Stool For H.pylori ( H.pylori Ag ) titer') has more than 300 patients. with 597 patients.\n",
      "Subset ('LH', 'FSH') has more than 300 patients. with 781 patients.\n",
      "Subset ('LH', 'Prolactin') has more than 300 patients. with 629 patients.\n",
      "Subset ('LH', 'Testosterone') has more than 300 patients. with 562 patients.\n",
      "Subset ('FSH', 'Prolactin') has more than 300 patients. with 702 patients.\n",
      "Subset ('FSH', 'Testosterone') has more than 300 patients. with 558 patients.\n",
      "Subset ('Prolactin', 'Testosterone') has more than 300 patients. with 532 patients.\n"
     ]
    }
   ],
   "source": [
    "from itertools import combinations\n",
    "\n",
    "# bring back all the patients that are tested for v tests.\n",
    "# with more than 300 patients\n",
    "\n",
    "limit = 300\n",
    "v = 2\n",
    "\n",
    "df_grouped_by_patient = df.groupby('Patient Name')[[i for i in unique_tests]].sum()\n",
    "\n",
    "# for each subset of v items together in unique_tests,\n",
    "# we find the subset that has more than 300 patients\n",
    "subsets = list(combinations(unique_tests, v))\n",
    "\n",
    "for subset in subsets:\n",
    "    # Handle subsets of any size, not just pairs\n",
    "    if len(subset) >= 2:\n",
    "        # Create a boolean mask for patients who have all tests in the subset\n",
    "        mask = df_grouped_by_patient[subset[0]] > 0\n",
    "        for test in subset[1:]:\n",
    "            mask = mask & (df_grouped_by_patient[test] > 0)\n",
    "        \n",
    "        count = mask.sum()\n",
    "        if count > limit:\n",
    "            print(f\"Subset {subset} has more than {limit} patients. with {count} patients.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "id": "6a6e0174",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Completed for v=2 for limits [300, 500, 1000], results: [260, 167, 59]\n",
      "Completed for v=3 for limits [300, 500, 1000], results: [443, 191, 36]\n",
      "Completed for v=4 for limits [300, 500, 1000], results: [409, 114, 4]\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>260</td>\n",
       "      <td>443</td>\n",
       "      <td>409</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>167</td>\n",
       "      <td>191</td>\n",
       "      <td>114</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>59</td>\n",
       "      <td>36</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        2    3    4\n",
       "300   260  443  409\n",
       "500   167  191  114\n",
       "1000   59   36    4"
      ]
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "limits = [300, 500, 1000]\n",
    "vs = [2, 3, 4]\n",
    "\n",
    "pivot_table = pd.DataFrame(index=limits, columns=vs)\n",
    "\n",
    "for v in vs:\n",
    "    subsets = list(combinations(unique_tests, v))\n",
    "    count_of_possible_df = [0] * len(limits)\n",
    "    for subset in subsets:\n",
    "        # Create a boolean mask for patients who have all tests in the subset\n",
    "        \n",
    "        mask = df_grouped_by_patient[subset[0]] > 0\n",
    "        for test in subset[1:]:\n",
    "            mask = mask & (df_grouped_by_patient[test] > 0)\n",
    "        \n",
    "        count = mask.sum()\n",
    "        for i, limit in enumerate(limits):\n",
    "            if count > limit:\n",
    "                count_of_possible_df[i] += 1\n",
    "            # print(f\"Subset {subset} has more than {limit} patients. with {count} patients.\")\n",
    "    pivot_table[v] = count_of_possible_df\n",
    "    print(f\"Completed for v={v} for limits {limits}, results: {count_of_possible_df}\")\n",
    "\n",
    "\n",
    "# let's create a pivot table\n",
    "# row is limits, column is v, values are count of possible dfs\n",
    "\n",
    "# visualizing the pivot table\n",
    "\n",
    "pivot_table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "id": "1bc025fe",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total number of subsets of size 5: 1370754\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 318 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'TSH', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 579 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 361 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 320 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'S.Creatinine', 'Erythrocyte Sedimentation Rate ( ESR )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 308 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 337 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 301 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 362 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 303 patients.\n",
      "Subset ('CRP Titer', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 325 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'TSH', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 456 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL') has more than 300 patients. with 308 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL') has more than 300 patients. with 363 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Cholestrol', 'S.HDL', 'S.LDL') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol') has more than 300 patients. with 310 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 375 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 416 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GOT ( AST )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 375 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 377 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 365 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 376 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 644 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 583 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 655 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 584 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL') has more than 300 patients. with 350 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL') has more than 300 patients. with 400 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea') has more than 300 patients. with 303 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.Creatinine') has more than 300 patients. with 327 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'Vitamin D3') has more than 300 patients. with 312 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL') has more than 300 patients. with 349 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 302 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 349 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Triglyceride', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 304 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Ferritin', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 748 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 359 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 360 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 645 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 310 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 422 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 367 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 333 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol') has more than 300 patients. with 768 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Triglyceride') has more than 300 patients. with 572 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 603 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'Total Cholestrol', 'Triglyceride') has more than 300 patients. with 536 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'Total Cholestrol', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 522 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 382 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'Erythrocyte Sedimentation Rate ( ESR )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 402 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )', 'Stool For H.pylori ( H.pylori Ag ) titer') has more than 300 patients. with 328 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride') has more than 300 patients. with 573 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 535 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'LDL ( Low density lipoprotein )', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 391 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 530 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'Total Cholestrol', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 360 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 735 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.Creatinine') has more than 300 patients. with 409 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'Vitamin D3') has more than 300 patients. with 341 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )') has more than 300 patients. with 320 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea') has more than 300 patients. with 417 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 460 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GPT ( ALT )') has more than 300 patients. with 325 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 381 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 377 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 389 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 405 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 522 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 381 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 395 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 303 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 409 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 342 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 373 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 307 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 320 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 416 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 312 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 378 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 378 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 390 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 382 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 375 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 409 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 341 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 322 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 416 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 314 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 392 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 383 patients.\n",
      "Subset ('Blood Sugar', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 301 patients.\n",
      "Subset ('Blood Sugar', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 568 patients.\n",
      "Subset ('Blood Sugar', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 344 patients.\n",
      "Subset ('Blood Sugar', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 631 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'S.Creatinine', 'HBs Ag', 'HCV Ab') has more than 300 patients. with 306 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'S.Creatinine', 'HBs Ag', 'HIV Ab') has more than 300 patients. with 306 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'S.Creatinine', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 306 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 312 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'Sodium  Na+', 'Potassium K+', 'Chloride CL-') has more than 300 patients. with 395 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride') has more than 300 patients. with 643 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 563 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 412 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 571 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'Total Cholestrol', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride', 'HDL ( High density lipoprotein )') has more than 300 patients. with 313 patients.\n",
      "Subset ('Blood Sugar', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 396 patients.\n",
      "Subset ('HBA1C', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 488 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 455 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 399 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 468 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 400 patients.\n",
      "Subset ('S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 705 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 576 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea') has more than 300 patients. with 308 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.Creatinine') has more than 300 patients. with 328 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'Vitamin D3') has more than 300 patients. with 337 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea') has more than 300 patients. with 334 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 360 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 382 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 378 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 308 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 327 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 341 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 306 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 331 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 309 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 327 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 337 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 306 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 331 patients.\n",
      "Subset ('TSH', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 308 patients.\n",
      "Subset ('TSH', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 439 patients.\n",
      "Subset ('TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 326 patients.\n",
      "Subset ('TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 439 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'Sodium  Na+', 'Potassium K+', 'Chloride CL-') has more than 300 patients. with 333 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride') has more than 300 patients. with 577 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 548 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'LDL ( Low density lipoprotein )', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 392 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 325 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'Total Cholestrol', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 360 patients.\n",
      "Subset ('TSH', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride', 'HDL ( High density lipoprotein )') has more than 300 patients. with 381 patients.\n",
      "Subset ('TSH', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 380 patients.\n",
      "Subset ('TSH', 'LH', 'FSH', 'Prolactin', 'Testosterone') has more than 300 patients. with 417 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )') has more than 300 patients. with 352 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 505 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 553 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GPT ( ALT )') has more than 300 patients. with 361 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 530 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'ESR') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'PCV') has more than 300 patients. with 363 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 310 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 324 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 353 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 502 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 316 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 332 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 339 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 353 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 384 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 562 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 345 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'Vitamin D3') has more than 300 patients. with 307 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 361 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 325 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 438 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 438 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 452 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 444 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 355 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 324 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 354 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 502 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 317 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 332 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 325 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 317 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 340 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 340 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 354 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 346 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 307 patients.\n",
      "Subset ('S.Cholestrol', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 439 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 312 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 325 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 354 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 503 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 318 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 333 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 312 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 312 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 326 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 318 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 341 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 341 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 357 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 347 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 306 patients.\n",
      "Subset ('S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 443 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 315 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 315 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 328 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 321 patients.\n",
      "Subset ('S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 315 patients.\n",
      "Subset ('S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 344 patients.\n",
      "Subset ('S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 349 patients.\n",
      "Subset ('B.Urea', 'S.Creatinine', 'Sodium  Na+', 'Potassium K+', 'Chloride CL-') has more than 300 patients. with 399 patients.\n",
      "Subset ('B.Urea', 'S.Creatinine', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 508 patients.\n",
      "Subset ('S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride', 'HDL ( High density lipoprotein )') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Creatinine', 'LDL ( Low density lipoprotein )', 'Total Cholestrol', 'Triglyceride', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 397 patients.\n"
     ]
    }
   ],
   "source": [
    "# for degree of 5:\n",
    "# limit of 300\n",
    "\n",
    "subsets = list(combinations(unique_tests, 5))\n",
    "print(f\"Total number of subsets of size 5: {len(subsets)}\")\n",
    "for subset in subsets:\n",
    "    # Create a boolean mask for patients who have all tests in the subset\n",
    "    mask = df_grouped_by_patient[subset[0]] > 0\n",
    "    for test in subset[1:]:\n",
    "        mask = mask & (df_grouped_by_patient[test] > 0)\n",
    "    \n",
    "    count = mask.sum()\n",
    "    if count > 300:\n",
    "        print(f\"Subset {subset} has more than 300 patients. with {count} patients.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8d43739b",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "cfed6448",
   "metadata": {},
   "source": [
    "## 2nd Process: Finding Multiple Tests at Different Times\n",
    "\n",
    "### Step 1: Remove Records with Missing Date of Sample (DOS)\n",
    "\n",
    "We'll clean the dataset by removing records where the Date of Sample (DOS) is missing, as these records cannot be used for temporal analysis.\n",
    "\n",
    "### Step 2: Identify Patients with Multiple Tests at Different Times\n",
    "\n",
    "After cleaning the dates, we'll identify patients who have undergone multiple laboratory tests at different time points, which will allow us to analyze temporal patterns in their health data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "id": "29a2b4cc",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Before removing null values in DOS: 137019\n",
      "After removing null values in DOS: 81578\n"
     ]
    }
   ],
   "source": [
    "# copying the df\n",
    "df2 = df.copy()\n",
    "\n",
    "print(\"Before removing null values in DOS: {}\".format(df2.shape[0]))\n",
    "\n",
    "df2.dropna(subset=['DOS'], inplace=True)\n",
    "print(\"After removing null values in DOS: {}\".format(df2.shape[0]))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "055c38e7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>S.Iron</th>\n",
       "      <th>CRP Titer</th>\n",
       "      <th>Troponin T hs Stat</th>\n",
       "      <th>Blood Sugar</th>\n",
       "      <th>HBA1C</th>\n",
       "      <th>S.ALP</th>\n",
       "      <th>TSH</th>\n",
       "      <th>S.Cholestrol</th>\n",
       "      <th>S.Triglyceride</th>\n",
       "      <th>S.HDL</th>\n",
       "      <th>...</th>\n",
       "      <th>Blood Group &amp; Rh</th>\n",
       "      <th>LH</th>\n",
       "      <th>FSH</th>\n",
       "      <th>BHCG Titer</th>\n",
       "      <th>Prolactin</th>\n",
       "      <th>Pregnancy Test (BHCG)</th>\n",
       "      <th>Fecal Calprotectein Titer</th>\n",
       "      <th>H.Pylori Antigen Titer</th>\n",
       "      <th>Stool For H.pylori ( H.pylori Ag ) titer</th>\n",
       "      <th>Testosterone</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Patient Name</th>\n",
       "      <th>DOS</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>ALI ABDUL KARIM AHMAD</th>\n",
       "      <th>24/09/2024</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AMR ABID RASHAD</th>\n",
       "      <th>24/04/2024</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ARez Mariwan Hama Saeed</th>\n",
       "      <th>19/11/2024</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Aadan Muhammed Ebrahim</th>\n",
       "      <th>21/10/2023</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Aaland Hemn Kamil</th>\n",
       "      <th>05/04/2024</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 46 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    S.Iron  CRP Titer  Troponin T hs Stat  \\\n",
       "Patient Name            DOS                                                 \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024       0          0                   0   \n",
       "AMR ABID RASHAD         24/04/2024       0          0                   0   \n",
       "ARez Mariwan Hama Saeed 19/11/2024       0          0                   0   \n",
       "Aadan Muhammed Ebrahim  21/10/2023       0          0                   0   \n",
       "Aaland Hemn Kamil       05/04/2024       0          0                   0   \n",
       "\n",
       "                                    Blood Sugar  HBA1C  S.ALP  TSH  \\\n",
       "Patient Name            DOS                                          \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024            0      0      0    1   \n",
       "AMR ABID RASHAD         24/04/2024            1      1      0    0   \n",
       "ARez Mariwan Hama Saeed 19/11/2024            1      0      0    0   \n",
       "Aadan Muhammed Ebrahim  21/10/2023            0      0      0    0   \n",
       "Aaland Hemn Kamil       05/04/2024            0      0      0    1   \n",
       "\n",
       "                                    S.Cholestrol  S.Triglyceride  S.HDL  ...  \\\n",
       "Patient Name            DOS                                              ...   \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024             0               0      0  ...   \n",
       "AMR ABID RASHAD         24/04/2024             0               0      0  ...   \n",
       "ARez Mariwan Hama Saeed 19/11/2024             0               0      0  ...   \n",
       "Aadan Muhammed Ebrahim  21/10/2023             0               0      0  ...   \n",
       "Aaland Hemn Kamil       05/04/2024             0               0      0  ...   \n",
       "\n",
       "                                    Blood Group & Rh  LH  FSH  BHCG Titer  \\\n",
       "Patient Name            DOS                                                 \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024                 0   0    0           0   \n",
       "AMR ABID RASHAD         24/04/2024                 0   0    0           0   \n",
       "ARez Mariwan Hama Saeed 19/11/2024                 0   0    0           0   \n",
       "Aadan Muhammed Ebrahim  21/10/2023                 0   0    0           0   \n",
       "Aaland Hemn Kamil       05/04/2024                 0   0    0           0   \n",
       "\n",
       "                                    Prolactin  Pregnancy Test (BHCG)  \\\n",
       "Patient Name            DOS                                            \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024          0                      0   \n",
       "AMR ABID RASHAD         24/04/2024          0                      0   \n",
       "ARez Mariwan Hama Saeed 19/11/2024          0                      0   \n",
       "Aadan Muhammed Ebrahim  21/10/2023          0                      0   \n",
       "Aaland Hemn Kamil       05/04/2024          0                      0   \n",
       "\n",
       "                                    Fecal Calprotectein Titer  \\\n",
       "Patient Name            DOS                                     \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024                          0   \n",
       "AMR ABID RASHAD         24/04/2024                          0   \n",
       "ARez Mariwan Hama Saeed 19/11/2024                          0   \n",
       "Aadan Muhammed Ebrahim  21/10/2023                          0   \n",
       "Aaland Hemn Kamil       05/04/2024                          0   \n",
       "\n",
       "                                    H.Pylori Antigen Titer  \\\n",
       "Patient Name            DOS                                  \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024                       0   \n",
       "AMR ABID RASHAD         24/04/2024                       0   \n",
       "ARez Mariwan Hama Saeed 19/11/2024                       0   \n",
       "Aadan Muhammed Ebrahim  21/10/2023                       0   \n",
       "Aaland Hemn Kamil       05/04/2024                       0   \n",
       "\n",
       "                                    Stool For H.pylori ( H.pylori Ag ) titer  \\\n",
       "Patient Name            DOS                                                    \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024                                         0   \n",
       "AMR ABID RASHAD         24/04/2024                                         0   \n",
       "ARez Mariwan Hama Saeed 19/11/2024                                         0   \n",
       "Aadan Muhammed Ebrahim  21/10/2023                                         0   \n",
       "Aaland Hemn Kamil       05/04/2024                                         0   \n",
       "\n",
       "                                    Testosterone  \n",
       "Patient Name            DOS                       \n",
       "ALI ABDUL KARIM AHMAD   24/09/2024             0  \n",
       "AMR ABID RASHAD         24/04/2024             0  \n",
       "ARez Mariwan Hama Saeed 19/11/2024             0  \n",
       "Aadan Muhammed Ebrahim  21/10/2023             0  \n",
       "Aaland Hemn Kamil       05/04/2024             0  \n",
       "\n",
       "[5 rows x 46 columns]"
      ]
     },
     "execution_count": 97,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2_grouped = df2.groupby(['Patient Name', 'DOS'])[[i for i in unique_tests]].sum()\n",
    "df2_grouped.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "id": "dc27a744",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(37117, 46)"
      ]
     },
     "execution_count": 98,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2_grouped.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "id": "d3a19aef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>DOS</th>\n",
       "      <th>S.Iron</th>\n",
       "      <th>CRP Titer</th>\n",
       "      <th>Troponin T hs Stat</th>\n",
       "      <th>Blood Sugar</th>\n",
       "      <th>HBA1C</th>\n",
       "      <th>S.ALP</th>\n",
       "      <th>TSH</th>\n",
       "      <th>S.Cholestrol</th>\n",
       "      <th>...</th>\n",
       "      <th>Blood Group &amp; Rh</th>\n",
       "      <th>LH</th>\n",
       "      <th>FSH</th>\n",
       "      <th>BHCG Titer</th>\n",
       "      <th>Prolactin</th>\n",
       "      <th>Pregnancy Test (BHCG)</th>\n",
       "      <th>Fecal Calprotectein Titer</th>\n",
       "      <th>H.Pylori Antigen Titer</th>\n",
       "      <th>Stool For H.pylori ( H.pylori Ag ) titer</th>\n",
       "      <th>Testosterone</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ALI ABDUL KARIM AHMAD</td>\n",
       "      <td>24/09/2024</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>AMR ABID RASHAD</td>\n",
       "      <td>24/04/2024</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ARez Mariwan Hama Saeed</td>\n",
       "      <td>19/11/2024</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Aadan Muhammed Ebrahim</td>\n",
       "      <td>21/10/2023</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Aaland Hemn Kamil</td>\n",
       "      <td>05/04/2024</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 48 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              Patient Name         DOS  S.Iron  CRP Titer  Troponin T hs Stat  \\\n",
       "0    ALI ABDUL KARIM AHMAD  24/09/2024       0          0                   0   \n",
       "1          AMR ABID RASHAD  24/04/2024       0          0                   0   \n",
       "2  ARez Mariwan Hama Saeed  19/11/2024       0          0                   0   \n",
       "3   Aadan Muhammed Ebrahim  21/10/2023       0          0                   0   \n",
       "4        Aaland Hemn Kamil  05/04/2024       0          0                   0   \n",
       "\n",
       "   Blood Sugar  HBA1C  S.ALP  TSH  S.Cholestrol  ...  Blood Group & Rh  LH  \\\n",
       "0            0      0      0    1             0  ...                 0   0   \n",
       "1            1      1      0    0             0  ...                 0   0   \n",
       "2            1      0      0    0             0  ...                 0   0   \n",
       "3            0      0      0    0             0  ...                 0   0   \n",
       "4            0      0      0    1             0  ...                 0   0   \n",
       "\n",
       "   FSH  BHCG Titer  Prolactin  Pregnancy Test (BHCG)  \\\n",
       "0    0           0          0                      0   \n",
       "1    0           0          0                      0   \n",
       "2    0           0          0                      0   \n",
       "3    0           0          0                      0   \n",
       "4    0           0          0                      0   \n",
       "\n",
       "   Fecal Calprotectein Titer  H.Pylori Antigen Titer  \\\n",
       "0                          0                       0   \n",
       "1                          0                       0   \n",
       "2                          0                       0   \n",
       "3                          0                       0   \n",
       "4                          0                       0   \n",
       "\n",
       "   Stool For H.pylori ( H.pylori Ag ) titer  Testosterone  \n",
       "0                                         0             0  \n",
       "1                                         0             0  \n",
       "2                                         0             0  \n",
       "3                                         0             0  \n",
       "4                                         0             0  \n",
       "\n",
       "[5 rows x 48 columns]"
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2_grouped.reset_index(inplace=True)\n",
    "df2_grouped.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "id": "35c83c9b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(18320, 48)"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# dropping patient names with one time being featured\n",
    "df2_grouped = df2_grouped[df2_grouped['Patient Name'].map(df2_grouped['Patient Name'].value_counts()) > 1]\n",
    "df2_grouped.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "id": "3e2d82f7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The total number of tests done across all patients in the new df is: 41901\n",
      "The total number of rows in the new df is: 18320\n",
      "The total number of unique patients in the new df is: 6146\n"
     ]
    }
   ],
   "source": [
    "print(f\"The total number of tests done across all patients in the new df is: {df2_grouped[[i for i in unique_tests]].sum().sum()}\")\n",
    "print(f\"The total number of rows in the new df is: {df2_grouped.shape[0]}\")\n",
    "\n",
    "print(f\"The total number of unique patients in the new df is: {df2_grouped['Patient Name'].nunique()}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "id": "a8f5e64b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>DOS</th>\n",
       "      <th>S.Iron</th>\n",
       "      <th>CRP Titer</th>\n",
       "      <th>Troponin T hs Stat</th>\n",
       "      <th>Blood Sugar</th>\n",
       "      <th>HBA1C</th>\n",
       "      <th>S.ALP</th>\n",
       "      <th>TSH</th>\n",
       "      <th>S.Cholestrol</th>\n",
       "      <th>...</th>\n",
       "      <th>Blood Group &amp; Rh</th>\n",
       "      <th>LH</th>\n",
       "      <th>FSH</th>\n",
       "      <th>BHCG Titer</th>\n",
       "      <th>Prolactin</th>\n",
       "      <th>Pregnancy Test (BHCG)</th>\n",
       "      <th>Fecal Calprotectein Titer</th>\n",
       "      <th>H.Pylori Antigen Titer</th>\n",
       "      <th>Stool For H.pylori ( H.pylori Ag ) titer</th>\n",
       "      <th>Testosterone</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Aanwar Saeed Mhamad</td>\n",
       "      <td>16/02/2024</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Aanwar Saeed Mhamad</td>\n",
       "      <td>18/08/2023</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Aanwar Saeed Mhamad</td>\n",
       "      <td>25/09/2023</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Ababakr Karim</td>\n",
       "      <td>01/12/2024</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Ababakr Karim</td>\n",
       "      <td>05/01/2025</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 48 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           Patient Name         DOS  S.Iron  CRP Titer  Troponin T hs Stat  \\\n",
       "5   Aanwar Saeed Mhamad  16/02/2024       0          0                   0   \n",
       "6   Aanwar Saeed Mhamad  18/08/2023       0          0                   0   \n",
       "7   Aanwar Saeed Mhamad  25/09/2023       0          0                   0   \n",
       "10        Ababakr Karim  01/12/2024       0          0                   0   \n",
       "11        Ababakr Karim  05/01/2025       0          0                   0   \n",
       "\n",
       "    Blood Sugar  HBA1C  S.ALP  TSH  S.Cholestrol  ...  Blood Group & Rh  LH  \\\n",
       "5             0      0      0    0             0  ...                 0   0   \n",
       "6             0      0      0    0             0  ...                 0   0   \n",
       "7             1      0      0    0             0  ...                 0   0   \n",
       "10            0      0      0    1             0  ...                 0   0   \n",
       "11            0      0      0    1             0  ...                 0   0   \n",
       "\n",
       "    FSH  BHCG Titer  Prolactin  Pregnancy Test (BHCG)  \\\n",
       "5     0           0          0                      0   \n",
       "6     0           0          0                      0   \n",
       "7     0           0          0                      0   \n",
       "10    0           0          0                      0   \n",
       "11    0           0          0                      0   \n",
       "\n",
       "    Fecal Calprotectein Titer  H.Pylori Antigen Titer  \\\n",
       "5                           0                       0   \n",
       "6                           0                       0   \n",
       "7                           0                       0   \n",
       "10                          0                       0   \n",
       "11                          0                       0   \n",
       "\n",
       "    Stool For H.pylori ( H.pylori Ag ) titer  Testosterone  \n",
       "5                                          0             0  \n",
       "6                                          0             0  \n",
       "7                                          0             0  \n",
       "10                                         0             0  \n",
       "11                                         0             0  \n",
       "\n",
       "[5 rows x 48 columns]"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2_grouped.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "id": "96b28b30",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "S.Iron                                      1279\n",
       "CRP Titer                                   1192\n",
       "Troponin T hs Stat                           388\n",
       "Blood Sugar                                 5309\n",
       "HBA1C                                       2688\n",
       "S.ALP                                        275\n",
       "TSH                                         3813\n",
       "S.Cholestrol                                2236\n",
       "S.Triglyceride                              2321\n",
       "S.HDL                                       1240\n",
       "S.LDL                                       1640\n",
       "S.Ferritin                                   697\n",
       "S.GOT ( AST )                                607\n",
       "B.Urea                                      1511\n",
       "S.Creatinine                                1691\n",
       "S.GPT ( ALT )                                623\n",
       "Vitamine B12                                 510\n",
       "Vitamin D3                                  2340\n",
       "Sodium  Na+                                  285\n",
       "Potassium K+                                 285\n",
       "Chloride CL-                                 284\n",
       "PSA                                          438\n",
       "ESR                                          832\n",
       "S.Calcium                                    335\n",
       "Glucose                                        4\n",
       "LDL ( Low density lipoprotein )                0\n",
       "HBs Ag                                      1012\n",
       "HCV Ab                                      1001\n",
       "HIV Ab                                       999\n",
       "PCV                                         2086\n",
       "Free T4 ( FT4 )                                2\n",
       "Total Cholestrol                               1\n",
       "Triglyceride                                   3\n",
       "HDL ( High density lipoprotein )               0\n",
       "Erythrocyte Sedimentation Rate ( ESR )         2\n",
       "T.S.B ( Total Serum Bilirubin )              641\n",
       "Blood Group & Rh                             259\n",
       "LH                                           306\n",
       "FSH                                          336\n",
       "BHCG Titer                                   786\n",
       "Prolactin                                    520\n",
       "Pregnancy Test (BHCG)                       1124\n",
       "Fecal Calprotectein Titer                      0\n",
       "H.Pylori Antigen Titer                         0\n",
       "Stool For H.pylori ( H.pylori Ag ) titer       0\n",
       "Testosterone                                   0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# count of each test\n",
    "test_counts = df2_grouped[[i for i in unique_tests]].sum()\n",
    "test_counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "id": "380a5f7a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of unique tests: 46\n",
      "Number of unique tests with more than 100 counts: 35\n"
     ]
    }
   ],
   "source": [
    "\n",
    "print(\"Number of unique tests:\", len(unique_tests))\n",
    "unique_tests_cleaned = [test for test in test_counts.keys() if test_counts[test] > 100]\n",
    "print(\"Number of unique tests with more than 100 counts:\", len(unique_tests_cleaned))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "id": "40104da0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Completed for v=2 for limits [300, 500, 1000], results: [202, 131, 50]\n",
      "Completed for v=3 for limits [300, 500, 1000], results: [356, 152, 30]\n",
      "Completed for v=4 for limits [300, 500, 1000], results: [337, 87, 4]\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>202</td>\n",
       "      <td>356</td>\n",
       "      <td>337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>500</th>\n",
       "      <td>131</td>\n",
       "      <td>152</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>50</td>\n",
       "      <td>30</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        2    3    4\n",
       "300   202  356  337\n",
       "500   131  152   87\n",
       "1000   50   30    4"
      ]
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "limits = [300, 500, 1000]\n",
    "vs = [2, 3, 4]\n",
    "\n",
    "pivot_table_2 = pd.DataFrame(index=limits, columns=vs)\n",
    "\n",
    "for v in vs:\n",
    "    subsets = list(combinations(unique_tests_cleaned, v))\n",
    "    count_of_possible_df = [0] * len(limits)\n",
    "    for subset in subsets:\n",
    "        # Create a boolean mask for patients who have all tests in the subset\n",
    "        mask = df_grouped_by_patient[subset[0]] > 0\n",
    "        for test in subset[1:]:\n",
    "            mask = mask & (df_grouped_by_patient[test] > 0)\n",
    "        \n",
    "        count = mask.sum()\n",
    "        for i, limit in enumerate(limits):\n",
    "            if count > limit:\n",
    "                count_of_possible_df[i] += 1\n",
    "            # print(f\"Subset {subset} has more than {limit} patients. with {count} patients.\")\n",
    "    pivot_table_2[v] = count_of_possible_df\n",
    "    print(f\"Completed for v={v} for limits {limits}, results: {count_of_possible_df}\")\n",
    "\n",
    "\n",
    "# let's create a pivot table\n",
    "# row is limits, column is v, values are count of possible dfs\n",
    "\n",
    "# visualizing the pivot table\n",
    "\n",
    "pivot_table_2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "id": "8bdb0bac",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "THE TOTAL NUMBER OF TEST COMBINATIONS IN EACH CRITERIA\n",
      "1. Without caring about different dates in DOS\n",
      "2. With caring about different dates in DOS\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABI0AAAHqCAYAAACJAb5xAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjYsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvq6yFwwAAAAlwSFlzAAAPYQAAD2EBqD+naQAAkudJREFUeJzt3Qd4VFW3gOGVhCRAIIHQkd57ERAQRKQKiCL425CiCIKAAooYRapIsdCkqQgoYENBBaRKsdAFQZqASJFA6CVAEpK5z9q5M2SY9Ewymcz33ufcyZxz5mTPyeCsf+219/ayWCwWAQAAAAAAAOLwjvsEAAAAAAAAUCSNAAAAAAAA4ICkEQAAAAAAAByQNAIAAAAAAIADkkYAAAAAAABwQNIIAAAAAAAADkgaAQAAAAAAwAFJIwAAAAAAADggaQQAAAAAAAAHJI2QodavXy9eXl7mMbnnLlq0SLKiuXPnmvf377//2u1/9913pUyZMuLj4yO1atUy+27duiWvvfaaFC9eXLy9vaVDhw4uajWSS/+2I0aMcHUzAAAeJLPHWfq9qL8zroRinGvXrsnzzz8vhQsXNq8ZMGBAhrUTKafxrP6dNL4FkLWQNEKyff311+bLYPHixQ7HatasaY6tW7fO4ViJEiXk3nvvTfC6CxculEmTJklmcv36dRPYJCfoiht4WTd/f38pVKiQNG3aVN555x05e/Zssq6zatUqEzg1atRI5syZY16rPv30U5NMeuyxx2TevHkycOBAyayWL1+eomSJ3iPrfdNgMTAwUCpWrChdunSR1atXp6kt06dPzzLBS/fu3e0+Y7ly5TLJRf1MfPvttxITExPv6ywWi3z++efSpEkTyZMnj+TMmVOqV68uo0aNkvDwcIfz9TqfffaZ1K9fX4KDgyV37txSoUIF6dq1q2zevDkD3ikAeCZ3i7OsnV/WLXv27FK0aFFp3bq1TJkyRa5evZqs6yQU42gMpL+jT58+5ntM44LMKqX3uFSpUnaxj34/63dzr169ZMuWLWlqi963JUuWSFaQ2hgxKirKfAbr1atn4hiNmfRn3afH7hQZGSmTJ0+W2rVrm9+hf4+qVauav8eBAwfS+V0CbsACJNN///1n0Y/MoEGD7PZfvnzZ4u3tbcmWLZtl9OjRdseOHz9uXjN48GDzPDo62nLjxg3zaNWuXTtLyZIlHX7funXrzGu/+eYbS0Y7e/as+d3Dhw9P1vnWtr700kuWzz//3DJ37lzLu+++a3n00UfNfcmXL59l7dq1dq+5deuWuRcxMTG2fUOGDDH3MiIiwu7cJ554wnLXXXdZ3EHfvn3NvUiu+++/31KsWDFz33SbOXOm5dVXX7WUKVPGXOfxxx+3REZGpqotVatWNdd3Bf3bRkVFOe163bp1s/j7+9vu00cffWR58803LTVq1DD3qWnTpubf4p2fMb1/evy+++6zTJw40TJr1izLM888Yz5n1apVs5w+fTrev98jjzximTx5smXatGnmc12+fPlk/3sAAGT9OGvOnDnm9aNGjTLfS59++qnlnXfesbRq1cri5eVlfueff/5p9xr9XtT2JSfGqV+/vqVRo0YWd5DQPU6InlurVi3bd/r06dMt/fv3txQuXNjc04EDB6a6LQEBASZmyGgaz+rfVmMPZ0lNjHjt2jXzOj3+0EMPWT788ENzfx9++GGzT4/pOXHpeT4+PiY+0rhn0qRJlt69e5vfrZ9zwNORNEKKlC5d2nLPPffY7VuxYoUJDp566ilL69at7Y4tXLjQ/Af6+++/T/CaWSlpFF9bd+3aZSlYsKAlT548llOnTiV6nWeffdZ82d/pgQceMAkQZ36xX79+3ZJZkkbxvTcNOl588UVzrddee83tkkbOpgFgfJ8NNXbsWFvwFJcG77pfA6w7/fDDD+Z/hDz44IO2fZpA0n/LPXv2jPczc+bMGae8FwCA+8dZ1qTRtm3bHI5pR1mOHDnM700q3kgoxtF7oW13FmtCLbMkjeJ7b3qvOnToYO6rJjrcKWmUHlITI/bq1cvsnzp1qsPrNIGkxzQhZLV161azb8yYMfH+nnPnzjnt/QDuiqQRUqRLly4WX19fuwDgrbfeMhULn332mSUoKMiud0sTCBroWP+Daw1Q9FFZewLibtYvXeu5X331leXtt982vVBaadGsWTPLoUOHHNr29ddfW+6++25L9uzZTWVP586dLSdPnrQ7R39ffEkE/XK1/t6jR486tCmpBFJSgZc1qHvjjTccgi39fSq+32k9587Nev/0Xmv1SJUqVcy90eSUflleuHAh3uBEA886deqYc/V16uLFi5aXX37Z9Kb4+flZypYtaxk3bpzd39F6T7R6SitVtIdHz61bt675so17H+Nrb2oCAuuXtb63nDlzWi5dumTbr72ZGmQWKFDAtKNy5coOwZW+5zvbEfdvn5z3rb744gvzucqVK5cld+7c5rOuPVBJufMzoz/rPv3s6n3SfyuBgYGW7t27W8LDw9OUNFLWnt2DBw+a5/pvNG/evJYKFSokWPGkSUpt06ZNm8xzfdTnWikHAMh4mTnOSknSKG7HhVbG3vldmFi8ZW3XnZs1Xrp586Zl2LBh5ntbv7/1e1wrrXR/XPoavT/z5883sYRWai1evNgc0/hQvwM1btJr6PHZs2fbvT659yexe5zSpJG6evWqJTg42Py+uNXoGoM1bNjQHNNYV2OTO+PO+O5b3ARSct63mjJlijmmiT/t9NTYccGCBYm+J+vfM25ljjV20d+rFcz6c/78+S2vvPJKsiqSUhojnjhxwlQM6d8oIRo/6mdBz7XGedru9evXJ9kewFMxpxFSpHHjxmYscNzx1r/99psZS6/b5cuX5a+//rI7VqlSJcmXL1+813vzzTfNZM/58+c349V1u3NM+Lhx48z4/ldffVVCQkLMvCqdO3e2O0fHvD/++ONm8uixY8dKz5495bvvvjPtvXTpUoreY4ECBWTGjBnm50cffdTWro4dO0pq6Tj9HDlymDmLEqK/47777jPzIVl/p46/1ke9h8WKFbPtr1y5snnNCy+8IIMHDzZzIOlY7GeffVYWLFhg5hO4c8z2wYMH5amnnpKWLVuac/W+69xN999/v8yfP9/MWaNjvfVaep8HDRoU75h9nXdAf+/bb79tJj3U+2L9Xbpfr299P9YttfTvqW3Wdv7666+2/fr3KVmypLzxxhvy/vvvm8kzX3zxRZk2bZrtHP0c6T3Te2dth37eVHLft46X19+fN29eGT9+vPks6vh6/Vynln5OdZ4H/Zzqz/rZHTlypKSVju/XeNE6xl/v18WLF+Xpp5+WbNmyxfsafe9q6dKl5lHvqfrmm2/MPQIAZKzMGmelhnUOooRiH423Eopx9FHbrG237tfzdd69hx9+WN577z1p3769TJ061UycPXHiRHniiSccfsfPP/9s5kjSYxr76FxCZ86ckQYNGsiaNWukX79+Zn+5cuWkR48e8c5LlNT9Sc49Tgmdf0fjz//++0/27dtn22+dc0fnJNR5i/S7/X//+58sW7bMdo7+bo0jNZ60tkVjM5Xc9/3xxx/LSy+9JFWqVDH7NUbR95fauZaio6NNXKqfUf27afylsdtHH30kaRFfjPjTTz+Z32eNb+Kjx3Ty9RUrVtjFPho/634A8XB11gruZe/evSYbbx1TrxUM2mswb94887xQoUJmLLC6cuWKyfbHHepyZw9YcsqmtYok7hw/Os+K7t+zZ495rmOZtcdEe+Hilh0vXbrUnKe9USmpNHL28DSrmjVrmsqPhCqNEqsmia+n5ZdffjGvv7PnR6uJ7txvrbrRY3Hp31F/399//223//XXXzd/O50rIW7vkVZwxa1i0nJ43f/jjz86fXialfYK6vX0724VX6m7luxrBVRyhqcl931rJZJWA6VmfH5ClUbPPfec3Xk675Xe17RWGu3cudNuHgSthtLn1l7V+OjfUs/p2LGjbV/Xrl3NPv2satvee+89y/79+5NsHwAga8ZZqa00UloZVbt27XgrjZKKA+KrxtF5bXRotcZAcelcN3rd3377zbZPn+u5ek/j6tGjh6VIkSIOw46efPJJ015rjJGS++Os4WlWWg1+57DDO2MfjX819r2zqiah4WnJfd9aEZSaKRESqjSyznsVl34mtHrJ2THigAEDzHONiRLyxx9/2M0dptVc1mox/felw0D139ixY8eS9b4BT0ClEVJEe3+0p8Ca0f/zzz/NCkzWVTv00VqFsWnTJpPt116ztNDqGT8/P9tz7T1R//zzj3ncvn27hIWFmUoTXbnDql27dqb3Km4PjCtpz1FyVxJJDq0GCQoKMpU9586ds2116tQxv+vOFVZKly5tenruvIbeT62kiXuNFi1amL/dxo0b7c7Xnjo9N6G/RXrQ96Li3jut2rLSXldts/ZcaTv0eVKS+7519Qz9fKd1Fbe4evfubfdc23H+/Hm5cuWKU++T9VFXDUmI9Vjc362r9n344Yfm82LtWdV/982bNze9ngAAz4qzMlvso/dI47u439/NmjUzx++MfTQ20IoZK80l6YqjWqWkP8e9hsZIGkP88ccfGXZ/Uhv7aCWxtlXbcmd745OS962xz8mTJ2Xbtm3pGvs46/OV1thHV2ZbuXKlqaDXuPCLL76Qvn37mgokjXtTOmIByIriH7MAJED/w6oBi/6Pai0R1sClYMGCprxV6TH9H5zKGtSkNZjRpWTjsiYt9AtTHTt2zDzqEpx30qAi7rAmV7p27VqiX2IpdejQIfMlr/c/PppIi0uTAPFdY/fu3abkOznXSOpvkV73TcW9d/rZGj58uAmY7xxGpfdEk2mJSe771kSkLoHcpk0bueuuu6RVq1ZmSNmDDz6Y6veT2D3UZV6ddZ+sj4kF6/EFV7qkrQZLumkyS+/1zJkzTcn3k08+Kb/88kuq2wgAcL84Ky30uymhOCU19Pt7//79yY5b7ox9zp49a5IAOjQqoeFRmTX20aHkmtjYtWuXRERE2H1mkpKS9z1kyBAzhO2ee+4xnzuNfXSouw7jTw3t0L3z76X30FmfL2fEPjqkT4cZ6hYaGiobNmwww/c0BvT19TXTGQCejKQRUkyDkx9//FH27NljG2dvpT/rHDtakaDJmqJFi0qZMmXSPGY5PrGVxymjX6zxvU576tKTzk/w999/S7Vq1Zx2TQ0mNRDTMdjxufMLOm4PVdxraKXSa6+9Fu81KlSokG5/i+Syzt1gDZiPHDliql40IfjBBx+Y+Yy0B3D58uVmTgN9T0lJ7vvW+6vBmfZAadJEN63E0fHw8+bNS9X7Sa97eOd9ss57pckxne8hPnpMxe2FjUt7u3XuCN10LicNojRJax3/DwBwPneOs+LSahXtyLF+LzmDfn9Xr17dfP/HR2OCxGIfa4zwzDPPSLdu3eK9Ro0aNTJd7KMdNvpd3KRJE5k+fboUKVLEJDM0JtH5JpOSkvet8YPOg6lJKp33RyuU9HcOGzYsVXMwJnT/nCGx2EfnYUpN7KP3VjvJOnXqJFWrVjWJI51/MqH5IQFPwKcfKWbt0dJgRYOZAQMG2I7p0CjN1q9fv95MmNe2bdskr5ecHpLEWP8HrH7BWcuTrXRf3P+Bqz0b8ZXDWquVnNWmOy1atEhu3LjhMDwsLcqWLWt6grTnJ76EUHKvob00OizLWZx57zSZp8FQzpw5bZ87DaS1h+2HH36w6/27syQ9sbak5H1rQkrLuXXToEurj2bNmiVvvfWWUwPhtNLJLvX9Wici1/ulJeZ6/7TnLL6g7bPPPjOPDz30UJLXr1u3rkkaaQ8cSSMA8Jw4K7WsC2E4O/bRIXvaeZSa96UdalphovFFZo19ND7R4eGaALMmQTRxoxU72omlf38rTRolpy0pfd8BAQFmaJZukZGRZtGTMWPGmInA404F4UrxxYhaGa7xjn72EpoMW2MfTQAlVTWuSTlNpGl1mw7jK1y4cLq8D8AdMKcRUkz/x6N+YWiFi/Z0xe0B0y+yu+++26xipWPwk1MyrV9MyZmHJrH2aEWIDqGJW66rVSFawqxzG8UNNg4cOGDKdK00+LhzNSz9AlLOGMes19eATxNWOuTHWXSYlH5hjh492uGYrv6QnLbrNXSIlwYhd9LXp2YVCf17Wl+fFvredPUO/Rvqo3XoljX5EbeHTz8/8QVO2pb42pHc963Ds+LSoVvWnri4nzVX05VddHUaDe7Kly9v+wzrfESaOLWuGheXzvWlPWcazOtqKur06dN2K7VYacC4du1a8/4zU6IMALKizBZnpYauWqbxiQ4Pc8ZKbHG/v/We6Apfd9LOOb0nidEYQitINAkTdxU6q7jxYUo46x7re9BV5y5cuGC+u60JIG23/hy3Ml5XsF2yZEmyYp+UvO87Yx/tPNOqHI277lyZ11USihE10aZzUGmnqnUl5Lj0fyvoZ1NXjNMV+5QmhY4fP+5wrt5DjRU1fk9oOCTgKag0Qorpl4cuBa+lshq8aK9XXBrc6FKaKjnBjL7+q6++Mkud63V1Ujut6kgu7QnQ5dD1S0InPNTlN3VZUevSqrrUqtVzzz1nSpr1fyjrF4aO39YvEC0/jTsZsFbu6BektkuHKgUHB5uhZUkNL9N7cvPmTfNlZp0PRitidI4d7TVyZi+FvlddRlWXbtchVDrmXO+FfvnpRJH6/h977LFEr6El7to+rTTp3r27+VtowKUl8VodpQGJLiGbEtbPg36J633WQEXLfBOjgZZ1vLjOUXT48GH57rvvzFA0fW3cxJi+T2v1j75/7ZHT4FETh1oFc2dbNGjQOQA02aHnaDVact/3888/bwI3fY0GF1qRpsv7asmztfcvI2kyy3qf9HOm7dH3oaXWDzzwgMM8Ba+//rrs3LnT/PvQwEcDRv1sa++1XkffQ9xhdjqUQOcw0Pervbj6edV/IzoppDX5mdLPAwDAveOspGgnnXbI6XeUxl/6P8p1AQmtStXvKGdWpmhCRYcL6cTKWmGs1dYac+nv1/3aGaRJt6Q6WvS19evXl549e5p4T7/rdSJoTTbozymVmnusyS/rd7rGMtppo/GbduC88sorJsax0g5QjV+1OkbnF9LvZk0camxjHW4Vty36PvR8Hb6oiTt9r8l93xpn6fe/3ttChQqZxIzOo6VtcObcnMmVkhhR6VQF+nnQynAdXmetKNLPxvfff2/iZ+u/H6Xxjd5TrVLSCbo15te/jcZHp06dkkmTJqXrEDvALbh6+Ta4p5CQELM05b333utw7LvvvjPHcufO7bBUeXxLwV67ds3y9NNPW/LkyWOOWZcsTWgZ+/iW9FRfffWVWcLT39/fEhwcbOncubPl5MmTDu2bP3++WZrdz8/PUqtWLcvKlSvNkqB3LpX6+++/m+VA9bw7l0+/k7Wt1s3X19dSoEABS5MmTSxjxoyxhIWFJbhUrb6fpJZVT2zJ0Y8++si0M0eOHOaeV69e3fLaa69ZTp06laylXa9evWr+nuXKlTPvNX/+/Obvqkut63Kuce/5u+++6/D6O++N/s379+9v3r+Xl5fD0rrxvbe49y5XrlyW8uXLW5555hnLqlWr4n3NDz/8YKlRo4Yle/bsllKlSlnGjx9v+fTTTx3u5+nTp8371vuix/R3peR9L1q0yNKqVStLwYIFzTklSpSwvPDCC5bQ0NBE31N898W6zPDZs2eT/BzEx7psrXXLmTOnee+dOnUy7YyOjo73dbpff0ejRo0sgYGB5p7pZ2nkyJHm315cunyzLlvbunVrS7FixcznWO9dw4YNLR9//LFZlhYA4Jlx1p2s31/WTb8nCxcubGnZsqX5LtHvlDtZvwuTE+MkFLvod7R+7+trNObLmzeviYP0e+3y5cu28/T39O3bN962nzlzxhwrXry4+a7Tdjdv3tzEVHfey+Tcn4TucUL0uPW+aayk38/6fnr27GnZsmVLvK+ZPXu2iY/0PVeqVMn8/vju54EDB0z8qXGhHtP4ISXve9asWeb1+fLlM7+rbNmylsGDB9vd2/jEd18Simvja7ezYkQVERFhmThxovlc6O/XmOnuu++2TJo0yRbjxb0n48aNM7+rSJEilmzZspnPVLNmzUx8BcBi8dL/5+rEFQAAAAAAADIX5jQCAAAAAACAA5JGAAAAAAAAcEDSCAAAAAAAAA5IGgEAAAAAAMABSSMAAAAAAAA4IGkEAAAAAAAABySNAAAAAAAA4CCbZEEdPtnu6ibAja2cNtfVTYC7yl/c1S2AG7uxekiG/a4ctfs59Xo3dn7o1Osh49x8s5KrmwA3Ne7bI65uAtxYHj9XtwDuasDuqAz7XSMq+Tr3egcyru3ORKURAAAAAAAAPKPSCAAAJMKLPiMAAIDEeLm6AZkEUSMAAJ7Gy8u5GwAAQBbjynBpxowZUqNGDQkMDDRbw4YN5aeffrIdb9q0qXh5edltvXv3trvG8ePHpV27dpIzZ04pWLCgDB48WG7dupXi+0ClEQAAAAAAQCZRrFgxGTdunJQvX14sFovMmzdPHnnkEdm5c6dUrVrVnNOzZ08ZNWqU7TWaHLKKjo42CaPChQvL77//LqGhodK1a1fx9fWVd955J0VtIWkEAICnYXgaAABAolwZLbVv397u+ZgxY0z10ebNm21JI00SaVIoPqtWrZJ9+/bJmjVrpFChQlKrVi0ZPXq0DBkyREaMGCF+fsmfjZ6oEQAAAAAAIB1FRETIlStX7DbdlxStGvryyy8lPDzcDFOzWrBggeTPn1+qVasmISEhcv36dduxTZs2SfXq1U3CyKp169bmd+7duzdF7SZpBACAp2FOIwAAgAwNl8aOHStBQUF2m+5LyJ49eyRXrlzi7+9v5itavHixVKlSxRx7+umnZf78+bJu3TqTMPr888/lmWeesb329OnTdgkjZX2ux1KC4WkAAHgahqcBAAAkytndYiEhITJo0CC7fZoQSkjFihVl165dcvnyZVm0aJF069ZNNmzYYBJHvXr1sp2nFUVFihSR5s2by5EjR6Rs2bJObTdJIwAAAAAAgHTk7++faJLoTjrvULly5czPderUkW3btsnkyZNl1qxZDufWr1/fPB4+fNgkjXSuo61bt9qdc+bMGfOY0DxICaGrEQAAT8PwNAAAALcKl2JiYhKcA0krkpRWHCmd+0iHt4WFhdnOWb16tQQGBtqGuCUXlUYAAHgahqcBAAAkypXRUkhIiLRp00ZKlCghV69elYULF8r69etl5cqVZgiaPm/btq3ky5dPdu/eLQMHDpQmTZpIjRo1zOtbtWplkkNdunSRCRMmmHmMhg4dKn379k1RtZMiaQQAAAAAAJBJhIWFSdeuXSU0NNRMmK3JIE0YtWzZUk6cOCFr1qyRSZMmmRXVihcvLp06dTJJISsfHx9ZunSp9OnTx1QdBQQEmDmRRo0aleK2kDQCAMDTMKQMAAAg04ZLs2fPTvCYJol0QuyklCxZUpYvX57mtlCfDgAAAAAAAAdUGgEA4GmY0wgAACBR1GXHImkEAICnYXgaAABAogiXYtHVCAAAAAAAAAdUGgEA4GkYngYAAJAoCo1ikTQCAMDTUG8NAACQKG/CJYOuRgAAAAAAADig0ggAAE/D8DQAAIBEUWgUi6QRAACehqQRAABAohjNH4uoEQAAAAAAAA6oNAIAwNMwsyMAAECiiJZiUWkEAAAAAAAAB1QaAQDgaZjTCAAAIFHeXhZXNyFTIGkEAICnYWZHAACARBEtxaKrEQAAAAAAAA6oNAIAwNMwPA0AACBRVBrFImkEAICnYXgaAABAogiXYtHVCAAAAAAAAAdUGgEA4GkYngYAAJAoCo1iETUCAAAAAADAAZVGAAB4GgbpAwAAJMqbcMmg0ggAAE8cnubMLZXGjRsnXl5eMmDAANu+mzdvSt++fSVfvnySK1cu6dSpk5w5c8budcePH5d27dpJzpw5pWDBgjJ48GC5detWmm4JAABAXF5O3twVSSMAAJDhtm3bJrNmzZIaNWrY7R84cKD8+OOP8s0338iGDRvk1KlT0rFjR9vx6OhokzCKjIyU33//XebNmydz586VYcOGueBdAAAAZG0kjQAA8MThac7cUujatWvSuXNn+fjjjyVv3ry2/ZcvX5bZs2fLBx98IM2aNZM6derInDlzTHJo8+bN5pxVq1bJvn37ZP78+VKrVi1p06aNjB49WqZNm2YSSQAAAFkgXMo0SBoBAOBpXDw8TYefabVQixYt7Pbv2LFDoqKi7PZXqlRJSpQoIZs2bTLP9bF69epSqFAh2zmtW7eWK1euyN69e9N0WwAAAKwYnhaLibABAECaREREmC0uf39/s93pyy+/lD/++MMMT7vT6dOnxc/PT/LkyWO3XxNEesx6TtyEkfW49RgAAACch0ojAAA8jZPrrceOHStBQUF2m+6704kTJ+Tll1+WBQsWSPbs2V3y1gEAAJK7epq3Ezd3RaURAACeJg0rnsUnJCREBg0aZLcvviojHX4WFhYmd999t93E1hs3bpQPP/xQVq5caeYlunTpkl21ka6eVrhwYfOzPm7dutXuutbV1aznAAAApJUb53mcikojAACQJpogCgwMtNviSxo1b95c9uzZI7t27bJtdevWNZNiW3/29fWVtWvX2l5z8OBBOX78uDRs2NA810e9hiafrFavXm1+Z5UqVTLoHQMAAHgGKo0AAPA0Tq40Sq7cuXNLtWrV7PYFBARIvnz5bPt79OhhqpaCg4NNIqh///4mUdSgQQNzvFWrViY51KVLF5kwYYKZx2jo0KFmcu34ElUAAACp4c4rnjkTSSMAAJBpTJw4Uby9vaVTp05mcm1dGW369Om24z4+PrJ06VLp06ePSSZp0qlbt24yatQol7YbAAAgKyJpBACAp8lEXWfr16+3e64TZE+bNs1sCSlZsqQsX748A1oHAAA8VeaJllyLpBEAAJ7GRcPTAAAA3EUm6mNzKaJGAAAAAAAAOKDSCAAAT0PXGQAAQKKosIlF0ggAAE/D8DQAAIBE0ccWi6gRAAAAAAAADqg0AgDA09B1BgAAkCiipVgkjQAA8DBeJI0AAAAS5U24ZDA8DQAAAAAAAA6oNAIAwMNQaQQAAJA4oqVYVBoBAAAAAADAAZVGAAB4GrrOAAAAEsWcRrFIGgEA4GEYngYAAJA4hmVloqTRrVu3ZO/evXL69GnzvHDhwlKlShXx9fV1ddMAAAAyBeIlAADgUUmjmJgYGTZsmEybNk0uX75sdywoKEj69esnI0eOFG9vcnwAADgLlUbuhXgJAICMR7gUy6XRxeuvvy4fffSRjBs3Tv755x8JDw83m/48fvx4cywkJMSVTQQAIEsmjZy5IX0RLwEA4JpkibcTt5SYMWOG1KhRQwIDA83WsGFD+emnn2zHb968KX379pV8+fJJrly5pFOnTnLmzBm7axw/flzatWsnOXPmlIIFC8rgwYNN1bJbVRp99tln8vnnn0vr1q3t9pcqVUp69eolJUuWlK5du5qACAAAwBMRLwEA4FmKFStmOovKly8vFotF5s2bJ4888ojs3LlTqlatKgMHDpRly5bJN998Y6s67tixo/z222/m9dHR0SZhpEPZf//9dwkNDTWxgg5pf+edd9wnaXT16lUpWrRogseLFClietKQuE41C0uDUnmlWFB2iYiOkYNnrsm8bSfl1OUIu/MqFgyQznXvkgoFAiTGInL0/HUZueJviYy2mOO5/H2kZ8MSUq9EHvPB3PTvRflk0wm5eSvGRe8MGe3VZ1vK6JcekQ8XrJPB733rcHzJh32kdaOq8vjAj+TH9bvNvuCgAJkzpptUr3CXBAfllLMXrsnS9btl2Ic/ytXwmy54F3CVV5+oL6OfbyoffrddBs9Ya/b5+/rIuN7N5H9NK5uf12w/Ki9PWSVhl67bXte0dkkZ3u0+qVo6v4TfjJIFq/+S4Z9ulGj9DxXSBdVB7oV4yTl8mvQSn6otxatAGZGomxJzfKfcWvm+WM4dvX1SNj/J1maI+NRoJ+LjKzGHfpOoH0aKhJ83h70KV5RsTXqJd8m7RQLyiuXifxK99UuJ3vS5694YMkTdJ1+Qek+9IHnuKmmehx3eJxumvS2Hf1lpnnf/bI2Uuud+u9ds//IjWTqir92+Wo92lYbdB0i+UuUl4toV2bviW1k++qUMfCdwhRqPvyDVH39BAovGfn4uHNknW2a9Lf/+Gvv5af7WdCneoJnkKlBUIq9fk9A/N8mvE9+Qi/8eNMerPNxVWr09O95rz2paVG5cOJuB78ZzuDJcat++vd3zMWPGmOqjzZs3m4TS7NmzZeHChdKsWTNzfM6cOVK5cmVzvEGDBrJq1SrZt2+frFmzRgoVKiS1atWS0aNHy5AhQ2TEiBHi5+fnHkmjpk2byquvvioLFiyQ/Pnz2x07d+6ceUN6DhJXtXBu+WlfmBw6Gy4+3l7yTN27ZMSDFaT/t3sl4v8TPpowGvZgefl212n5+PfjEm2xSOngnCZ5ZDWwaRkJzukrw3/6W7J5e0n/JqXkxcYl5YP1cYIpZFl1qpSQHp0aye6/T8Z7vH/nB8RiiX+ujaUbdsvI6Uvl3MWrUqZ4AZn0+uMyNShAur8xN/0bjkyhToXC0qNdLdl9JMxu/4Q+zaVN/bLSefQSuRIeIRP7tZQvRzwqzQYsMMerlykgS95+TMZ/sUl6TFgqRfPnlqkvtxYfb28J+Widi94NkLkQLzmHd+l6Er15ocT8t0fE20eytRooft0/kYjJD4lE3TDnZGsbIj4V75eoL14Wy81r4tv+LfHrPFUiP3o69hp3VRVL+HmJ/OY1kcuh4lWitvh2GCViiZHozbH/XUPWdOXMSVnz/hty/thhk3iv2aGLPDXtO5nZsZ6cPbzPnLPj609k3ZQRttdE3bjdQaI0WdTw2QGy+t3X5eSfW8UvR4AtCYWs7eqZk/LbpDfk0vHDJhNR5eEu0n7yd7Lg8XomgXRm3x9yYPlCuRp6QvyDgqVBn7fk0VnLZU6b8mKJiZGDK7+Wf3+LTTBZaRIpm192EkYeIDo62lQUaQeRDlPbsWOHREVFSYsWLWznVKpUSUqUKCGbNm0ySSN9rF69ukkYWWnFcp8+fcyiGrVr13aPpNHMmTOlbdu2pocs7hvSsXh79uwxK4IsXbrUlU10C6NWHrJ7PmXjv/LZM7WkbP6csu/0NbPvuQbFZdneMPlud+yKKypuJVKxPNmlTvEgeWXJPjlyLvYL7uNNx+Wt1uVlztaTcvF6VIa9H2S8gBx+Mued7vLi6C/k9ecfdDheo8Jd8nKXZtKo8wT5d81Yu2OXrt6Qj7/51fb8eOhF+eibX2Rg19v/EUPWFpDdV+aEtJcXJ66Q1zvfa9sfmNNPuj9YQ7qP/VE27Dpu9vV6b7n8+WlPuadyUdm6/5Q81rSy/HX0rIyd/7s5/s+pS/Lmx+tk/tBHZMznv8m1G5Eue19ZGoVGboV4yTmi5vW0f74oRLK/uUm8NBH073YR/1ziU6eTRH09WGL+2RJ7zrch4j/wJ/EqXlMsJ/6U6B3f2V3DcvGkRJeoJd5VWpI0yuL+XrfM7vnPk4ZJvSdfkGI169uSRpokunbOfk4Rq+yBeaTZyyNlYZ8OcnTz7U6RM3/vSeeWIzM4usH+8/P71GGm+qhIjfomafTXt5/cPnjqmGyaOlye+fYPCSxaSi6f/EeiI27K9YjbFfw58uaX4vc8IKuH98rIt+FxvL2cW/UeERFhtrj8/f3NFh/9jtckkc5fpPMWLV682Hzn79q1y1QK5cmTx+58jQ+sK6zqY9yEkfW49ZjbTIRdvHhx+fPPP+WHH34w5VeaGdNNf/7xxx/NeD09BymT08/HPF6LiJ3kKih7NqlYMJdcvnFLxrWvJHM715S321WUyoVy2V6jlUh6vjVhpP7874qpLNHhbMjaJoU8ISt++UvWbYktgY0rR3ZfmTu2uwwY97WcOX81yWsVKRAkjzSrJb/ssE9mIuua1L+lrNhyRNbtPGa3v3aFwuLn6yM///Gvbd/fJy7I8TOXpX7l2KE2OmTtZqT9hHw3Im5JDn9fqV3e/osOzsNE2O6FeCl9eGXPHfvD9cu2KiKvbH4ScyQ2ia106JoOQfMuXivx69ywX9UOWZuXt7dUa/u4+OYMkJO7Ntv2V2//lLy2KVRe/GGnNB/0tvhmz2E7VvbeFuZ1gYXukr7Ldsug9UflfxMXSmDhYi56F3AV/RxUePBxyZYjQEL/vP35scqWI6dU6dDNJIuunj4R7zUqt39Gbt24LodWO04ngcw7EfbYsWPN/ENxN92XkIoVK5oE0ZYtW0yFULdu3cyQs4zm0kojpcvDtmnTxmxIOw3dezQoLvtOX5XjF2Oz0YVyx2Yun7i7qMzdckKOXrguD5TLL6PaVpCXvt0roVciJG8OX5NUikuHrl2NuCV5c/q65L0gY/yvdR2pVam4NH5mQrzHJ7zSSTb/eVSWrk+8J2ze2O7y0P01JGcOP1m6YY/0GbUwnVqMzETnKqpVvrA07jvP4VjhvAESEXlLLofb96iEXQyXQsGxyejV249Kv0fryuMPVJZFGw6Y17zxTCNzrEi+24ltwNMRLzmZl5dka/eGxPy7Qyxh/9/JkauAWG5Fity07yDR4WheufPHf5kStcW7ehuJ+qx3RrQaLlawQjV5/otfJJt/djPvzFf9HpOzR/abY3uWfimXTh2Tq2GhUqhCdWn56juSv1QF+eqlx83xvMVLi5eXt9z3whD56Z1BEnH1iqk86vrpTzLjkbslOoqq/qwuX/lq8sTnv5ghZVHXr8nSAY/JhX9iPz+qxhO9pfHAseKXM5dcOHpAvuvVRmJuxf+5qPros3Lgpy9NBRLcR0hIiAwaNMhuX0JVRkqricqVK2d+rlOnjmzbtk0mT54sTzzxhERGRsqlS5fsqo20Alknvlb6uHXrVrvrWVdXs57jNkkjpW9Gx9xZy6T0Tdx7771Sr169VJV4RUdFio9v8id2ykp6NSohJfPmkJAfD9j2WTuBVx04Kz8fip3I8ej5E1LjrtzSvEJ+mb/9P1c1Fy5WrFAeeXdwJ3moz4fmf9zfqd391aXpPRWkwZPjkrzWa+99K2Nm/STlSxaUUf0flvGvdJQBY79Op5YjMyhWILe8+2JzeWjIVxIRFZ2qa6zd8a+88fF6mfJya5k95CHzORy34HdpXKO4xDARdrqhOsg9pSVeSihmstyKEf9sLi08d4ls7YeJd6HyEvH/cxWlhlfB8uL3zDS59fM0iTkcu1oNsrbzRw/KzEfrin/uIKnSuqN0GPepzO3S3CSOdD4jq7C//5JrZ0Ol27zVkrd4Gbl44h9TXeLj5yc/jRkoR35bY85b9Moz8uqvJ6VU/aZy5NfVLnxnyAgXjx6UBf+rK/65gqR8y47S6u1PZdFzzW2JowPLFsrxTWskoEBhubvbIGn73hfyddcmEh1p/9/tIjUaSL6yVWTlG8+66J14DmeHS/6JDEVLDp1LVr/HNYGkq6CtXbtWOnXqZI4dPHhQjh8/boazKX3UybPDwsKkYMGCZt/q1aslMDDQDHFzm6SRvgF9k7osnJZZxx2jr0vINWrUSL799lvbm4yPlnONHDnSbl/F9j2l0sOeN77TrHxWPI+8sfSAnI8zB5F1PqITl2InebQ6eemmFMgVm1y7eCNKgnLYfxy8vURy+2djPqMsrHblElIoX6BsWjjEti9bNh9pfHdZ6f1EE/l40a9Splh+Ob3xXbvXffHe8/LbziPSuudk2z4duqbb3/+ekYuXw2XtnEEy7uMVcvrclQx9T8g4tcsXlkJ5A2TTjO62fdl8vKVx9eLS+5G7pX3I1+Lvl02CAvztqo0K5g2QMxdur/Q05dttZtPKootXb0rJwkFmFbajoZcy/D15CpJG7sUZ8VJCMdObjfPJ0CbxV9FkVdnavyU+FZtK5CfP6OzGtw9cO2uGp4kON4tTbeQVkE8sV8/ZXcOrQFnx6zFHord9LdHrZ2Zk8+FCWg104fgR83Po3j/krmp1pX7X/rJ0+IsO557cHdvDH1yyrEkaXT0bm+w9e/h2Zcn1i+fMFlSkRIa9B7iOVg1dPhH7+Qnb/4cUqlZXanfuL2tHx35+Iq9dMZtOlh365xbp89tZKde8gxz86Su761Tt+JyE7d9lroH05e3iqqQ2bdqY731dRVVXSlu/fr2sXLnSDGvr0aOHqVoKDg42iaD+/fubRJFOgq1atWplkkNdunSRCRMmmA6noUOHSt++fVOcuHJp0ujFF180M4Hv37/fjNeLSzNlzz33nHlTOlN4Skq8Oi/4SzwxYdSgVB4ZuuyghF2znzhWn58Pj5S7grLb7S8amF3+OBk7Bv9gWLjk8s8mZfPllCPnY+c1qlE00GRX/z7LMr5Z1bqtB6XOY2Ps9n008hk5ePSMvD93tZy/dE0+WXR7kmu1Y9Gb8tr738qyDQn/O/PSjKOWVPpmimJGpBOdw6hOT/vlXz96ta0cPHFe3v9qi5wMuyKRUdHyQO2SsuTXv83x8sWCpUShINmy/5TD9ULPx07cr0PVToRdkZ2H459MFPA0zoiXEoqZLGPqiscljKq0kMhPupq5iuKK+W+vGZ7mXbahxOxdZfZ55S8tXnnvkpgTu2zneRUsJ3495kr0H0vk1upJGf4ekHlo9VA2v/j/x1fhSrHzYF0Li00Wnfgjdq6sfKUryJUzsZ+9HEF5JWfe/HL5lP2cgPAMsdVn/ol07niJj6/9cd8cAVKh9WPy2+ShGdRKuLLDqGvXrhIaGmqSRDVq1DAJo5YtW5rjEydONEPXtVNJq490ZbTp06fbXu/j42MWydC5kDSZFBAQYOZEGjVqVIrb4tL/RadveuPGjQ4BkNJ9U6ZMSXIJ2fhKvDxtaNoL95aQJmWD5Z3Vh+VGVLTk+f+KoeuR0RIZHTu8Y8nu0/JknaJy9PwNM6dRs/L55K482WXC2iO2qqMdJy7Li/eVlJm/HRcfby/peW8J+fXIBSqNsrBr1yNk35FQu33hNyLlwuVw2/74Jr8+EXpRjp2KHerYunEVKRgcKDv2HjPXq1K2iLwzsIP8vvOIHA+9kEHvBK6gK5vt+9e+9z38ZpRcuHLTtn/uit0yvnczuXD1ply9HiEf9G0pm/f+Z1ZOsxr4v3tk1bZ/zDxqjzSuIK8+0UCeeft7hqelIyqN3Isz4qWEYqabHjQ0LdvDw8SnxkMSOb+vWCLCRXL9f4WVVhXdihCJuCbRO74V3zZDJOr6ZbFEXBPfh4ZKzLGdZuU025C0HnMl5tCvcuu3ubevEROtZSMufHdIbzqx9eGNK+Ry6AnxC8gt1R96Ukrdc798/nxbMwRNnx/auEJuXDpv5jRqHfKe/Ltto211tPP/HpIDa76XNm98ID8Of1Eirl0x1zz3zwE5umW9q98e0lmjl96Wf39bIVdDT4hvQG6p1OZJKVb3flncu60E3lVaKj74Pzn2+xq5cfGs5CpUTOr2GCy3Im7I0V9/sruOTqDt7ZNNDixjtcaM4MpwafZs+47ZO2XPnl2mTZtmtoSULFlSli9fnua2uDRppIHLlSsJD13RMqy0jPnzFG2qxJajj3mokt3+KRuO2uYw+nFvmPj6eJtJsnP5+8i/F27IiJ/+ltNXbw8Zmbj+H+nVsISMalNBYsQim45ekk82xS6TDSTkxs0oea7jvTLh1Y7i75tNTp65JN//vEve+5Sx+RB5bcZaibFY5IthHcxKaWt2HJWXp9h/NlrVKyOvPd3QHN/zz1n53/DvTBIJ6YickVshXnKObPVj5y/y7/m53f6oRSESvXOx+fnW8rEilhjxfXqyiK6kduhXifrhdq+sT7XW4pUrn/jUfsRsVlq1FPFe8wx7L8h4AcEF5dHxcyRXgSIScfWynDm4xySM/vl9rVkBrcy9zaVBt5fEL0eASSztX7VYNs54x+4ai4c8K61D3penZ34vFkuMHNu6Ueb3fEhibjnOK4msJUdwQWn99hzJWaCIRF67LOf+3mMSRsc3r5WAAkWk6N2NpdYzL0n2wLxy/fwZ+W/Hr2Y+oxsXzjpMgH147RLzGUT685xulcR5WSy6qLpraCn1smXLTGlV8+bNzVg8pYGRTuqkJdQPPfSQTJ06NUXX7fDJ9nRqMTzBymlzXd0EuKv8LHmN1Lux+vbcYuktX7cvnHq98/Oecur1kDHxkrr5pn2HE5Bc476NrVYHUiOPZw0MgRMN2J1xo2DWNPFx6vVabEzdwjGu5tJKow8++MDMAP7kk0/KrVu3zJJySpePy5Ytm5nc6b333nNlEwEAyHIYnuZeiJcAAMh4/z9Nq8dz+fC0GTNmyPjx42XHjh12S8jqMnLWnjQAAABPRbwEAAA8dpiergSiy8QWKVJEnnrqKaldu7Z8/fXXMmDAAPn5559d3TwAALJkpZEzN6Q/4iUAADKWhjheTtzclUsrjVasWCGPPPKI5MqVS65fvy6LFy82y8rVrFnTlGG3atVKVq1aJc2aNXNlMwEAyFJI9LgX4iUAADywwiaTcOl9GDVqlAwePFjOnz8vc+bMkaefflp69uwpq1evNhM76rFx48a5sokAAAAuRbwEAAA8Mmm0d+9e6d69u/n58ccfN0vGPvbYY7bjnTt3lt27d7uwhQAAZEFeTt6QroiXAADIeAxPywTD0+KWyHt7e0v27NklKCjIdix37txy+fJlF7YOAICsh+Fp7od4CQCAjMXwtExwH0qVKiWHDh2yPd+0aZOUKFHC9vz48eNmwkcAAABPRbwEAAA8stKoT58+Eh0dbXterVo1u+M//fQTkzoCAOBkVBq5F+IlAAAynjfhkusrjXr37i3t2rVL8Pg777wjn3zySYa2CQAAT0gaOXNLiRkzZkiNGjUkMDDQbA0bNjRJD6umTZs6XF/jhbi0skbjh5w5c0rBggXNRNC3bt2SrIp4CQCAjMcUkJlkTiMAAOA5ihUrZlb6Kl++vFgsFpk3b55ZTn7nzp1StWpVc46uDKYrhllpcshKK240gVK4cGH5/fffJTQ01Cw/7+vra5InAAAAcB6SRgAAeBhXDk9r37693fMxY8aY6qPNmzfbkkaaJNKkUHxWrVol+/btkzVr1kihQoWkVq1aMnr0aBkyZIiMGDFC/Pz8MuR9AACArI3habGYEBwAAKRJRESEXLlyxW7TfUnRqqEvv/xSwsPDzTA1qwULFkj+/PnN3D0hISFy/fp1u0mgq1evbhJGVq1btza/U5emBwAAgPOQNAIAwNM4eZD+2LFjzRLwcTfdl5A9e/ZIrly5xN/f38zXs3jxYqlSpYo59vTTT8v8+fNl3bp1JmH0+eefyzPPPGN77enTp+0SRsr6XI8BAAA4A3MaxWJ4GgAAHsbZw9M0uTNo0CC7fZoQSkjFihVl165dcvnyZVm0aJF069ZNNmzYYBJHvXr1sp2nFUW6lHzz5s3lyJEjUrZsWae2GwAAICEMT4tF0ggAAKSJJogSSxLdSecdKleunPm5Tp06sm3bNpk8ebLMmjXL4dz69eubx8OHD5ukkc51tHXrVrtzzpw5Yx4TmgcJAAAAqcPwNAAAPMydS9qndUurmJiYBOdA0ookpRVHSuc+0uFtYWFhtnNWr14tgYGBtiFuAAAAaeXtZXHq5q6oNAIAwMO4cvU0HcrWpk0bKVGihFy9elUWLlwo69evl5UrV5ohaPq8bdu2ki9fPtm9e7cMHDhQmjRpIjVq1DCvb9WqlUkOdenSRSZMmGDmMRo6dKj07ds3RdVOAAAAiWF0WiySRgAAIMNohVDXrl0lNDTUTJitySBNGLVs2VJOnDgha9askUmTJpkV1YoXLy6dOnUySSErHx8fWbp0qfTp08dUHQUEBJg5kUaNGuXS9wUAAJAVkTQCAMDTuLDrbPbs2Qke0ySRToidlJIlS8ry5cud3DIAAIDbmAg7FnMaAQAAAAAAwAGVRgAAeBhXzmkEAADgDoiWYpE0AgDAw5A0AgAASBzD02IxPA0AAAAAAAAOqDQCAMDDUGkEAACQOCpsYpE0AgDAw5A0AgAASBzhUiySZwAAAAAAAHBApREAAJ6GnjMAAIBEMRF2LJJGAAB4GIanAQAAJI5oKRbD0wAAAAAAAOCASiMAADwMlUYAAACJI16KRaURAAAAAAAAHFBpBACAh6HjDAAAIHHES7FIGgEA4GEotwYAAEgC8ZLB8DQAAAAAAAA4oNIIAAAPQ8cZAABA4oiXYpE0AgDAwzA8DQAAIHHES7EYngYAAAAAAAAHVBoBAOBh6DgDAABIHJVGsUgaAQDgYby9CYIAAAASxbgsg9sAAAAAAAAAB1QaAQDgYai2BgAASBzD02JRaQQAAAAAAAAHVBoBAOBh6DkDAABIHOFSLJJGAAB4GIIgAACAxNHJFovhaQAAAAAAAJnE2LFjpV69epI7d24pWLCgdOjQQQ4ePGh3TtOmTU1iK+7Wu3dvu3OOHz8u7dq1k5w5c5rrDB48WG7dupWitlBpBACAh6HnDAAAIAkuDJc2bNggffv2NYkjTfK88cYb0qpVK9m3b58EBATYzuvZs6eMGjXK9lyTQ1bR0dEmYVS4cGH5/fffJTQ0VLp27Sq+vr7yzjvvJLstJI0AAPAwJI0AAAAyb7y0YsUKu+dz5841lUI7duyQJk2a2CWJNCkUn1WrVpkk05o1a6RQoUJSq1YtGT16tAwZMkRGjBghfn5+yWoLw9MAAAAAAADSUUREhFy5csVu033JcfnyZfMYHBxst3/BggWSP39+qVatmoSEhMj169dtxzZt2iTVq1c3CSOr1q1bm9+7d+/eZLebpBEAAB5GO86cuQEAAGQ1zo6Xxo4dK0FBQXab7ktKTEyMDBgwQBo1amSSQ1ZPP/20zJ8/X9atW2cSRp9//rk888wztuOnT5+2Sxgp63M9llwMTwMAAAAAAEhHISEhMmjQILt9/v7+Sb5O5zb666+/5Ndff7Xb36tXL9vPWlFUpEgRad68uRw5ckTKli3rtHaTNAIAwMMwpxEAAEDGxkv+/v7JShLF1a9fP1m6dKls3LhRihUrlui59evXN4+HDx82SSOd62jr1q1255w5c8Y8JjQPUnwYngYAgIdheBoAAEDmDZgsFotJGC1evFh+/vlnKV26dJKv2bVrl3nUiiPVsGFD2bNnj4SFhdnOWb16tQQGBkqVKlWS3RYqjQAAAAAAADKJvn37ysKFC+X777+X3Llz2+Yg0nmQcuTIYYag6fG2bdtKvnz5ZPfu3TJw4ECzslqNGjXMua1atTLJoS5dusiECRPMNYYOHWqunZKKJ5JGAAB4GIanAQAAJM6V4dKMGTPMY9OmTe32z5kzR7p37y5+fn6yZs0amTRpkoSHh0vx4sWlU6dOJilk5ePjY4a29enTx1QdBQQESLdu3WTUqFEpagvD0wAA8DCuHJ6mQZD2gGlptG4axPz000+24zdv3jQ9YNprlitXLhMAWcffWx0/flzatWsnOXPmlIIFC8rgwYPl1q1bzro9AAAAppPNy4lbSoenxbdpwkhpkmjDhg1y/vx5EzsdOnTIVBNpbBVXyZIlZfny5XL9+nU5e/asvPfee5ItW8pqh0gaAQCADKOTOI4bN0527Ngh27dvl2bNmskjjzwie/fuNce1tPrHH3+Ub775xgRDp06dko4dO9peHx0dbRJGkZGR8vvvv8u8efNk7ty5MmzYMBe+KwAAgKyJ4WkAAHgYVw5Pa9++vd3zMWPGmOqjzZs3m4TS7NmzzRh9TSZZy7ArV65sjjdo0EBWrVol+/btMyXZhQoVklq1asno0aNlyJAhMmLECFOuDQAAkFaM5o9FpREAAB7G2cPTIiIi5MqVK3ab7kuKVg19+eWXZiy+DlPT6qOoqChp0aKF7ZxKlSpJiRIlZNOmTea5PlavXt0kjKxat25tfqe1WgkAACDNWG7WIGkEAADSZOzYsWY1j7ib7kuILv+q8xXpyh29e/c2y8nq6h66qodWCuXJk8fufE0QWVcN0ce4CSPrcesxAAAAOA/D0wAA8DDOHp4WEhIigwYNstuX2FKuFStWlF27dsnly5dl0aJFZiUPnb8IAAAgs3Dj4iCnImkEAADSRBNEiSWJ7qTVROXKlTM/16lTR7Zt2yaTJ0+WJ554wkxwfenSJbtqI109rXDhwuZnfdy6davd9ayrq1nPAQAAgHNkyaRRh5oFXd0EuLF7Pxjo6ibATd1XPJ+rmwC4Zc9ZTEyMmQNJE0i+vr6ydu1a6dSpkzl28OBBOX78uJnzSOmjTp4dFhYmBQvGft+vXr3aLDGrQ9yQMn4N2rq6CXBTwyrFJmuBVKltvygCkBm5cuGQzCRLJo0AAEDmDIJ0KFubNm3M5NZXr141K6WtX79eVq5caeZC6tGjhxnqFhwcbBJB/fv3N4kiXTlNtWrVyiSHunTpIhMmTDDzGA0dOlT69u2bomonAACAxJA0ikXSCAAAZBitEOratauEhoaaJFGNGjVMwqhly5bm+MSJE8Xb29tUGmn1ka6MNn36dNvrfXx8ZOnSpdKnTx+TTAoICDBzIo0aNcqF7woAACBrImkEAICHcWXH2ezZsxM9nj17dpk2bZrZElKyZElZvnx5OrQOAAAgFoVGsUgaAQDgYSi3BgAASALxkuEd+wAAAAAAAADcRqURAAAeho4zAACAxBEvxaLSCAAAAAAAAA6oNAIAwMMwpxEAAEDiiJdikTQCAMDDEAQBAAAkjnApFsPTAAAAAAAA4IBKIwAAPAw9ZwAAAEkgYDJIGgEA4GEYngYAAJA44qVYDE8DAAAAAACAAyqNAADwMHScAQAAJI54KRZJIwAAPAzl1gAAAIkjXorF8DQAAAAAAAA4oNIIAAAPQ8cZAABAEoiXDCqNAAAAAAAA4IBKIwAAPIw3pUYAAACJ8vKmxkaRNAIAwMOQMwIAAEgCAZNB6gwAAAAAAAAOqDQCAMDDsIQsAABAEoiXDJJGAAB4GG9iIAAAgER5eTEwS3EXAAAAAAAAkPakkY+Pj4SFhTnsP3/+vDkGAAAy//A0Z25wRLwEAICb0xjHy4mbpwxPs1gs8e6PiIgQPz8/Z7QJAACkIzeOW9wG8RIAAG6OgCllSaMpU6aYR+1R/OSTTyRXrly2Y9HR0bJx40apVKlSci8HAACQ5RAvAQAAj0waTZw40dZzNnPmTLvSau0xK1WqlNkPAAAyNy+h5yy9EC8BAJA1MAQ/hUmjo0ePmscHHnhAvvvuO8mbN29yXwoAAOARiJcAAEBWkuI5jdatW5c+LQEAABnCm46zdEe8BACAm/NisflkJ40GDRoko0ePloCAAPNzYj744APn/IEAAEC6oNw6fRAvAQCQdXjRy5b8pNHOnTslKirK9nNCCEIBAICnIl4CAAAemTSKW2JNuTUAAO6NnEX6IF4CACALIWBK3ZxGAADAvXkTBAEAACSOOY1SlzS6efOmTJ061fSghYWFSUxMjN3xP/74I6WXBAAAyFKIlwAAgEcmjXr06CGrVq2Sxx57TO655x7G5QMA4Gb46k5/xEsAALg3vrtTmTRaunSpLF++XBo1apTSlwIAAHgE4iUAAOCRSaO77rpLcufOnT6tAQAA6Y6es/RHvAQAgJsjXjJSPLPT+++/L0OGDJFjx46l9KUAACCTxEDO3FJi7NixUq9ePZNQKViwoHTo0EEOHjxod07Tpk1NYivu1rt3b7tzjh8/Lu3atZOcOXOa6wwePFhu3bolmQXxEgAAbs6VAZM7J43q1q1rJncsU6aMCfiCg4PtNgAAgIRs2LBB+vbtK5s3b5bVq1dLVFSUtGrVSsLDw+3O69mzp4SGhtq2CRMm2I5FR0ebhFFkZKT8/vvvMm/ePJk7d64MGzZMMgviJQAAkFrJ6WTTOENjqnz58kmuXLmkU6dOcubMGad3sqV4eNpTTz0l//33n7zzzjtSqFAhStwBAHAz3i787l6xYoXdc032aBCzY8cOadKkiW2/BjeFCxeO9xo6wfS+fftkzZo1JhapVauWjB492lT2jBgxQvz8/MTViJcAAHBvXl4prrFxeiebJo40yfPGG2+YTjaNfwICAsw5AwcOlGXLlsk333wjQUFB0q9fP+nYsaP89ttvdp1sGk9pJ5t2wnXt2lV8fX1NfJJuSSP9ZZs2bZKaNWum9KUAACATcHb6IiIiwmxx+fv7my0ply9fNo93Vt8sWLBA5s+fbwKd9u3by1tvvWUSSUrjkOrVq5tkjFXr1q2lT58+snfvXqldu7a4GvESAABuLhN3sl2+fFlmz54tCxculGbNmplz5syZI5UrVzbV3A0aNHBaJ1uKU2eVKlWSGzdupPRlAAAgC5dQaw9X3E33JSUmJkYGDBhgVhirVq2abf/TTz9tEkbr1q2TkJAQ+fzzz+WZZ56xHT99+rRdwkhZn+uxzIB4CQAAOMudnWyaPNIh/i1atLCLPUqUKGE6rRLrZLty5YrpZEu3SqNx48bJK6+8ImPGjDEN0NKmuAIDA1N6SQAAkIGcPVRKEzuDBg2y25ecKiMtu/7rr7/k119/tdvfq1cv288aaxQpUkSaN28uR44ckbJly4o7IF4CAMC9eXk7N15KbWV2fJ1s2kmmlUJ58uSxO1cTRNYONGd1sqU4afTggw+aRw3e4rJYLCYI1XFzAAAg83JyDJTsoWhx6bj7pUuXysaNG6VYsWKJnlu/fn3zePjwYZM00iFrW7dutTvHOvFjQvMgZTTiJQAA3JyT5zQaO3asjBw50m7f8OHDzVCx1HSyZZQUJ420VBwAACA1NGnSv39/Wbx4saxfv15Kly6d5Gt27dplHrXiSDVs2NBU8ISFhZnx/UpXYtPqnSpVqkhmQLwEAADSWpmdUCebdpLpKrKXLl2yqzbSTjRrB5qzOtlSnDS6//77U/oSAACQibhyJS/tLdNJG7///nuzjKy1PFrnQcqRI4cZgqbH27Zta5aQ3b17t1kdRCd9rFGjhjlXVw/R5FCXLl1kwoQJ5hpDhw41105pxVN6IV4CAMDNOTle8k9BZXZSnWx16tQxQ9/Xrl0rnTp1MvsOHjwox48fN51rzuxkS1bSSAM2HTvn7e1tfk6MNaADAAC404wZM8xj06ZN7fbrih/du3c34/N1lY9JkyZJeHi4FC9e3ARDmhSy8vHxMb1uulqaBkS69Gy3bt1k1KhR4krESwAAICM62fSxR48epnJJJ8fWRJAmmTQu0pXTnNnJlqykkS7Npr9As1P6s/ZQaubrTozRBwAg83NhoVG88UNcmiTasGFDktcpWbKkLF++XDIT4iUAALIOV1Zmz0iik01NnDjRdFRp55pOsK0ro02fPt3pnWzJShodPXpUChQoYPsZAAC4L1cGQVkZ8RIAAFmIC+MlSxKdbCp79uwybdo0s6VnJ1uykkb6i+L7OS4dJ/fJJ5/IG2+8kaYGAQAAuCPiJQAAkNU4bQ250NBQeeutt5x1OQAAkE68vZy7IfmIlwAAcBNe3s7d3FSKV08DAADujeFpAAAAiSNeiuW+6S4AAAAAAACkGyqNAADwMPSbAQAAJIEx+ClLGg0aNCjR42fPnk3upQAAgAt5U26dboiXAADIGrzceB4ilySNdu7cmeQ5TZo0SWt7AAAA3BbxEgAA8Mik0bp169KtEbdu3ZK9e/fK6dOnzfPChQtLlSpVxNfXN91+JwAAnopCo/RDvAQAQBZBwOT6OY1iYmJk2LBhMm3aNLl8+bLdsaCgIOnXr5+MHDlSvL0pCwMAAJ6JeAkAAHhk0uj111+XuXPnyrhx46R169ZSqFAhs//MmTOyatUqeeuttyQyMlLGjx/vymYCAJClsISseyFeAgDABYiXXJ80+uyzz+Tzzz83AVBcpUqVkl69eknJkiWla9euBEEAADgRMZB7IV4CACDj0cmWCZJGV69elaJFiyZ4vEiRIhIeHp6hbXJHxw/sli3LvpHTR/+Wa5cuSKcBI6RC3UZ255z775is+/ITOXFgtylzz1e0hHR8ebgE5S8ol86elhkDu8R77Q79h0rl+vdn0DuBK4Qe2iN7Vn0r548fluuXL0jz3kOlVK17bcdvXLko276bI//t/0MirodL4fLVpOETvSWo0F22cw788pMc2bpezp84LFE3b8gzH3wt/jlzuegdIaMc/GunLP92vhw7fEAuXTgn/YdOkDoNb//3Yvtv62TdT9/Jv4cPSPjVKzJyyudSsmyFeK9lsVjkg+EDZc+OTQ7XATwd8ZLzbDtyXj5d/4/s/e+ynL0SIVO715EW1Qrbjn+48m9ZvuuUnL50U3yzeUmVYkEy4MGKUrNkXts5M9cckg37w+TAqSvi6+MtW9+2T+Yha9p27Kp8uvm07A29LmevRcnU/5WVFhVvfy5CfjgqS3aft3tN4zKB8vHTsd97/12KkOm/hMqWf6/IufAoKZjLT9pXD5YXGhcRPx+Glnqa6OgY+fDrdfLjxt1y7tI1KZg3t3R4oJb0eex+W6Kicqfh8b721S4tpUeHxhncYniyFCeNjh8/LsWLF3fIumnAf+LECSlRokSyr9W0aVN59dVXZcGCBZI/f367Y+fOnZMhQ4aYc5C4qIibUrBEGanRpLV8N3mkw/GLZ07J56MHSs3728h9nbqJf46ccu7kv5Lt/yfODMxXQPp/+JXda3atW2YSUWVr3pNh7wOucSvipgQXKy0V7m0la2e97fDvevWM0eLt4yMt+gwT3+w55a+1i+WnyW9Ip+GzxNc/e+w1IiOkWNU6Ztu+ZK6L3gkyWsTNG1KidHlp0rK9TB0zxPF4xA2pUKWm3HNfC5kz5Z1Er7VqyZdUv2Qgb252uiNeypxuREZLxaKB0vGe4vLSvB0Ox0sVCJChj1aT4vlyys2oaJm38ag8//FWWfl6UwnO5W/OiYq2SOuaRaRWybzy7dYTLngXcIUbUTFSsWBO6Vgzv7y06Ei859xXNlDGtC9te+7nc/vf/z/nb5p//yPblpQSwdnl0NkbMmzZv+a6r7UoniHvAZnHJ0t+lS9Xbpex/R+V8sULyF9HTskbHy6R3DmzS5d2Dcw5Gz951e41v+w8LEOnfy+tGlRxUas9kBcJ3VQljUqXLi2hoaFSsGBBu/0XLlwwx6Kjo5N9rZkzZ0rbtm1ND1n16tXtxujv2bPHrAiydOnSlDbR42hiJ7HkzoZv5pjjzZ7qaduXt9DtHktvbx/JlSfY7jV/b/9NKtW/X/yy50inViOzKF6tntnicyXsPzl79IB0HDZD8hYtafY1eqqvLBzSWf7Ztl4qNn7Q7KvWvIN5DD24OwNbDlerUfdesyWkUbO25vHsmVOJXufYkb9lxeIFMnzSPBnQJfY1SF/kjNIf8VLm1KRyQbMl5KG7b1fRqtcfrmwSQwdDr0rD8rFJo/6tYytHFm8jYeRJmpQLMltitGKoQK74VzO8r2yQ2ayK5/WXo+cLy5c7wkgaeaCdB09Is3oVpWmd2P+e3FUwryz7ZY/sOfyf7ZwCeXPbvebnrQekfrVSUryw/f9uQzoiYDJSnDrTDHl8Y/uuXbsm2bPHVh0kl/bA/fnnn/LDDz9I+/btTa+bbvrzjz/+KDt37jTnIPUsMTFyZNcWCS5cTL4c/7pMfvF/Mnd4f5MUSkjo0b/lzLEjUvP+2IQAPFf0rSjz6OPrZ9vn5e0tPtl85czhfS5sGbKKiJs3Zda7b0mXPoMlT3A+VzcHcBriJfcXeStGvt58XHJnzyaViga6ujlwA1uPXZVGH+ySNtP3yIjlx+Ti9VuJnn/1ZrQE5XDpbCFwkdoVi8vmPUfl6Klz5vmBf0/LHweOy321y8d7vg5h2/DH39Kp+d0Z3FIgBZVGgwYNMo8aAOkqHTlz5rQd096yLVu2SK1atVLcAF0etk2bNmaD84VfuSSRN2/I5qVfSZPHussDTz4v//y5Xb6dPFI6v/GulKhc0+E1f65fYeY8KlahqkvajMwjT+HiEhBcQLYvniONOveXbP7Z5a+1SyT84jm5fuWCq5uHLOCLjydKuco15G7mMMpQTOyYfoiX3N+6fWfk1fk75UZUtBTI7S+ze9WXvAG3O0+A+DQuGyQtK+WVYnn85PjFCJm07j954cu/5YvulcXH2/G/uccu3JQF28NkcPNiLmkvXKvno43l2vUIaffSh+bzER1jkQFPN5P2TWrEe/6S9bskIIe/tKxfOcPb6smIl1KYNNJeLGvPmZZC+/nd/vLUn2vWrGnG26fG1q1bZdOmTXL69GnzvHDhwnLvvfdKvXrxD5mJKyIiwmxxRUVGiK9fbAmxp7NYYsxj+bsbyj1tOpmfC5UsJycP7ZU/1i51SBrpvdu36Wdp1KGzS9qLzMXbJ5u0eGGo/PL5ZJn/yhOmyqhopdpSrGpd/XS5unlwczs3b5T9u7ebCbKBrCKzxksJxUy+UbfE35dKh7jql80n3w26Ty6GR8o3W47LwM//kK9eaiT5chNbImHtqt4eMlShYE4z/1GraXtM9VHD0vaVameuREqvLw5J68p55fG7C7igtXC1n37fK0t/2S3vDugk5YsXlP1HT8vYOT9JwbyBZkLsO323dqc8dF918feLf/gjkJ6SHSWsW7fOPD777LMyefJkCQxMe5luWFiYdOrUSX777TdTZh13jP7AgQOlUaNG8u233zrMBxDX2LFjZeRI+8mfH3l+gHToNTDN7csKcuYOMpMY578rdj4aq/x3lZATB/9yOP/A1o0SFREh1Ru3zMBWIjPLX7K8PDr0Q4m8ES7Rt25JjtxB8sO4AWY/kBb7dm+XsND/5MXHW9jt//Cd16VC1VoSMm6Gy9qW1TGtY/rJrPFSQjHTsCcbyPCnG6a5jVlJTv9sUlK3/AFmsuvW49aZeY16NS/n6qbBjeicRXlzZpPjFyKk4e25sSXsaqR0m39QahXLJaPa2cfn8BzvfbZKnn+0sbRrXN08r1CykJw6d0k++u4Xh6TR9n3HzDC2D175n4ta68G8iZhUiruW5syZ47S/wYsvvmhKtffv3y8VK1a0O3bw4EF57rnnpG/fvvLNN98keI2QkBBbKbjVV3vOOK2N7k7nnilSpqKcD7WfrPFC6H8SlD826Ixr9/oVpiopZ2CeDGwl3IFfjgDzePnMf3Lu2GG5++Gurm4S3Fy7x7rJ/a0esds3tO/T8nTPAVLrnvtc1i5PQLl1+sts8VJCMZPvmqFOa2dWZbHEzm8EpMTpK5Fy6fotKZDb167CSBNGVQsHyDvtS7GSpQe7ERHl8PfXYWox+h+cO3y79g+pWraoVCpVOANbCIN/o6lLGoWHh8u4ceNk7dq1pucrJsb+S/Sff/5J9rVWrlwpGzdudAiAlO6bMmVKkkvI+vv7my0uX79L4kl0zqKLZ27PtH/p7Gk5c+ywZA8IlKD8BaV+2//Jkg/HSIlKNcxwtH92b5NDOzdJ5zfft7vOhdP/yfGDe+TxV8e44F3AVaJu3pArZ2+vbnXt3Bk5f+KI+AfkllzBBeXojl8ke64gM7fRxf/+lc1fz5KStRpIsSq3J+K7fvmC3Lhy0XYdPc83ew7zer0OsqabN67LmVMnbc/PnT5lVkLLlTtQ8hUsLNeuXpbzYWfk0oWz5vjp/46Zx6C8+cyk19btTsEFCkuBwrdXeATcUWaLlxKKmWI8bGhaeMQtOX4u3Pb85IXrsv+/yxKU00/y5PSVWWsPywNVC5m5jC5dj5KFv/0rZy7flNY1i9hec+riDbl8PVJOXbwp0RaLeb0qkT9AAvw96356kvDIaFM1ZHXyUoTsP31dgnL4mMmsp288ZeY00tXTdE6j99aelBLB/tK4TKAtYdT184NSNMhPXmtRTC7EmSQ7oRXXkHU9ULeizPr2FylSII+UL15A9h09LXN/3CQdm9W2O+/a9ZuyctNeea1ba5e1FUjxN9vzzz8vGzZskC5dupilX9PSW6mBy5UrVxI8fvXqVYfgBo5C//lbFr5ze36EtQtmmsfq97WUh154TSrWaywPPveybPrhC1n92TQJLlJMOr48XIpXrGZ3nd0bVkhgcH4pU71Ohr8HuM65Y4dk+cTXbc+3LPrYPJZv0EKadB9kEkK678aVS5IjKK+Ub9BcarV9yu4aBzYul53LFtqeL3v/NfN4X9eBUuFehjpmVUcP7ZfxIS/ann/xySTz2Kh5O+k5aJjs3PyLzJ402nZ8xvjYioZHnn5eHu3c0wUthlU8c7LCyYiXMqe9Jy5Lt5mbbc/H/7DfPHaoW0xGdKom/4RdkyXbT8rF8CjJE+Ar1YvnkfkvNpTyhW93gExd+bc5x6rjxF/N47zeDeSecqwCmVXtPRUu3eb/bXs+fnXsZ6BDjXwyvE1JORh2Q5bsPm9WRNPqokZlAuWl++8Sv2yxw1t+P3rFJJN0azplt9219w/VuSLhSYY+31Ymf/GzjPpoqVy4Ei4F8+aWx1vWlRf/Z78wyPJf/zLVjtZhbMhgXgxPM7fBojM1pkCePHlk2bJlZvx8WmkptV5r4sSJ0rx5c9u4fw2MtGdOS6gfeughmTp1aoquO3fb8TS3DZ4r7FrsMvNASt1XnP+xgNRrWC7jhgUP+uGAU6/3wcOVnHq9rMAd4iUV86P9cDUg2S4xHQTSoHZ7V7cAbsq72pMZ9rtipjRz6vW8X/pZPKLSKG/evBIcfHt1gLT44IMPTLn2k08+Kbdu3bKtMBIZGSnZsmWTHj16yHvvveeU3wUAAJBRiJcAAIBHVhrNnz9fvv/+e5k3b57kzJnTKY3QnrIdO3bYLSFbp06dVK84QqUR0oJKI6QWlUZwl0qjV3486NTrvd/eca4dT+cO8ZKi0gipRqUR0oJKI7hDpdFU+xV+08q7/xrxiEqj999/X44cOWKWey1VqpT4+tpP3PbHH3+kuBEa7DzwwANm0sivv/5a1qxZI/v27TM9avny8T/CAABwJuY0Sn/ESwAAuDlWT0td0qhDhw7iLFWqVJFff/3VlG+fOHFCmjRpIhcvXpQKFSqYQGvUqFGyefNmKV26tNN+JwAAQHojXgIAAB6ZNBo+fLjTfvmBAwfM2HwVEhIiRYsWlV27dklQUJBcu3ZNHn30UXnzzTdl4cLbqzIBAIC0oeMs/REvAQDg5lg9zUjVXbh06ZJ88sknJnC5cOGCrcz6v//+k9TatGmTjBgxwgRAKleuXDJy5EjTswYAAOBuiJcAAIDHVRrt3r1bWrRoYYKVf//9V3r27GnKpb/77js5fvy4fPbZZym6ntf/d3fevHlTihQpYnfsrrvukrNnz6a0iQAAIBHelBqlO+IlAADcHPFS6iqNBg0aJN27d5dDhw5J9uzZbfvbtm0rGzduTOnlpHnz5nL33XebFUEOHrRfzeXYsWNM7AgAQDp8+TtzgyPiJQAAssDwNC8nbp5SabRt2zaZNWuWw37t5bIuAZva8f5aYh3Xjz/+KPfdd19KmwgAAOBSxEsAACArSHHSyN/f3/Ry3envv/+WAgUKOHWSyHfffTelzQMAAEmg2jr9ES8BAODmCJiMFNdIPfzww2Zp16ioKNsYex2bP2TIEOnUqVNKLwcAAFwwp5EzNzgiXgIAwM1pjOPlxM1Tkkbvv/++Wd61YMGCcuPGDbn//vulXLlykjt3bhkzZkz6tBIAAMCNEC8BAICsIMVJI10FZPXq1Wb8/JQpU6Rfv36yfPly2bBhgwQEBKRPKwEAQJboOBs7dqzUq1fPJE80odKhQweHiZ11hbC+ffuayZ11/h6tzDlz5ozdOVq1065dO8mZM6e5zuDBg+XWrVuSWRAvAQDg5pgIO3VzGlk1btzYbAAAwL14u7BCWpMmmhDSxJEmed544w1p1aqV7Nu3z5ZMGThwoCxbtky++eYbk3zRhEvHjh3lt99+M8ejo6NNwqhw4cLy+++/S2hoqHTt2lV8fX3lnXfekcyEeAkAADflxkPKMjxppD1kvXr1MkvG6s+Jeemll5zVNgAAkMWsWLHC7vncuXNNpdCOHTukSZMmcvnyZZk9e7YsXLhQmjVrZs6ZM2eOVK5cWTZv3iwNGjSQVatWmSTTmjVrpFChQlKrVi0ZPXq0mS9oxIgR4ufn55L3RrwEAAA8Mmk0ceJE6dy5swmC9OeE6CSPBEEAAGRuzp68OiIiwmx3rh6mW1I0SaSCg4PNoyaPdPLoFi1a2M6pVKmSlChRQjZt2mSSRvpYvXp1kzCyat26tfTp00f27t0rtWvXFlcgXgIAIAtx4yFlGZ40Onr0aLw/AwAA6DxFI0eOdFgmXqt+EhMTEyMDBgyQRo0aSbVq1cy+06dPm0qhPHny2J2rCSI9Zj0nbsLIetx6zFWIlwAAQFaT4tSZLh97/fp1h/26MogeAwAAnjURdkhIiKkYirvpvqTo3EZ//fWXfPnll5LVEC8BAODmXLlyiDsnjbQnUZeQvZMGRnf2MgIAgMw5EbYzNx2GFhgYaLclNTRNJ7deunSprFu3TooVK2bbr5NbR0ZGyqVLl+zO19XT9Jj1nDtXU7M+t57jasRLAAC4OVZPM1LccovFYsbi3+nPP/+0zUcAAACQUByhCaPFixfLzz//LKVLl7Y7XqdOHbMK2tq1a237Dh48KMePH5eGDRua5/q4Z88eCQsLs52jy9trsqpKlSqSGRAvAQAAj5nTSOXNm9cEP7pVqFDBLhDSpW+1N613797p1U4AAOAkXuK6EmkdkqYro33//feSO3du2xxEQUFBkiNHDvPYo0cPGTRokEmuaCKof//+JlGkk2CrVq1ameRQly5dZMKECeYaQ4cONddOzuTb6Yl4CQCALMKNh5S5JGk0adIk02v23HPPmbJqDeqsdMLKUqVK2XoAAQBA5qVDylxlxowZ5rFp06Z2++fMmSPdu3c3P+vKY97e3tKpUyezKpuujDZ9+nTbuT4+PmZom66WprFHQECAdOvWLVPMFUS8BABAFuHGQ8pckjTSYExpGfm9995rSscBAABSQhMqSdEl66dNm2a2hJQsWVKWL18umQ3xEgAA8MikkdX9999v+/nmzZtmssq4tIwcAABkXq6sNPIUxEsAALg5hqcZKa630lU/dALLggULmnJwHbsfdwMAAPB0xEsAACAtNm7cKO3bt5eiRYuaORKXLFlid1yH9VvnUbRuDz74oN05Fy5ckM6dO5vOqjx58ph5I+Nb3dWpSaPBgweb1U50TgKdbPKTTz4xY/b1jXz22WcpvRwAAMhgdwYYad3giHgJAIAsMKeRlxO3FAoPD5eaNWsmOlxfk0ShoaG27YsvvrA7rgmjvXv3mlVmdT5ITUT16tUrfYen/fjjjybY0Qksn332WbnvvvukXLlyZm6BBQsWmEYBAIDMi+Fp6Y94CQAAN+fijrE2bdqYLTHaMVW4cOF4j+3fv19WrFgh27Ztk7p165p9U6dOlbZt28p7771nOrKSI8XpLi1vKlOmjPlZS5z0uWrcuLHJWgEAAHg64iUAAJDe1q9fb4bCV6xY0awqe/78eduxTZs2mSFp1oSRatGihVmhdsuWLcn+HSlOGmkAdPToUfNzpUqV5Ouvv7b1qGmDAABA5u84c+YGR8RLAAC4OScPT4uIiJArV67YbbovtXRomlY1r127VsaPHy8bNmwwlUnR0dHm+OnTp01CKa5s2bJJcHCwOZZuSSMtsf7zzz/Nz6+//roZX6dL4w4cONCM3wcAAJmbt5eXUzc4Il4CAMDNObmXbezYsRIUFGS36b7UevLJJ+Xhhx+W6tWrS4cOHcycRToUTauPnCnFcxppsBO3tOnAgQOyY8cOM06/Ro0aTm0cAACAOyJeAgAAcYWEhMigQYMc5iRyZpVz/vz55fDhw9K8eXMz11FYWJjdObdu3TJD5hOaBylNSaOYmBh599135YcffpDIyEjTiOHDh5sJHXUDAADugYmw0w/xEgAAWUQqVjxLjCaInJkkutPJkyfNnEZFihQxzxs2bCiXLl0ynVZ16tQx+3RlV41V6tevn+zrJvsujBkzRt544w3JlSuX3HXXXTJ58mTp27dvat4LAABwIeY0Sj/ESwAAZBEuDpiuXbsmu3btMpvSuRL15+PHj5tjOtx98+bN8u+//5p5jR555BFT0dy6dWtzfuXKlc28Rz179pStW7fKb7/9Jv369TPD2pK7clqKkkY6wdL06dNl5cqVsmTJEjORoy4Zq1kqAAAAEC8BAADn2L59u9SuXdtsSoe26c/Dhg0THx8f2b17t5nTqEKFCtKjRw9TTfTLL7/YVTNpDKILcmjlc9u2bc0qrh999FGK2pHs4WmazdJfEnd8vpeXl5w6dUqKFSuWol8KAABcx1soD0ovxEsAAGQRTh6ellJNmzYVi8WS4HHtoEqKrpS2cOFCSYtk3wWdMElX/YjL19dXoqKi0tQAAACArIJ4CQAAZCXJrjTSDFf37t3tSp1u3rwpvXv3loCAANu+7777zvmtBAAATsM8ROmHeAkAgCyCgCllSaNu3bo57HvmmWeS+3IAAJBJsHpa+iFeAgAgi3Dx8DS3SxrNmTMnfVsCAADg5oiXAACARyaNAABA1uBNuTUAAEDiKM02SBoBAOBhyBkBAAAkgYDJYJAeAAAAAAAAHFBpBACAh2F4GgAAQBKYCNsgaQQAgIchZwQAAJAEAiaD1BkAAAAAAAAcUGkEAICHoccIAAAgCQxPM7gLAAAAAAAAcEClEQAAHsaLMfoAAACJo9LIIGkEAICHIWUEAACQBJJGBncBAAAAAAAADqg0AgDAw3gzPA0AACBxxEsGSSMAADwMIRAAAEASGJ5mcBcAAAAAAADggEojAAA8DNXWAAAASaDSyOAuAAAAAAAAwAGVRgAAeBgvSo0AAAASR7xkkDQCAMDDUGYMAACQBIanGdwFAAAAAAAAOCBpBACABw5Pc+aWEhs3bpT27dtL0aJFzWuXLFlid7x79+4O13/wwQftzrlw4YJ07txZAgMDJU+ePNKjRw+5du2aU+4NAACArdLIy4mbm3LflgMAgFTxcvKWEuHh4VKzZk2ZNm1agudokig0NNS2ffHFF3bHNWG0d+9eWb16tSxdutQkonr16pXKuwEAABAPkkYGcxoBAIAM06ZNG7Mlxt/fXwoXLhzvsf3798uKFStk27ZtUrduXbNv6tSp0rZtW3nvvfdMBRMAAACcw33TXQAAIFMMT4uIiJArV67YbbovtdavXy8FCxaUihUrSp8+feT8+fO2Y5s2bTJD0qwJI9WiRQvx9vaWLVu2pPneAAAAGDoE38uJm5vKkpVG95cu6OomwI0F+Pu4uglwU4E5fF3dBMAlPUZjx46VkSNH2u0bPny4jBgxIsXX0qFpHTt2lNKlS8uRI0fkjTfeMJVJmizy8fGR06dPm4RSXNmyZZPg4GBzDCnjVaezq5sAd5U9yNUtgBvzyp7H1U0AkubGQ8qcKUsmjQAAQMYJCQmRQYMGOQwxS40nn3zS9nP16tWlRo0aUrZsWVN91Lx58zS3FQAAAMlH0ggAAA+T0hXPkqIJotQmiZJSpkwZyZ8/vxw+fNgkjXSuo7CwMLtzbt26ZVZUS2geJAAAgBSj0sjgLgAAgEzr5MmTZk6jIkWKmOcNGzaUS5cuyY4dO2zn/PzzzxITEyP169d3YUsBAACyHiqNAADwMK6civHatWumasjq6NGjsmvXLjMnkW46N1KnTp1M1ZDOafTaa69JuXLlpHXr1ub8ypUrm3mPevbsKTNnzpSoqCjp16+fGdbGymkAAMBpvKmxUSSNAADwMK5cwGP79u3ywAMP2J5b50Lq1q2bzJgxQ3bv3i3z5s0z1USaBGrVqpWMHj3abvjbggULTKJIh6vpqmmaZJoyZYpL3g8AAMii3HjFM2ciaQQAADJM06ZNxWKxJHh85cqVSV5DK5IWLlzo5JYBAADgTiSNAADwMN4uHaAGAADgBpgI2yBpBACAh6HaGgAAIAkkjQzuAgAAAAAAABxQaQQAgIfxYngaAABA4ijNNqg0AgAAAAAAgAMqjQAA8DB0nAEAACSBOY0MkkYAAHgYVk8DAABIAkkjg7sAAAAAAAAAB1QaAQDgYRieBgAAkAQqjQySRgAAeBiSRgAAAEkgYDJInQEAAAAAAMABlUYAAHgYLybCBgAASBzD0wySRgAAeBhvckYAAACJI2lkcBcAAAAAAAAykY0bN0r79u2laNGi4uXlJUuWLLE7brFYZNiwYVKkSBHJkSOHtGjRQg4dOmR3zoULF6Rz584SGBgoefLkkR49esi1a9dS1A6SRgAAeODwNGf+HwAAQJacCNvLiVsKhYeHS82aNWXatGnxHp8wYYJMmTJFZs6cKVu2bJGAgABp3bq13Lx503aOJoz27t0rq1evlqVLl5pEVK9evVLUDoanAQAAAAAAZCJt2rQxW3y0ymjSpEkydOhQeeSRR8y+zz77TAoVKmQqkp588knZv3+/rFixQrZt2yZ169Y150ydOlXatm0r7733nqlgSg4qjQAA8DAu7jgDAABwjzmNvJy3RUREyJUrV+w23ZcaR48eldOnT5shaVZBQUFSv3592bRpk3mujzokzZowUnq+t7e3qUxKLpJGAAB4GIanAQAAZGzSaOzYsSaxE3fTfamhCSOllUVx6XPrMX0sWLCg3fFs2bJJcHCw7ZzkYHgaAAAAAABAOgoJCZFBgwbZ7fP395fMjqQRAAAexpviIAAAgMRphZATaYLIWUmiwoULm8czZ86Y1dOs9HmtWrVs54SFhdm97tatW2ZFNevrk4PhaQAAeBiGpwEAACSjl83biZsTlS5d2iR+1q5da9uncyTpXEUNGzY0z/Xx0qVLsmPHDts5P//8s8TExJi5j5KLSiMAAAAAAIBM5Nq1a3L48GG7ya937dpl5iQqUaKEDBgwQN5++20pX768SSK99dZbZkW0Dh06mPMrV64sDz74oPTs2VNmzpwpUVFR0q9fP7OyWnJXTlMkjQAA8DCseAYAAJCxw9NSavv27fLAAw/YnlvnQ+rWrZvMnTtXXnvtNQkPD5devXqZiqLGjRvLihUrJHv27LbXLFiwwCSKmjdvblZN69Spk0yZMiVF7fCyWCwWyWKOnrvp6ibAjQX4+7i6CXBTgTl8Xd0EuLHsGdiN89uhi069XqPyeZ16PWQcy6nbJetAimQPcnUL4Ma8sudxdRPgrnLmz7BfFbNrnlOv512rm7gj5jQCAAAAAACAA4anAQDgYbwZnwYAAJCph6dlFtwFAAAAAAAAOKDSCAAAD0OdEQAAQBKozDZIGgEA4GmIgQAAAJJAwKQYngYAAAAAAAAHVBoBAOBhvOg5AwAASBwTYRskjQAA8DAM0QcAAEgCAZNB6gwAAAAAAAAOqDQCAMDD0G8GAACQFGpsuAsAAAAAAACIF0kjAAA8jZeTtxTYuHGjtG/fXooWLSpeXl6yZMkSu+MWi0WGDRsmRYoUkRw5ckiLFi3k0KFDdudcuHBBOnfuLIGBgZInTx7p0aOHXLt2zRl3BgAA4PacRl5O3NwUSSMAADxw9TRn/l9KhIeHS82aNWXatGnxHp8wYYJMmTJFZs6cKVu2bJGAgABp3bq13Lx503aOJoz27t0rq1evlqVLl5pEVK9evdJ8XwAAAGxIGhleFu3Sy2KOnrsdWAIpFeDv4+omwE0F5vB1dRPgxrJn4CyD249ecer16pYOTNXrtNJo8eLF0qFDB/NcQxKtQHrllVfk1VdfNfsuX74shQoVkrlz58qTTz4p+/fvlypVqsi2bdukbt265pwVK1ZI27Zt5eTJk+b1SD7LqR2ubgLcVfYgV7cAbswrex5XNwHuKmf+DPtVMfsWOfV63lUeE3dEpREAAB7G2R1nERERcuXKFbtN96XU0aNH5fTp02ZImlVQUJDUr19fNm3aZJ7row5JsyaMlJ7v7e1tKpMAAACcly7xduLmnty35QAAIFNMaTR27FiT3Im76b6U0oSR0sqiuPS59Zg+FixY0O54tmzZJDg42HYOAABAmjE8zcjAYngAAJAVhYSEyKBBg+z2+fv7u6w9AAAAcA6SRgAAeBond3ZpgsgZSaLChQubxzNnzpjV06z0ea1atWznhIWF2b3u1q1bZkU16+sBAADSzI2rg5yJ4WkAAHgYV66elpjSpUubxM/atWtt+3R+JJ2rqGHDhua5Pl66dEl27Lg9gfPPP/8sMTExZu4jAAAA52BOI0WlEQAAyDDXrl2Tw4cP201+vWvXLjMnUYkSJWTAgAHy9ttvS/ny5U0S6a233jIrollXWKtcubI8+OCD0rNnT5k5c6ZERUVJv379zMpqrJwGAADgXCSNAADwMK6stt6+fbs88MADtufWuZC6desmc+fOlddee03Cw8OlV69epqKocePGsmLFCsmePbvtNQsWLDCJoubNm5tV0zp16iRTpkxxyfsBAABZFMPTDC+LxWKRLObouZuubgLcWIC/j6ubADcVmMPX1U2AG8uegd04u45fder1apXI7dTrIeNYTt0e5gekSPYgV7cAbswrex5XNwHuKmf+DPtVMQd/dOr1vCu2F3eUaSqNLl++bFsqV+cz0OV6AQCA89Fv5t6ImQAAyABeTAGtXH4XPvnkE6lSpYqZy0Af4/48e/ZsVzcPAICsmTVy5oYMQcwEAEBGImByeaXRu+++KyNGjJCXXnpJWrduLYUKFbItrbtq1Sp5+eWX5eLFi/Lqq6+6spkAAAAuRcwEAAA8bk6jkiVLmiDo8ccfj/f4V199JYMHD5bjx4+n6LrMaYS0YE4jpBZzGsFd5jTafeKaU69Xo3gup14PGRczMacRUo05jZAGzGkEt5jT6NBPTr2ed/k24o5cWmkUFhYm1atXT/C4Hjt37lyGtgkAgKyOxUDcDzETAAAZjDmNDJfehXr16sm4cePk1q1bDseio6Nl/Pjx5hwAAABPRswEAAA8rtLoww8/NOPydeWPJk2a2I3P37hxo/j5+Zlx+gAAwHkoNHI/xEwAAGQsL0qzXT+nkbp69arMnz9fNm/ebLd8bMOGDeXpp5+WwMDAFF+TOY2QFsxphNRiTiO4y5xGf/3n3DmNqt3FnEbuGjMxpxFSjTmNkAbMaQR3mNPIcmSNU6/nVbaFuCOXJ43Sg6cnjT6fPUMWfDrTbl+xEqXkky++Nz+fOnlCPpn2vuzdvUuiIiOlToNG8uLA1yVvcD4XtThz8fSk0eJFX8qSRV/J6dBT5nnpMuWk+/O9pUGj+2zn/LV7l3w8fYrs+2uPePt4S/kKleT9qbPEP3t28WQkjRI3++OPZMqk96XzM13ltZA3Xd2cTIekEVzB05NGU+cukmnzvrPbV7p4Efnps/fNzxGRkTJ++gJZtm6TREVGSaN6NWT4gOckfzAJE09PGn3x3TL54rvl8l/oGfO8XJmS0ve5p6RJw7rmeUREpIyf8oksW7NRoqKipFH9u2X44Bclf3BeF7c8cyBplLiPPv1c3p86U7o+/T95c/AAVzcncyFp5FnD06y0t2zLli22XrMiRYrIPffcY3rPkDolS5eVsZM/sj338YlNhNy8cV3eHNhbSperIOOmfGz2ffbxNBn+Wn+Z9NF88fZmsi9PV7BgYendb6AUK1FSNKe8Yun3EvJKf/l0wSIpXbacSRi92r+3PPPs8zJg8Bvms3X40EHx4rODRPy1Z7cs+uZLqVChoqubAjM8jXJrd0XM5HzlSxWTT99/w/Y8m8/t77Ox0z6XDZt3yeThL0uugBwyespc6T9sonzx4QgXtRaZRaEC+eWVF7tLyeJFRbvglyxfI31fGy3fzZsi5cuUlLGTP5YNv2+TyWNCJFeunDL6/ZnS//Ux8sVH77m66cjkdu/dL19++71ULF/O1U0Bw9NcnzQKDw+XF154Qb788kszXjA4ONjsv3Dhgvkfq0899ZTMmjVLcubM6cpmuiUfn2wSnM8xC6vVRWdOn5IP534lAQGxPcOvDh0tjz14n+zasVXurtfABa1FZtKoSVO75736vixLvv1K9u750ySNpn4wQR57srM80/152zklSpV2QUvhLq6Hh0vIkMEyfOTb8vGsGa5uDuCWiJnSj3Z+FAh2rHq4eu26fLt8vbw7tJ80uLuq2Td2yAvStttg2bXvkNSqUt4FrUVm0ey++nbPB/buJl9+t1z+/OuAFC6YX779cZW8O3KwNKhb0xwf++YAaftUb9n11wGpVa2Si1qNzC78+nUZ/MZIefutITLjk3mubg5guLQ04OWXX5atW7fKsmXL5ObNm2YyR9305+XLl5tjeg5S7r+Tx+Tph1tI9/+1lfEjQiTsdKjZHxUVaTKmvr5+tnN9/fxNlcje3Ttd2GJkRroiz5qVy+XmjRtStUYtuXjhvOz7a7fkyRssfZ7rLA+3aiL9enWX3bv+cHVTkYm98/YoadLkfmnQ8F5XNwVxOs6cuSH9ETOln2P/nZb7HntRWjz9srz69ody6sw5s3/v30cl6la03Funmu3cMiXukqKF8suuvYdc2GJkxnhp2eoNcv3mTalVvbLsPXBYom7dknvr1bKdU6ZUcSlauIDs2rPfpW1F5jZq7Pty/30N5d4GrIaZKRAwub7S6NtvvzXBz7333uvQ49OqVSv59NNP5aGHHpKPP44dRoXkqVSlurzy5mgzj9GF82dlwaez5NUXn5WZn38rlarWkOzZc8in0ydJ9979RetpP50xWWKio825gDpy+G/p82xniYyMlBw5csqYdydL6TJlTbWRmvPxdHnx5VfNXEYrlv0gA/r0kHlfLZHiJUq6uunIZH5avkz2798nC79a5OqmIA73DVs8FzFT+qhZuZypHipdvKiEnb8o0z77Tp55eZT88Ol4OXvhkvj6ZpPAXAF2r8mXN1DOXbjssjYj8zh4+F95qtcrZu6rnDlyyIfjhkq50iVk/9//xH52ctvP95Yvb145d+Giy9qLzG3ZijWy78Dfsmj+J65uCmyYfsPlSaOYmBizRGxC9Jiek5iIiAiz2e+ziL+/v3iqeg0b234uU66CSSJ17dRGNv68Uh5s31HeHP2ufPjeGPl+0UJTYdS0xYNSrmJl8fbiHwVilShZWj5d+K2EX7sq69aukjEj3pSpH821/Xt8uOP/pN3Dj5qfK1SqLDu2bZZlP3xn5kICrE6HhsqEcWNk1sefevR/k4HMHDP5RUSKv3/C183qmtS/XQlSsWwJqVmlnDR78iVZsW6zR98XJE/pknfJ4nlT5Wp4uKz8+Td5ffQH8vn08a5uFtxQ6OkzMubdSfLpjEnETMh0XJol0B6xXr16yc6djsOidF+fPn2kffv2iV5j7NixEhQUZLfNmPxuOrba/eTKHSh3FS9pVk1TderfK3O+WSZfLl0nXy9bL68Ne0fOnw2TwkWLubqpyCR8fX2lWPESUrFyVZMIKlehoiz6Yr7ky1/AHC9Vuqzd+aVKl5Gw/5+UFbDat2+vXDh/Xp78X0e5u0YVs23ftlUWLvjc/Kzl/HBhqZEzN7htzDT2wznp2Gr3o1VFpYoVkWOnzph5jqKibsmVa+F255y/eIXV02D4+fqaibCrVSpvJsWuVK60fPbV91IgX97Yz85V+5Uqz1+8yOppiNfe/Qfl/IWL0vHp56RK3SZm27pjp3z+xSLzMzGTizA8zfWVRh9++KE8/fTTUqdOHcmbN68ULFjQ7A8LC5NLly5J69atzTmJCQkJkUGDBtntO3XVkq7tdjc3rl+X0P9OSPMH29ntD8oT+6W1a8cWuXTxgjRobD8BMmBliYmRyKhIKVL0LslfoKCcOPav3fETx45J/Ua3K9wAVb9BA1m05Ee7fcPfDJFSZcrIsz162lZ1RMZj9TT3k14xk9/5venabncTfuOmnDh1Rh5u2ViqVigtvtl8ZNOOvdL6/nvM8X+OnzJzHtWqyiTYcBRjsUhkVJRUrVROfLNlk03b/5TWDzQyx/45dlJOnT5r5jwC7tTgnjry4zef2+0LGT5GypQuKT27P0PM5CpunOjJMkkjDXp++ukn2b9/v2zevNm2fKwuG9uwYUOpVCnplQW0fO/OEr7zkTfFk3384ftSv9H9UrBwEblw7qx8/skM8x+api3amOOrli2R4iXLmKTR/r1/ysxJE+TRJ56R4iVLubrpyARmfjhRGtx7nxQqXESuXw+X1SuWyc4d2+T9qbPMij1PdXlWPp01TcqWryjlK1aSFUu/l2PHjsroCR+4uunIZHSFxvLlK9jty5Ezp+QJyuOwH4BrYibLNc8egjV+xgJ5oOHdUrRwfgk7d1E+nLtIvL295aHm90ruXDmlU9umMn7GfAkKDJBcOXPI21PnmYQRK6fh/elzpUnDulKkcAEJD78hS1etl61/7JFPJo2W3LkCpFP7VjJ+yscSFJhLcgXklLffn2lWTWPlNMQnV0CAVChXxm6fzpOVJyjQYT/gUUkjq8qVK5sNznEu7IyMG/66XL1yySSGqtaoLRNnfW5WvFInj/8rc2ZOkatXLkuhIkXlyW7PS8cnuri62cgkLl24IGOGvyHnz52VgFy5pWz5CiZhVK9B7OSrjz/dRSIjI+TDiePlyuUrUq5CBZk47WO5q1gJVzcdQDLRcea+iJmc68zZ8/LK21Pl0pVrEhwUKHWqV5Cvpo2S4DyB5nhI3y5mzseXh0+SyKhb0rheDRk24FlXNxuZwIWLl2TIqPfl7PkLJklUsWwpkzBqdE9tczzk5Z7i7eUlL4e8Y6qPGte/W4YNftHVzQaQIsz5q7wsFotLx3Lp6kxLliyRTZs22fWa6eogjzzySKKTPibk6DnPrjRC2gT4U/6J1AnM4evqJsCNZc/AbpyDp6879XoVC+d06vWQcTGT5dSOdGgpPEJ25nVC6nllz+PqJsBd5cyfYb/KcuxXp17Pq6R7Tufh0tTZ4cOHTW9Zt27dzCSOuuqHbvpz165dpWrVquYcAADgPMyD7X6ImQAAyGBMhO36SqOWLVtKQECAfPbZZxIYGFsGbHXlyhUTBN24cUNWrlyZoutSaYS0oNIIqUWlEdyl0ujvM86tNKpQiEojd42ZqDRCqlFphDSg0ghuUWl0YpNTr+dVvKG4I5cmjXLmzClbt26VatWqxXt8z549Ur9+fbl+PWXBLUkjpAVJI6QWSSOkBUkjuCJmImmEVCNphDQgaYRUI2nkWcPT8uTJI//+a790d1x6TM8BAADO4+Xk/0P6I2YCACCjMaDf5aunPf/886ac+q233pLmzZtLoUKFzP4zZ87I2rVr5e2335b+/fu7sokAAGQ5bjys3mMRMwEAkMEImDLH6mnjx4+XyZMnm1VAvP7/j6JN0tVABgwYIK+99lqKr8nwNKQFw9OQWgxPg7sMTzscdsOp1ytXMIdTr4eMi5kYnoZUY3ga0oDhaXCL4Wkntzj1el7F6if73BEjRsjIkSPt9lWsWFEOHDhgfr5586a88sor8uWXX0pERIS0bt1apk+fbutUylJJI6ujR4/aLR9bunTp1F+LpBHSgKQRUoukEdwlaXTEyUmjsiSN3DZmImmEVCNphDQgaQS3SBr9t82p1/O6q16KkkaLFi2SNWvW2PZly5ZN8uePff99+vSRZcuWydy5cyUoKEj69esn3t7e8ttvvzm1zeb3SiahAc+dQc+JEydk+PDh8umnn7qsXQAAZDlUW7s1YiYAALL+8LRs2bKZzqE7Xb58WWbPni0LFy6UZs2amX1z5syRypUry+bNm6VBgwZZZyLspFy4cEHmzZvn6mYAAABkasRMAABkLYcOHZKiRYtKmTJlpHPnznL8+HGzf8eOHRIVFSUtWrSwnVupUiUpUaKEbNrk3BXfXF5p9MMPPyR6/J9//smwtgAA4ClY8cz9EDMBAJDRnBsv6dxDusXl7+9vtjvVr1/fDD3TeYxCQ0PN/Eb33Xef/PXXX2aIup+fn8OqqTqfkXX4epZJGnXo0MFM5JjYtErWiR4BAAA8FTETAADubezYsQ6TW+vQcp2/6E5t2rSx/VyjRg2TRCpZsqR8/fXXkiNHxs4l6dLhaUWKFJHvvvtOYmJi4t3++OMPVzYPAIAsSXMLztyQ/oiZAADIYF7eTt1CQkLMfERxN92XHFpVVKFCBTl8+LCZ5ygyMlIuXbpkd86ZM2finQPJrZNGderUMePxEpJUjxoAAEg5LydvSH/ETAAAuHfE5O/vL4GBgXZbfEPT4nPt2jU5cuSI6UTSmMDX11fWrl1rO37w4EEz51HDhg2z1vC0wYMHS3h4eILHy5UrJ+vWrcvQNgEAAGQ2xEwAAHiOV199Vdq3b2+GpJ06dcoMY/Px8ZGnnnpKgoKCpEePHjJo0CAJDg42yaf+/fubhJGzV05zedJIJ3JKTEBAgNx///0Z1h4AADwC5UFuh5gJAIAM5sIx+CdPnjQJovPnz0uBAgWkcePGsnnzZvOzmjhxonh7e0unTp3M5NqtW7eW6dOnp0tbvCxZsJb56Lmbrm4C3FiAv4+rmwA3FZjD19VNgBvLnoHdOMfO26/ckVYl8yWvtBqZj+VUwkPegERlD3J1C+DGvLLbr/oEJFvO/Bn2qyyndzv1el6Fa4g7cumcRgAAwLPoCiE6/07crVKlSrbjN2/elL59+0q+fPkkV65cpgdNJ3YEAABAxiNpBACAh3H16mlVq1aV0NBQ2/brr7/ajg0cOFB+/PFH+eabb2TDhg1mHH/Hjh2dewMAAAAye8CUSbh0TiMAAJDxXB22ZMuWLd4lYXXp2dmzZ8vChQulWbNmZt+cOXOkcuXKZhx/ekzuCAAAgIRRaQQAANJEJ2C8cuWK3ab7EnLo0CEpWrSolClTRjp37myWiFW6pHxUVJS0aNHCdq4OXStRooRs2rQpQ94LAAAAbiNpBACAh3F2tfXYsWPN8q9xN90Xn/r168vcuXNlxYoVMmPGDDl69KhZGezq1aty+vRp8fPzkzx57CdILVSokDkGAACQYRieZjA8DQAApElISIgMGjTIbp+/f/wrqrVp08b2c40aNUwSqWTJkvL1119Ljhw50r2tAAAASD6SRgAAeBzn9nb5+/slmCRKilYVVahQQQ4fPiwtW7aUyMhIuXTpkl21ka6eFt8cSAAAAOnHfauDnInhaQAAeJjMVG197do1OXLkiBQpUkTq1Kkjvr6+snbtWtvxgwcPmjmPGjZsmPY3DgAA4I4BkwtRaQQAADLMq6++Ku3btzdD0k6dOiXDhw8XHx8feeqpp8xcSD169DBD3YKDgyUwMFD69+9vEkasnAYAAJDxSBoBAOBhXNnXdfLkSZMgOn/+vBQoUEAaN24smzdvNj+riRMnire3t3Tq1MmswNa6dWuZPn26C1sMAAA8k/tWBzmTl8VisUgWc/TcTVc3AW4swN/H1U2AmwrM4evqJsCNZc/AbpzQy5FOvV6RID+nXg8Zx3Jqh6ubAHeVPcjVLYAb88puv0omkGw582fYr7KcO+DU63nlryTuiDmNAAAAAAAA4IDhaQAAeBgvyq0BAACSQLykqDQCAAAAAACAAyqNAADwNHScAQAAJM6LgEmRNAIAwMMQAgEAACSFiEkxPA0AAAAAAAAOqDQCAMDDUG0NAACQBAImg6QRAAAehtXTAAAAkkK8pBieBgAAAAAAAAdUGgEA4GnoOAMAAEAykDQCAMDDkDMCAABInBdzGhkMTwMAAAAAAIADKo0AAPAwdJwBAAAkhYBJUWkEAAAAAAAAB1QaAQDgYbzoOQMAAEgcpdkGSSMAADwMMRAAAEBSCJgUw9MAAAAAAADggEojAAAAAACAuCjNNkgaAQDgYYiBAAAAkkLApBieBgAAAAAAAAdUGgEA4GFYPQ0AACAJlGYbVBoBAAAAAADAAZVGAAB4GDrOAAAAkkLApEgaAQDgYQiBAAAAkkAvm8HwNAAAAAAAADig0ggAAE9DxxkAAEASCJgUSSMAADwMq6cBAAAkgXDJYHgaAAAAAAAAHFBpBACAh2FeRwAAgKQQMCmSRgAAeBhCIAAAgCTQy2YwPA0AAAAAAAAOqDQCAMDT0HEGAACQBAImRaURAAAAAAAAHFBpBACAh/Gi5wwAACBxzGlkkDQCAMDDEAMBAAAkhYBJMTwNAAAAAAAADrwsFovFcTeyqoiICBk7dqyEhISIv7+/q5sDN8PnB6nFZweAu+G/W0gtPjtICz4/yGxIGnmYK1euSFBQkFy+fFkCAwNd3Ry4GT4/SC0+OwDcDf/dQmrx2UFa8PlBZsPwNAAAAAAAADggaQQAAAAAAAAHJI0AAAAAAADggKSRh9HJ1IYPH86kakgVPj9ILT47ANwN/91CavHZQVrw+UFmw0TYAAAAAAAAcEClEQAAAAAAAByQNAIAAAAAAIADkkYAAAAAAABwQNLIQ4wdO1bq1asnuXPnloIFC0qHDh3k4MGDrm4W3MCMGTOkRo0aEhgYaLaGDRvKTz/95OpmwQ2NGzdOvLy8ZMCAAa5uCgDEi3gJaUHMBGchZkJmQtLIQ2zYsEH69u0rmzdvltWrV0tUVJS0atVKwsPDXd00ZHLFihUzX1w7duyQ7du3S7NmzeSRRx6RvXv3urppcCPbtm2TWbNmmWAaADIr4iWkBTETnIGYCZkNq6d5qLNnz5oeNA2OmjRp4urmwM0EBwfLu+++Kz169HB1U+AGrl27JnfffbdMnz5d3n77balVq5ZMmjTJ1c0CgCQRLyGtiJmQEsRMyIyoNPJQly9ftn2RAckVHR0tX375pelx1ZJrIDm0175du3bSokULVzcFAFKEeAmpRcyE1CBmQmaUzdUNQMaLiYkx42MbNWok1apVc3Vz4Ab27NljAp6bN29Krly5ZPHixVKlShVXNwtuQAPmP/74w5RaA4A7IV5CahAzIbWImZBZkTTy0Az2X3/9Jb/++qurmwI3UbFiRdm1a5fpcV20aJF069bNlOoTBCExJ06ckJdfftnMC5I9e3ZXNwcAUoR4CalBzITUIGZCZsacRh6mX79+8v3338vGjRuldOnSrm4O3JSWzJYtW9ZM0gckZMmSJfLoo4+Kj4+PXbm+rgbi7e0tERERdscAILMgXoKzEDMhOYiZkJlRaeQhNDfYv39/UyK7fv16AiCkuWRfv7yAxDRv3tyU6cf17LPPSqVKlWTIkCEEPwAyHeIlOBsxE5KDmAmZGUkjDyqxXrhwoek1y507t5w+fdrsDwoKkhw5cri6ecjEQkJCpE2bNlKiRAm5evWq+RxpIL1y5UpXNw2ZnP635s55QAICAiRfvnzMDwIgUyJeQloQMyG1iJmQmZE08hAzZswwj02bNrXbP2fOHOnevbuLWgV3EBYWJl27dpXQ0FATNNeoUcMEPy1btnR10wAAcCriJaQFMROArIg5jQAAAAAAAODA23EXAAAAAAAAPB1JIwAAAAAAADggaQQAAAAAAAAHJI0AAAAAAADggKQRAAAAAAAAHJA0AgAAAAAAgAOSRgAAAAAAAHBA0ggAAAAAAAAOSBoBAAAAAADAAUkjwA38+++/4uXlJbt27ZLM4sCBA9KgQQPJnj271KpVS9zR2rVrpXLlyhIdHZ2s8/ft2yfFihWT8PDwdG8bAABIGeKl9EG8BHg2kkZAMnTv3t0EIePGjbPbv2TJErPfEw0fPlwCAgLk4MGDJpi4k96XxLYRI0ak+nfr6/Xep9Vrr70mQ4cOFR8fn2SdX6VKFRP4ffDBB2n+3QAAZDXES46IlwC4O5JGQDJpD9H48ePl4sWLklVERkam+rVHjhyRxo0bS8mSJSVfvnwOx0NDQ23bpEmTJDAw0G7fq6++Kq7066+/mvfQqVOnFL3u2WeflRkzZsitW7fSrW0AALgr4iV7xEvES4C7I2kEJFOLFi2kcOHCMnbs2ATP0d6gO0uPNQAoVaqUXS9chw4d5J133pFChQpJnjx5ZNSoUeZLdfDgwRIcHGxKeufMmRNvifO9995rArJq1arJhg0b7I7/9ddf0qZNG8mVK5e5dpcuXeTcuXO2402bNpV+/frJgAEDJH/+/NK6det430dMTIxpk7bD39/fvKcVK1bY9Vzt2LHDnJNQL5jeK+sWFBRkzou778svvzSlzvpeKlWqJNOnT7cLzrSdRYoUMcc10LLed+u9fPTRR801rc///PNPeeCBByR37twm4KpTp45s3749wb+V/v6WLVua66u///7bXE/vcVwTJ06UsmXL2p7ray5cuOBw7wEAAPES8VIs4iUg6yBpBCSTluRq4DJ16lQ5efJkmq71888/y6lTp2Tjxo2mdFdLlx966CHJmzevbNmyRXr37i0vvPCCw+/RIOmVV16RnTt3SsOGDaV9+/Zy/vx5c+zSpUvSrFkzqV27tvny16DlzJkz8vjjj9tdY968eeLn5ye//fabzJw5M972TZ48Wd5//3157733ZPfu3SZYevjhh+XQoUPmuPZ8Va1a1bQlNb1gCxYskGHDhsmYMWNk//795r6+9dZbpm1qypQp8sMPP8jXX39tyrn1fGuws23bNvOoQaL+buvzzp07m6BNn2uA9vrrr4uvr2+Cbfjll1+kbt26tucVKlQwz/V33dnWp59+2vZc750Ghfp6AABgj3iJeEkRLwFZiAVAkrp162Z55JFHzM8NGjSwPPfcc+bnxYsXW+L+Mxo+fLilZs2adq+dOHGipWTJknbX0ufR0dG2fRUrVrTcd999tue3bt2yBAQEWL744gvz/OjRo+b3jBs3znZOVFSUpVixYpbx48eb56NHj7a0atXK7nefOHHCvO7gwYPm+f3332+pXbt2ku+3aNGiljFjxtjtq1evnuXFF1+0Pdf3qe83OebMmWMJCgqyPS9btqxl4cKFdudo+xs2bGh+7t+/v6VZs2aWmJiYeK+n70nvfVy5c+e2zJ0715Jc2p7PPvvM4W+lbbPS+6a/a//+/XbnPfroo5bu3bsn+3cBAOAJiJeIl+IiXgKyBiqNgBTScfraw6M9PqmlvU7e3rf/+WlpdPXq1e166XTce1hYmN3rtLfMKlu2bKanx9oOLTdet26dKbW2blrGrHQsupWWISfmypUrplevUaNGdvv1eVres5WupKHt6dGjh11b3377bVs7tSRdVz6pWLGivPTSS7Jq1aokrzto0CB5/vnnTVm8TsAZ9z3H58aNG7ZSa6snn3zSrLyyefNmW6/Z3XffbbuPVjly5JDr16+n4t0DAOAZiJfShngJQGZB0ghIoSZNmpjy45CQEIdjGtjEduzcFhUV5XDenWXAOjY8vn06Vj65rl27ZsqvNXiIu2mJtLbZSlfwcCVtp/r444/t2qnzC1iDDw08jh49KqNHjzbBipaMP/bYY4leV+cJ2Lt3r7Rr186Us+vKHYsXL07wfJ2j4M5JOnXuAC1ZX7hwoXmuj1rGfScdo1+gQIFUvX8AADwB8VLaEC8ByCxIGgGpoD0zP/74o2zatMluv34xnj592i4Q0i94Z7EGCUongtSx6Do5ojVw0CBAx7KXK1fObktJ4KOTIhYtWtSM4Y9Ln2tgkVbaS6jX/+effxzaWbp0abt2PPHEEyZY+uqrr+Tbb781wYfSgDE6Otrh2jrOfuDAgaanrWPHjvFOjmmlcxns27fPYb8GPfr79G+rbdTetDtpwKavBwAACSNeSj3iJQCZBUkjIBW0NFq/LHUCwrh0tY2zZ8/KhAkTTLnvtGnT5KeffnLa79XraW+QrljRt29f0/Pz3HPPmWP6XIOEp556ykxuqL9/5cqVZsnT+AKGxOgEklpWrsGATqyokyRqMPfyyy875X2MHDnSrO6h909X4dizZ48JWHSSS6WPX3zxhXmfevybb74xvVq6corSQG/t2rUm4NR7oL1runrI+vXr5dixYyZg03tgDRDjo72fuozsnTR4unr1qvTp08esLqIBW1xajv3ff/+Zsm4AAJAw4qW0IV4CkBmQNAJSSZdPvbMcWr90dSlUDVZq1qwpW7duTfFKGUn12Omm19YvcF0xQ8uGlbW3SwOeVq1amUBNl4rVwCHufADJoePidcy7rvah19GVRfR3lS9f3invQ8fSf/LJJybw0evff//9MnfuXFvPmS4Dq4GkzkFQr149E3gsX77c9j50pZLVq1dL8eLFTQ+Wzmmgq6J07drV9J5pebYupavBVkI0iNWeRg3y4tLfrWXrOudBfKXWGpzp/dVlbQEAQOKIl1KPeAlAZuCls2G7uhEA4AraQ6gTWc6aNStZ50dGRppAUMfu3znxJQAAQFZEvAR4NiqNAHisN9980/SAJXcCzePHj8sbb7xBAAQAADwG8RLg2ag0AgAAAAAAgAMqjQAAAAAAAOCApBEAAAAAAAAckDQCAAAAAACAA5JGAAAAAAAAcEDSCAAAAAAAAA5IGgEAAAAAAMABSSMAAAAAAAA4IGkEAAAAAAAABySNAAAAAAAAIHf6P8oKcZfr62sFAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 1200x500 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(\"THE TOTAL NUMBER OF TEST COMBINATIONS IN EACH CRITERIA\\n1. Without caring about different dates in DOS\\n2. With caring about different dates in DOS\")\n",
    "\n",
    "# Create visualizations for the pivot tables\n",
    "fig, axes = plt.subplots(1, 2, figsize=(15, 6))\n",
    "\n",
    "# Plot for pivot_table (without caring about different dates)\n",
    "pivot_table.plot(kind='bar', ax=axes[0], color=['skyblue', 'lightcoral', 'lightgreen'])\n",
    "axes[0].set_title('Test Combinations\\n(Without caring about different dates in DOS)')\n",
    "axes[0].set_xlabel('Patient Limit')\n",
    "axes[0].set_ylabel('Number of Possible Combinations')\n",
    "axes[0].legend(title='Number of Tests (v)', bbox_to_anchor=(1.05, 1), loc='upper left')\n",
    "axes[0].grid(True, alpha=0.3)\n",
    "\n",
    "# Plot for pivot_table_2 (with caring about different dates)\n",
    "pivot_table_2.plot(kind='bar', ax=axes[1], color=['skyblue', 'lightcoral', 'lightgreen'])\n",
    "axes[1].set_title('Test Combinations\\n(With caring about different dates in DOS)')\n",
    "axes[1].set_xlabel('Patient Limit')\n",
    "axes[1].set_ylabel('Number of Possible Combinations')\n",
    "axes[1].legend(title='Number of Tests (v)', bbox_to_anchor=(1.05, 1), loc='upper left')\n",
    "axes[1].grid(True, alpha=0.3)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Create a comparison heatmap\n",
    "fig, axes = plt.subplots(1, 2, figsize=(12, 5))\n",
    "\n",
    "# Heatmap for pivot_table\n",
    "sns.heatmap(pivot_table, annot=True, fmt='d', cmap='Blues', ax=axes[0])\n",
    "axes[0].set_title('Without Different Dates in DOS')\n",
    "axes[0].set_xlabel('Number of Tests (v)')\n",
    "axes[0].set_ylabel('Patient Limit')\n",
    "\n",
    "# Heatmap for pivot_table_2\n",
    "sns.heatmap(pivot_table_2, annot=True, fmt='d', cmap='Oranges', ax=axes[1])\n",
    "axes[1].set_title('With Different Dates in DOS')\n",
    "axes[1].set_xlabel('Number of Tests (v)')\n",
    "axes[1].set_ylabel('Patient Limit')\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Create difference visualization\n",
    "difference_table = pivot_table - pivot_table_2\n",
    "fig, ax = plt.subplots(figsize=(8, 6))\n",
    "sns.heatmap(difference_table, annot=True, fmt='d', cmap='RdBu_r', center=0, ax=ax)\n",
    "ax.set_title('Difference in Number of Combinations\\n(Without DOS dates - With DOS dates)')\n",
    "ax.set_xlabel('Number of Tests (v)')\n",
    "ax.set_ylabel('Patient Limit')\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 144,
   "id": "da7ecb44",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total number of subsets of size 5: 324632\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 318 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'TSH', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 579 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 361 patients.\n",
      "Subset ('CRP Titer', 'Blood Sugar', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 320 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 337 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 301 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 362 patients.\n",
      "Subset ('CRP Titer', 'S.ALP', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 303 patients.\n",
      "Subset ('CRP Titer', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 325 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'TSH', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 456 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL') has more than 300 patients. with 308 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL') has more than 300 patients. with 363 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Cholestrol', 'S.HDL', 'S.LDL') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'HBA1C', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 375 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 416 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GOT ( AST )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 375 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 377 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 365 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'TSH', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 376 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 644 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 583 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 655 patients.\n",
      "Subset ('Blood Sugar', 'S.ALP', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 584 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL') has more than 300 patients. with 350 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL') has more than 300 patients. with 400 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea') has more than 300 patients. with 303 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.Creatinine') has more than 300 patients. with 327 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.Triglyceride', 'Vitamin D3') has more than 300 patients. with 312 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL') has more than 300 patients. with 349 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Cholestrol', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 302 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 349 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Triglyceride', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 304 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Ferritin', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 748 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 359 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 360 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 645 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 310 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 422 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 367 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 333 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'TSH', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 530 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 735 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.Creatinine') has more than 300 patients. with 409 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'Vitamin D3') has more than 300 patients. with 341 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )') has more than 300 patients. with 320 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea') has more than 300 patients. with 417 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 460 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GPT ( ALT )') has more than 300 patients. with 325 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 381 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 377 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 389 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 405 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 522 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 381 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 395 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.Triglyceride', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 303 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 409 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 342 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 373 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 307 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 320 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 416 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 312 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 378 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 378 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 390 patients.\n",
      "Subset ('Blood Sugar', 'S.Cholestrol', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 382 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 375 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 409 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 341 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 322 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 416 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 314 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 379 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 392 patients.\n",
      "Subset ('Blood Sugar', 'S.Triglyceride', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 383 patients.\n",
      "Subset ('Blood Sugar', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 374 patients.\n",
      "Subset ('Blood Sugar', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 309 patients.\n",
      "Subset ('Blood Sugar', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 301 patients.\n",
      "Subset ('Blood Sugar', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 568 patients.\n",
      "Subset ('Blood Sugar', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 344 patients.\n",
      "Subset ('Blood Sugar', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 631 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'S.Creatinine', 'HBs Ag', 'HCV Ab') has more than 300 patients. with 306 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'S.Creatinine', 'HBs Ag', 'HIV Ab') has more than 300 patients. with 306 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'S.Creatinine', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 306 patients.\n",
      "Subset ('Blood Sugar', 'B.Urea', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 312 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'Sodium  Na+', 'Potassium K+', 'Chloride CL-') has more than 300 patients. with 395 patients.\n",
      "Subset ('Blood Sugar', 'S.Creatinine', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 571 patients.\n",
      "Subset ('HBA1C', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 488 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 455 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.GOT ( AST )', 'S.Creatinine', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 399 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.GOT ( AST )', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 468 patients.\n",
      "Subset ('S.ALP', 'TSH', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 400 patients.\n",
      "Subset ('S.ALP', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 705 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL') has more than 300 patients. with 576 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea') has more than 300 patients. with 308 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.Creatinine') has more than 300 patients. with 328 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'Vitamin D3') has more than 300 patients. with 337 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea') has more than 300 patients. with 334 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 360 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 382 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 378 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 308 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 327 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 341 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 306 patients.\n",
      "Subset ('TSH', 'S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 331 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 309 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 327 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 337 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 306 patients.\n",
      "Subset ('TSH', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 331 patients.\n",
      "Subset ('TSH', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 308 patients.\n",
      "Subset ('TSH', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 439 patients.\n",
      "Subset ('TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 326 patients.\n",
      "Subset ('TSH', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )', 'T.S.B ( Total Serum Bilirubin )') has more than 300 patients. with 439 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'Sodium  Na+', 'Potassium K+', 'Chloride CL-') has more than 300 patients. with 333 patients.\n",
      "Subset ('TSH', 'S.Creatinine', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 325 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )') has more than 300 patients. with 352 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea') has more than 300 patients. with 505 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine') has more than 300 patients. with 553 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GPT ( ALT )') has more than 300 patients. with 361 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'Vitamin D3') has more than 300 patients. with 530 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'ESR') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.LDL', 'PCV') has more than 300 patients. with 363 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 310 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 324 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 353 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 502 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 316 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.HDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 332 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 339 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 353 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 384 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 562 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 345 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'B.Urea', 'Vitamin D3') has more than 300 patients. with 307 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 361 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.LDL', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 325 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 438 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 438 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 452 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 444 patients.\n",
      "Subset ('S.Cholestrol', 'S.Triglyceride', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 355 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 324 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 354 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 502 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 317 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 332 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 311 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 325 patients.\n",
      "Subset ('S.Cholestrol', 'S.HDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 317 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 340 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 340 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 354 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 346 patients.\n",
      "Subset ('S.Cholestrol', 'S.LDL', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 307 patients.\n",
      "Subset ('S.Cholestrol', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 439 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea') has more than 300 patients. with 312 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine') has more than 300 patients. with 325 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.GPT ( ALT )') has more than 300 patients. with 354 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 503 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 318 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.LDL', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 333 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 312 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 312 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 326 patients.\n",
      "Subset ('S.Triglyceride', 'S.HDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 318 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 341 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 341 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 357 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 347 patients.\n",
      "Subset ('S.Triglyceride', 'S.LDL', 'B.Urea', 'S.Creatinine', 'Vitamin D3') has more than 300 patients. with 306 patients.\n",
      "Subset ('S.Triglyceride', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 443 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine') has more than 300 patients. with 315 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.GPT ( ALT )') has more than 300 patients. with 315 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'S.GOT ( AST )', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 328 patients.\n",
      "Subset ('S.HDL', 'S.LDL', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 321 patients.\n",
      "Subset ('S.HDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 315 patients.\n",
      "Subset ('S.LDL', 'S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )') has more than 300 patients. with 344 patients.\n",
      "Subset ('S.GOT ( AST )', 'B.Urea', 'S.Creatinine', 'S.GPT ( ALT )', 'Vitamin D3') has more than 300 patients. with 349 patients.\n",
      "Subset ('B.Urea', 'S.Creatinine', 'Sodium  Na+', 'Potassium K+', 'Chloride CL-') has more than 300 patients. with 399 patients.\n",
      "Subset ('B.Urea', 'S.Creatinine', 'HBs Ag', 'HCV Ab', 'HIV Ab') has more than 300 patients. with 508 patients.\n"
     ]
    }
   ],
   "source": [
    "# for degree of 5:\n",
    "# limit of 300\n",
    "\n",
    "subsets = list(combinations(unique_tests_cleaned, 5))\n",
    "print(f\"Total number of subsets of size 5: {len(subsets)}\")\n",
    "for subset in subsets:\n",
    "    # Create a boolean mask for patients who have all tests in the subset\n",
    "    mask = df_grouped_by_patient[subset[0]] > 0\n",
    "    for test in subset[1:]:\n",
    "        mask = mask & (df_grouped_by_patient[test] > 0)\n",
    "    \n",
    "    count = mask.sum()\n",
    "    if count > 300:\n",
    "        print(f\"Subset {subset} has more than 300 patients. with {count} patients.\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "303786ed",
   "metadata": {},
   "source": [
    "## Summary of Key Findings\n",
    "\n",
    "This analysis of laboratory test data revealed several important insights about data quality and test combination patterns:\n",
    "\n",
    "### Data Quality Issues\n",
    "\n",
    "**Date of Birth (DOB) Inaccuracy**: The DOB field contains systematic formatting errors where days of the week beyond 12 are incorrectly converted to 1, indicating an inconsistent date format (likely month/day/year instead of day/month/year). This contrasts with the Date of Sample (DOS) field, which maintains proper day/month/year formatting.\n",
    "\n",
    "**Name Matching and Consolidation**: Successfully identified and merged similar patient names using fuzzy matching with 85% similarity threshold and first name constraints, achieving high precision in combining duplicate patient records.\n",
    "\n",
    "### Test Combination Analysis\n",
    "\n",
    "The study examined test combinations across different criteria and patient volume thresholds:\n",
    "\n",
    "#### Without Date Constraints\n",
    "- **2 tests**: 260 combinations (300+ patients), 167 combinations (500+ patients), 59 combinations (1000+ patients)\n",
    "- **3 tests**: 443 combinations (300+ patients), 191 combinations (500+ patients), 36 combinations (1000+ patients)  \n",
    "- **4 tests**: 409 combinations (300+ patients), 114 combinations (500+ patients), 4 combinations (1000+ patients)\n",
    "\n",
    "#### With Temporal Analysis (Multiple Time Points Required)\n",
    "##### Temporal Analysis Results:\n",
    "- The total number of tests done across all patients is: **41901**\n",
    "- The total number of rows is: **18320**\n",
    "- The total number of unique patients is: **6146**\n",
    "\n",
    "After requiring multiple time points for patient testing (DOS constraint):\n",
    "- **2 tests**: 202 combinations (300+ patients), 131 combinations (500+ patients), 50 combinations (1000+ patients)\n",
    "- **3 tests**: 356 combinations (300+ patients), 152 combinations (500+ patients), 30 combinations (1000+ patients)\n",
    "- **4 tests**: 337 combinations (300+ patients), 87 combinations (1000+ patients), 4 combinations (1000+ patients)\n",
    "\n",
    "### Key Observations\n",
    "\n",
    "1. **Temporal constraints reduce available combinations** by 15-25% across most categories\n",
    "2. **Higher patient thresholds dramatically limit viable combinations**, especially for 4+ test combinations\n",
    "3. **3-test combinations show optimal balance** between complexity and patient volume availability\n",
    "4. **Data preprocessing significantly improved data quality** through name standardization and date validation\n",
    "\n",
    "These findings provide a foundation for selecting appropriate test combinations for longitudinal health analysis while ensuring adequate statistical power."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "341aa9fe",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
